false FY 0001857855 00-0000000

 FNVT:ClassOrdinarySharesParValue0.0001PerShareMember

 FNVT:RedeemableWarrantsEachWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50Member

 FNVT:UnitsEachConsistingOfOneClassOrdinaryShareAndThreequartersOfRedeemableWarrantMember

 2023-06-30

 2024-04-01

 2024-04-01

 2023-10-01

 FNVT:RedeemableOrdinarySharesMember

 FNVT:RedeemableOrdinarySharesMember

 FNVT:NonRedeemableOrdinarySharesMember

 FNVT:NonRedeemableOrdinarySharesMember

 FNVT:MarchTwentyTwentyOnePromissoryNoteMember
 srt: MaximumMember

 FNVT:PromissoryNoteMember

 2023-06-02

 2023-06-02
 2023-06-02

 FNVT:PromissoryNoteMember
 us-gaap: WarrantMember

 2023-06-02

 FNVT:UnsecuredPromissoryNoteMember
 FNVT:SunorangeMember

 2023-11-08

 FNVT:UnsecuredPromissoryNoteMember
 FNVT:SunorangeMember

 2023-04-27
 2023-04-27

 2023-04-27

 us-gaap: InvestorMember

 us-gaap: InvestorMember

 FNVT:TrustAccountMember

 FNVT:ScageInternationalLimitedMember

 2023-08-21
 2023-08-21

 FNVT:ScageInternationalLimitedMember

 2023-08-29

 FNVT:KeySellerLockUpAgreementMember

 2023-05-18

 FNVT:NonRedeemableOrdinarySharesMember

 FNVT:NonRedeemableOrdinarySharesMember

 FNVT:RedeemableOrdinarySharesMember

 FNVT:RedeemableOrdinarySharesMember

 srt: MaximumMember

 us-gaap: PrivatePlacementMember
 FNVT:EarlyBirdCapitalMember

 FNVT:UnderwriterMember

 us-gaap: PrivatePlacementMember
 FNVT:EarlyBirdCapitalMember

 us-gaap: PrivatePlacementMember

 2021-03-01

 srt: MaximumMember

 2021-03-01

 FNVT:UnderwriterMember

 FNVT:EBCFounderSharesMember

 2021-03-01

 FNVT:EBCFounderSharesMember

 2021-10-01
 2021-10-31

 2021-10-31

 FNVT:PromissoryNoteMember

 srt: MaximumMember

 us-gaap: WarrantMember

 us-gaap: RelatedPartyMember

 us-gaap: RelatedPartyMember

 FNVT:UnsecuredPromissoryNoteMember

 2023-11-08

 FNVT:AdministrativeServicesAgreementMember

 FNVT:AdministrativeServicesAgreementMember
 us-gaap: RelatedPartyMember

 FNVT:AdministrativeServicesAgreementMember

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 us-gaap: FairValueInputsLevel1Member

 us-gaap: FairValueInputsLevel2Member

 us-gaap: FairValueInputsLevel3Member

 FNVT:EarlyBirdCapitalMember

 FNVT:ThirdPartyConsultantMember
 srt: MinimumMember

 us-gaap: WarrantMember

 FNVT:PublicWarrantsMember

 us-gaap: SubsequentEventMember

 2024-01-31

 us-gaap: SubsequentEventMember

 2024-02-29

 us-gaap: SubsequentEventMember

 2024-03-31

 FNVT:TrustAccountMember
 us-gaap: SubsequentEventMember

 2024-03-31

 UNITED
STATES

 SECURITIES
AND EXCHANGE COMMISSION

 WASHINGTON,
D.C. 20549

 FORM

 (Mark One)

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the fiscal year ended December 31, 2023

 or

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the transition period from _______________ to _______________

 Commission
File Number 001-41012

 Finnovate
Acquisition Corp.

 (Exact
name of registrant as specified in its charter)

 Cayman
 Islands

 001-41012

 N/A

 (State
 or other jurisdiction

 of
 incorporation or organization)

 (Commission

 File
 Number)

 (I.R.S.
Employer

 Identification No.)

Franklin Street

 Suite
1702

 Boston,
 MA 02110

 (Address
of principal executive offices, including zip code)

 +1
424 - 253-0908

 (Registrant's
telephone number, including area code)

 Not
Applicable

 (Former
name or former address, if changed since last report)

 Securities
registered pursuant to Section 12(b) of the Act:

 Title
 of each class

 Trading
 Symbol(s)

 Name
 of each exchange on which registered

 Class
 A Ordinary Shares, par value $0.0001 per share

 FNVT

 The
 Nasdaq Stock Market LLC

 warrants, each warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50

 FNVTW

 The
 Nasdaq Stock Market LLC

 Units,
 each consisting of one Class A Ordinary Share and three-quarters of a redeemable warrant

 FNVTU

 The
 Nasdaq Stock Market LLC

 Securities
registered pursuant to Section 12(g) of the Act: None

by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
 No

by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes No

by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes No

by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller
reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large
 accelerated filer

 Accelerated
 filer

 Non-accelerated
 filer

 Smaller
 reporting company

 Emerging
 growth company

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.

 If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements.

by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No

 The
aggregate market value of the outstanding shares of the registrant's Class A Ordinary Shares, other than shares held by persons
who may be deemed affiliates of the registrant, computed by reference to the closing price for the Class A Ordinary Shares on June 30,
2023, as reported on the Nasdaq Stock Market LLC was $ 50,290,936.

 As
of April 1, 2024, 9,085,831 Class A Ordinary Shares, par value $0.0001 per share, and 1 Class B Ordinary Share, par value $0.0001
per share, of the registrant were issued and outstanding.

 ANNUAL
REPORT ON FORM 10-K

 TABLE
OF CONTENTS

 Page

 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 Item 1. Business

 Item 1A. Risk Factors

 Item 1B. Unresolved Staff Comments

 Item 1C. Cybersecurity

 Item 2. Property

 Item 3. Legal Proceedings

 Item 4. Mine Safety Disclosures

 Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 Item 6. [Reserved]

 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A. Quantitative and Qualitative Disclosures about Market Risk

 Item 8. Financial Statements and Supplementary Data

 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 Item 9A. Controls and Procedures

 Item 9B. Other Information

 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 Item 10. Directors, Executive Officers and Corporate Governance

 Item 11. Executive Compensation

 Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 Item 13. Certain Relationships and Related Transactions, and Director Independence

 Item 14. Principal Accountant Fees and Services

 Item 15. Exhibits, Financial Statement Schedules

 Item 16. Form 10-K Summary

 CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS

 This
Report (as defined below), includes, without limitation, statements under "Item 7. Management's Discussion and Analysis
of Financial Condition and Results of Operations," forward-looking statements within the meaning of Section 27A of the
Securities Act (as defined below) and Section 21E of the Exchange Act (as defined below). These forward-looking statements can be identified
by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates,"
"expects," "intends," "plans," "may," "will," "potential," "projects,"
"predicts," "continue," or "should," or, in each case, their negative or other variations or comparable
terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but
are not limited to, any statements relating to our ability to consummate any acquisition or other Business Combination (as defined below)
and any other statements that are not statements of current or historical facts. These statements are based on Management's (as
defined below) current expectations, but actual results may differ materially due to various factors, including, but not limited to:

 our
 ability to complete our initial Business Combination, including the Scage Business Combination (as defined below);

 our
 expectations around the performance of the prospective target business or businesses, such as Scage (as defined below);

 our
 success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial Business
 Combination;

 our
 officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or
 in approving our initial Business Combination, as a result of which they would then receive expense reimbursements;

 the
 potential incentive to consummate an initial Business Combination with an acquisition target that subsequently declines in value
 or is unprofitable for public investors due to the low initial price for the Founder Shares (as defined below) paid by our Sponsor
 (as defined below) and Initial Shareholders (as defined below);

 our
 potential ability to obtain additional financing to complete our initial Business Combination;

 the
 ability of our officers and directors to generate additional potential acquisition opportunities, if needed;

 our
 pool of prospective target businesses;

 our
 public securities' potential liquidity and trading;

 the
 lack of a market for our securities;

 the
 use of proceeds not held in the Trust Account (as defined below) or available to us from interest income on the Trust Account balance;

 the
 Trust Account not being subject to claims of third parties;

 the
 impact on the amount held in the Trust Account, our capitalization, principal shareholders and other impacts on our Company (as defined
 below) or Management Team should we seek to further extend the Combination Period (as defined below) consistent with applicable,
 laws, regulations and stock exchange rules;

 our
 financial performance; or

 the
 other risks and uncertainties discussed in "Item 1A. Risk Factors" below.

 Additionally,
on January 24, 2024, the SEC (as defined below) adopted the 2024 SPAC Rules (as defined below), which will become effective on July 1,
2024, that will affect SPAC (as defined below) Business Combination transactions. The 2024 SPAC Rules require, among other matters, (i)
additional disclosures relating to SPAC Business Combination transactions (ii) additional disclosures relating to dilution and
to conflicts of interest involving sponsors and their affiliates in both SPAC initial public offerings and Business Combination transactions;
(iii) additional disclosures regarding projections included in SEC filings in connection with proposed Business Combination transactions
and (iv) the requirement that both the SPAC and its target company be co-registrants for Business Combination registration statements.
In addition, the SEC's adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation
under the Investment Company Act (as defined below), including its duration, asset composition, business purpose, and the activities
of the SPAC and its management team in furtherance of such goals. The 2024 SPAC Rules may materially affect our ability to negotiate
and complete our initial Business Combination and may increase the costs and time related thereto.

 The
forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments
and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking
statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual
results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or
more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material
respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities
laws.

 CERTAIN
TERMS

 Unless
otherwise stated in this Report, or the context otherwise requires, references to:

 "2022
 Annual Report" are to our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the SEC on
 April 13, 2023;

 "2023
 EGM" are to our extraordinary general meeting of shareholders held on May 8, 2023;

 "2023
 Redemptions" are to the 12,626,668 Class A Ordinary Shares whose holders properly exercised their right to redeem their shares
 for cash at a redemption price of approximately $10.50 per share in connection with the approval of the Extension (as defined below)
 and the Conversion Amendment Proposal (as defined below).

 "2024
 SPAC Rules" are to the new rules and regulations for SPACs adopted by the SEC on January 24, 2024, which will become effective
 on July 1, 2024;

 "Administrative
 Services Agreement" are to the Administrative Services Agreement, dated November 8, 2021 which we entered into with our Sponsor;

 "Amended
 and Restated Memorandum" are to our Amended and Restated Memorandum and Articles of Association, as amended and currently in
 effect;

 "ASC"
 are to the FASB (as defined below) Accounting Standards Codification;

 "ASU"
 are to the FASB Accounting Standards Update;

 "Audit
 Committee" are to the audit committee of our Board of Directors (as defined below);

 "Board
 of Directors" or "Board" are to our board of directors;

 "Business
 Combination" are to a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business
 combination with one or more businesses;

 "Class
 A Ordinary Shares" are to our Class A ordinary shares, par value $0.0001 per share;

 "Class
 B Ordinary Shares" are to our Class B ordinary shares, par value $0.0001 per share;

 "Combination Period" are to the 30-month period, from the closing
of the Initial Public Offering to May 8, 2024 (or such earlier date as determined by the Board) as extended by the Extension (as defined
below), that we have to consummate an initial Business Combination; provided that the Combination Period may be further extended pursuant
to an amendment to the Amended and Restated Memorandum and consistent with applicable laws, regulations and stock exchange rules;

 "Company,"
 "our," "we," or "us" are to Finnovate Acquisition Corp., a Cayman Islands exempted company;

 "Continental"
 are to Continental Stock Transfer & Trust Company, trustee of our Trust Account and warrant agent of our Public Warrants (as
 defined below);

 "Conversion Amendment Proposal" are to the proposal to amend
the Amended and Restated Memorandum to entitle holders of Class B Ordinary Shares to convert such shares into Class A Ordinary Shares
prior to the closing of the initial Business Combination at the election of the holder, as approved by our stockholders at the 2023 EGM;

 "DWAC
 System" are to the Depository Trust Company's Deposit/Withdrawal At Custodian System;

 "EarlyBirdCapital"
 are to EarlyBirdCapital, Inc., the representative of the underwriters in our Initial Public Offering;

 "EBC
 Founder Shares" are to the 150,000 Class A Ordinary Shares that we have issued to EarlyBirdCapital and its designees in a private
 placement prior to our Initial Public Offering;

 "Equity-Linked
 Securities" are to any securities of our Company that are convertible into or exchangeable or exercisable for, Class A Ordinary
 Shares of our Company;

 "Exchange
 Act" are to the Securities Exchange Act of 1934, as amended;

 "Excise
 Tax" are to the U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and
 certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023 as provided for
 by the Inflation Reduction Act;

 "Extension" are to the extension of the date by which we must
consummate our initial Business Combination from May 8, 2023 to May 8, 2024, as approved by our stockholders at the 2023 EGM;

 "FASB"
 are to the Financial Accounting Standards Board;

 "FINRA"
 are to the Financial Industry Regulatory Authority;

 "First Merger" are to the merger whereby the First Merger Sub
(as defined below) will merge with merge with and into Scage, with Scage surviving as a wholly-owned subsidiary of Pubco (as defined below)
and Scage's outstanding securities being converted into the right to receive securities of Pubco;

 "First
 Merger Sub" are to Hero 1, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco;

 "Founder Share Conversion" are to the aggregate of 4,312,499
Class A Ordinary Shares issued on May 8, 2023, following the approval of the Conversion Amendment Proposal by our shareholders at the
2023 EGM, of which 4,237,499 Class A Ordinary Shares were issued to the Sponsor and 75,000 Class A Ordinary Shares were issued to Mitch
Garber, Nadav Zohar and Gustavo Schwed, former directors of our Company, upon the conversion of an equal number of Class B Ordinary Shares
held by the Sponsor, Mitch Garber, Nadav Zohar and Gustavo Schwed as Founder Shares;

 "Founder Shares" are to the 4,312,500 Class B Ordinary Shares
initially purchased by our Sponsor prior to the Initial Public Offering (of which 75,000 shares were transferred to our independent directors
at the time) and the Class A Ordinary Shares that (i) will be issued upon the automatic conversion of the Class B Ordinary Shares at the
time of our Business Combination as described herein (for the avoidance of doubt, such Class A Ordinary Shares will not be "Public
Shares" (as defined below)) (ii) were issued in connection with the Founder Share Conversion upon the conversion of an equal number
of shares of Class B Ordinary Shares;

 "GAAP"
 are to the accounting principles generally accepted in the United States of America;

 "Initial
 Public Offering" or "IPO" are to the initial public offering that we consummated on November 8, 2021;

 "Initial
 Shareholders" are to holders of our Founder Shares prior to our Initial Public Offering;

 "Insider
 Securities" are to 3,557,813 Class B Ordinary Shares and 6,160,000 Private Placement Warrants (as defined below) acquired by
 Sunorange (as defined below) pursuant to the Sunorange Investment (as defined below);

 "Investment
 Agreement" are to the agreement entered into between us, the Sponsor, and Sunorange on April 27, 2023;

 "Investment
 Company Act" are to the Investment Company Act of 1940, as amended;

 "IPO
 Registration Statement" are to the Registration Statement on Form S-1 initially filed with the SEC on October 15, 2021, as
 amended, and declared effective on November 3, 2021 (File No. 333-260261);

 "January
 2024 Promissory Note" are to that certain unsecured promissory note in the aggregate principal amount of up to $1,500,000 we
 issued to Scage on January 26, 2024;

 "JOBS
 Act" are to the Jumpstart Our Business Startups Act of 2012;

 "June
 2023 Promissory Note" are to that certain unsecured promissory note in the aggregate principal amount of up to $1,200,000 we
 issued to our Sponsor on June 2, 2023;

 "Letter
 Agreement" are to the letter agreement entered into between us and our Initial Shareholders, prior directors and officers on
 November 8, 2021, which is filed as an exhibit to this Report, and subsequently by New Management (as defined below) by a joinder entered
into on June 2, 2023, which is filed as an exhibit to this Report;

 "Management"
 or our "Management Team" are to our executive officers and directors;

 "March
 2021 Promissory Note" are to that certain unsecured promissory note in the aggregate principal amount of $250,000 we issued to
 the Sponsor in March 2021;

 "Marcum"
 are to Marcum LLP, our independent registered public accounting firm;

 "Mergers"
 are to the First Merger and the Second Merger (as defined below), together;

 "Nasdaq"
 are to the Nasdaq Global Market;

 "New
 Management" are to Calvin Kung, who replaced David Gershom as Chairman of the Board and Chief Executive Officer, and Wang Chiu
 (Tommy) Wong, who replaced Ron Golan as Chief Financial Officer and director on the Board;

 "November
 2023 Promissory Note" are to that certain unsecured promissory note in the aggregate principal amount of up to $1,500,000 we
 issued to Sunorange on November 8, 2023;

 "Ordinary
 Shares" are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;

 "PCAOB"
 are to the Public Company Accounting Oversight Board (United States);

 "Private
 Placement" are to the private placement of Private Placement Warrants (as defined below) that occurred simultaneously with the
 closing of our Initial Public Offering;

 "Private
 Placement Warrants" are to the warrants issued to our Sponsor and EarlyBirdCapital in the Private Placement (including warrants
 that were issued as a result of the over-allotment option being exercised in full), as well as any warrants that may be issued upon
 conversion of Working Capital Loans (as defined below)

 "Pubco"
 are to Scage Future, a Cayman Islands exempted company;

 "Public
 Shares" are to the Class A Ordinary Shares sold as part of the Units (as defined below) in our Initial Public Offering
 (whether they were purchased in our Initial Public Offering or thereafter in the open market);

 "Public
 Shareholders" are to the holders of our Public Shares, including our Initial Shareholders and Management Team to the extent
 our Initial Shareholders and/or the members of our Management Team purchase Public Shares, provided that each Initial Shareholder's
 and member of our Management Team's status as a "Public Shareholder" will only exist with respect to such Public
 Shares;

 "Public
 Warrants" are to the redeemable warrants sold as part of the Units in our Initial Public Offering (whether they were subscribed
 for in our Initial Public Offering or purchased in the open market);

 "Registration
 Rights Agreement" are to the Registration Rights Agreement, dated November 8, 2021, which we entered into with our Sponsor
 and the holders party thereto;

 "Report"
 are to this Annual Report on Form 10-K for the fiscal year ended December 31, 2023;

 "Rule"
 are to Rule 10D-1 under the Exchange Act;

 "Sarbanes-Oxley
 Act" are to the Sarbanes-Oxley Act of 2002;

 "Scage"
 are to Scage International Limited, a Cayman Islands exempted company;

 "Scage Business Combination" are to the Mergers together with
the other transactions contemplated by the Scage Business Combination Agreement (as defined below);

 "Scage Business Combination Agreement" are to the Business
Combination Agreement we entered into on August 21, 2023, with Pubco, First Merger Sub, Second Marger Sub and Scage;

 "Scage
 Registration Statement" are to the Registration Statement on Form F-4 to be filed with the SEC in connection with the Scage
 Business Combination;

 "SEC"
 are to the U.S. Securities and Exchange Commission;

 "Second
 Merger" are to the merger whereby, immediately following the First Merger, the Second Merger Sub will merge with and into our
 Company;

 "Second
 Merger Sub" are to Hero 2, a Cayman Islands exempted company and a wholly-owned subsidiary of Pubco;

 "Securities
 Act" are to the Securities Act of 1933, as amended;

 "SPACs"
 are to special purpose acquisition companies;

 "Sponsor"
 are to Finnovate Sponsor L.P., a Delaware limited partnership;

 "Sunorange"
 are to Sunorange Limited, the general partner of the Sponsor;

 "Sunorange
 Investment" are to Sunorange's acquisition of Insider Securities, the change to New Management, and the other transactions
 contemplated by the Investment Agreement;

 "Trust
 Account" are to the U.S.-based trust account in which an amount of $175,950,000 from the net proceeds of the sale of the Units
 in the Initial Public Offering and the Private Placement Warrants in the Private Placement was placed following the closing of the
 Initial Public Offering;

 "Trust Agreement" are
to the Investment Management Trust Agreement, dated November 8, 2021, which we entered into with Continental, as trustee of the
Trust Account, as amended;

 "Units"
 are to the units sold in our Initial Public Offering, which consist of one Public Share and three-quarters of one Public Warrant;

 "Waiting
 Period" are to the applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder, after which
 Mitch Garver's, Gustavo Schwed's and Nadav Zohar's resignations as directors of the Board became effective;

 "Warrants"
 are to the Private Placement Warrants and the Public Warrants, together;

 "Working
 Capital Loans" are to funds that, in order to provide working capital or finance transaction costs in connection with a Business
 Combination, the Sponsor, Initial Shareholders, or an affiliate of the Sponsor, up to $1,500,000 of which may be converted into warrants
 at a price of $1.00 per Warrant, at the option of the lender; and

 "$,"
 "US$" and "U.S. dollar" each refer to the United States dollar.

 PART
I

 Item
1. Business.

 General

 We are a blank check company incorporated
on March 15, 2021 as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination with one or more
businesses or entities. We have generated no revenues to date, and we do not expect that we will generate operating revenues at the earliest
until we consummate our initial Business Combination.

 The 2024 SPAC Rules may materially
affect our ability to negotiate and complete our initial Business Combination and may increase the costs and time related thereto.

 Initial
Public Offering

 On
November 8, 2021, we consummated our Initial Public Offering of 15,000,000 Units. On November 12, 2021, the Company closed on the underwriters'
exercise of the full over-allotment, resulting in the sale of an additional 2,250,000 Units. Each Unit consists of one Public Share and
three-quarters of one Public Warrant, with each whole Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share
for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to our Company of $172,500,000.

with the closing of the Initial Public Offering, we completed the private sale of an aggregate of 7,900,000 Private Placement
Warrants to our Sponsor in the Private Placement at a purchase price of $1.00 per Private Placement Warrant. Pursuant to the full
exercise of the over-allotment option, the Sponsor purchased an additional 900,000 Private Placement Warrants. The sale of the
Private Placement Warrants generated gross proceeds to our Company of $8,800,000.

 A
total of $175,950,000, comprised of $153,000,000 of the proceeds from the Initial Public Offering and $22,950,000 of the proceeds of
the Private Placement, was placed in the Trust Account maintained by Continental, acting as trustee.

 It
is the job of our Sponsor and Management Team to complete our initial Business Combination. Our Management Team is led by Calvin Kung,
our Chief Executive Officer, and Wang Chiu (Tommy) Wong, our Chief Financial Officer. We must complete our initial Business Combination
by May 8, 2024, the end of our Combination Period, which is 30 months from the closing of our Initial Public Offering. If our initial
Business Combination is not consummated by the end of the Combination Period, then, unless our Board of Directors shall otherwise determine, our existence will terminate, and we will distribute all amounts in the Trust Account.

 Sunorange

 On
April 27, 2023, we entered into the Investment Agreement with the Sponsor and Sunorange, pursuant to which Sunorange and its designees
acquired partnership interests in the Sponsor and Class B Ordinary Shares directly held by certain of our directors, which combined
interests entitled Sunorange to receive, in the aggregate, the Insider Securities, consisting of 3,557,813 Class B Ordinary Shares and
6,160,000 Private Placement Warrants, and we introduced a change in Management and the Board as follows: (i) Calvin Kung replaced David
Gershon as Chairman of the Board and Chief Executive Officer and Wang Chiu (Tommy) Wong replaced Ron Golan as Chief Financial Officer
and director on the Board, effective upon closing of the Sunorange Investment; (ii) Jonathan Ophir and Uri Chaitchik tendered their resignations
as Chief Investment Officer and Senior Consultant, respectively, effective upon closing of the Sunorange Investment; and (iii) Mitch
Garber, Gustavo Schwed and Nadav Zohar tendered their resignations as directors, to be effective upon expiration of the Waiting Period
and whose vacancies shall be filled by New Management.

 On
May 8, 2023, we completed the closing of the Sunorange Investment after our shareholders approved of certain proposals at the 2023 EGM,
and after certain closing conditions were met, including but not limited to: (i) a minimum of $30 million remaining in the Trust Account
after accounting for all redemptions in connection with the 2023 EGM; (ii) us obtaining or extending a directors and officers insurance
policy on terms satisfactory to the parties; (iii) the conversion of Class B Ordinary Shares into Class A Ordinary Shares as needed to
retain shareholders and meet continued listing requirements of Nasdaq in the event that the Extension is approved; (iv) the amendment
of the Sponsor's existing limited partnership agreement; (v) the transfer of 61,875 Class B Ordinary Shares from certain of our
directors to Sunorange or its designees and (vi) the cancellation of the outstanding Working Capital Loan from the Sponsor and the reduction
of certain advisory fees to be due upon the closing of an initial Business Combination.

 In
connection with the closing of the Sunorange Investment, on May 8, 2023, Sunorange caused $300,000 to be deposited into the Trust Account
to support the first three months of the Extension. Sunorange agreed to deposit into the Trust Account an additional $100,000 for
each successive month, or portion thereof, that is needed by us to complete an initial Business Combination until May 8, 2024. Through
December 31, 2023, $800,000 has been deposited into the Trust Account in support of the Extension.

 Extension
of Our Combination Period

 We
initially had until May 8, 2023, 18 months from the closing of the Initial Public Offering, to consummate our initial Business Combination.
On May 8, 2023, we held the 2023 EGM at which our stockholders approved, among other things, the Extension and the Conversion Amendment
Proposal. In connection with the vote to approve the Extension, the holders of 12,626,668 Class A Ordinary Shares properly exercised
their right to redeem their shares for cash at a redemption price of approximately $10.50 per share, for an aggregate redemption amount
of approximately $132.6 million. The 2023 Redemption was effected on May 18, 2023. Following the Founder Share Conversion and the 2023
Redemption, there were 9,085,831 Class A Ordinary Shares and one Class B Ordinary Share issued and outstanding.

 We
may seek to further extend the Combination Period consistent with applicable laws, regulations and stock exchange rules. Such an extension
would require the approval of our Public Shareholders, who will be provided the opportunity to redeem all or a portion of their Public
Shares. Such redemptions will likely have a material adverse effect on the amount held in our Trust Account, our capitalization, principal
shareholders and other impacts on our Company or Management Team, such as our ability to maintain our listing on Nasdaq.

 Founder
Share Conversion

 On
May 8, 2023, following the approval of the Conversion Amendment Proposal by our stockholders at the 2023 EGM, we issued an aggregate
of 4,312,499 Class A Ordinary Shares to the Sponsor and our former independent directors Mitch Garber, Nadav Zohar and Gustavo Schwed
upon the conversion of an equal number of Class B Ordinary Shares held by the Sponsor and our former independent directors Mitch Garber,
Nadav Zohar and Gustavo Schwed as Founder Shares. The 4,312,499 Class A Ordinary Shares issued in connection with the Founder Share Conversion
are subject to the same restrictions as applied to the Class B Ordinary Shares before the Founder Share Conversion, including the Sponsor's
agreement not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of
a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A Ordinary Shares
equals or exceeds $12.00 per share (as adjusted for share splits, share reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company
completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our
shareholders having the right to exchange their shares of Class A Ordinary Shares for cash, securities or other property. As a result
of the Founder Share Conversion and the 2023 Redemptions, the Sponsor and certain designees of Sunorange hold approximately 47.4% of
the issued and outstanding Ordinary Shares.

 Scage
Business Combination

 The
below subsection describes the material provisions of the Scage Business Combination Agreement
but does not purport to describe all the terms thereof. This summary of the Scage Business
Combination Agreement is qualified in its entirety by reference to the co m plete text of the
 Scage Business Combination Agreement, a copy of which is filed hereto as Exhibit 2.1 and incorporated
by reference herein. U nless otherwise defined herein, the capitalized terms used below have
the same meanings given to them in the Scage Business Combination Agr e ement.
Unless otherwise indicated, this Report does not assume the closing of the Scage Business
Combination.

 On August 21, 2023, we entered
into the Scage Business Combination Agreement, with Pubco, First Merger Sub, Second Merger Sub and Scage. The Scage Business Combination
Agreement was unanimously approved by our Board of Directors. If the Scage Business Combination Agreement is approved by our stockholders,
and the Scage Business Combination is consummated, (i) First Merger Sub will merge with and into Scage, with Scage surviving the First
Merger as a wholly-owned subsidiary of Pubco and the outstanding securities of Scage being converted into the right to receive securities
of Pubco; and (ii) immediately following the First Merger, Second Merger Sub will merge with and into our Company, with our Company surviving
the Second Merger as a wholly-owned subsidiary of Pubco and our outstanding securities being converted into the right to receive securities
of Pubco.

 Consideration

 Under
the Scage Business Combination Agreement, the Aggregate Merger Consideration Amount (as defined below) to be paid to our shareholders
is $1,000,000,000, subject to adjustment for net debt, and will be paid entirely in newly issued ordinary shares of Pubco, with each share
valued at the Per Share Price (as defined below).

 On the
date and time at which the Closing is actually held (the "Closing Date") and immediately prior to the effective time of the
First Merger (the "First Merger Effective Time"), each Series Angel preferred share, par value $0.00001 per share, Series
Pre-A preferred share, par value $0.00001 per share, and Series A preferred share, par value $0.0001 per share (collectively, the "Scage
Preferred Shares") that is issued and outstanding immediately prior to the First Merger Effective Time shall be canceled in exchange
for the right to receive a number of ordinary shares, par value $0.0001 per share (the "Scage Ordinary Shares") at the then
effective conversion rate (the "Conversion"). As a result of the Mergers, (a) each of the ordinary shares of Scage that are
issued and outstanding immediately prior to the First Merger Effective Time and after the Conversion shall be cancelled and converted
into the right to receive 100% of such number of ordinary shares of Pubco equal to the Exchange Ratio (as defined below); (b) each of
the convertible securities of Scage, to the extent then outstanding and unexercised immediately prior to the First Merger Effective Time,
shall automatically be assumed by Pubco and converted into a convertible security of Pubco; (c) each of our Ordinary Shares that is issued
and outstanding immediately prior to the effective time of the Second Merger (the "Effective Time") shall be cancelled and
converted automatically into the right to receive one Pubco ordinary share; and (d) each outstanding Public Warrant and Private Placement
Warrant shall be converted into two whole warrants entitling the holder thereof to purchase one Pubco ordinary share at a purchase price
of $11.50 per full share.

 For the
purposes of the Scage Business Combination Agreement, the following terms shall have the meanings set forth below:

 " Aggregate
Merger Consideration Amount " means (a) One Billion U.S. Dollars ($1,000,000,000) minus (b) if Closing Net Debt is a
positive number, the amount of Closing Net Debt, plus (c) if Closing Net Debt is a negative number, the absolute value of the
amount of Closing Net Debt.

 " Closing
Net Debt " means, as of the Reference Time, (i) the aggregate indebtedness of each of Scage and its direct and indirect subsidiaries
(excluding Pubco, First Merger Sub and Second Merger Sub) (the "Target Companies"), less (ii) the aggregate cash and cash
equivalents of the Target Companies on hand or in bank accounts, including deposits in transit, minus the aggregate amount of outstanding
and unpaid checks issued by or on behalf of the Target Companies, in each case of clauses (i) and (ii), on a consolidated basis and as
determined in accordance with GAAP.

 " Exchange
Ratio " means (i) the number of Pubco ordinary shares equal to the quotient determined by dividing (a) the Aggregate Merger
Consideration Amount by (b) the Per Share Price as of the First Merger Effective Time divided by (ii) the aggregate number of, without
duplication, the ordinary shares, par value $0.00001 par value per share, of Scage that are (a) issued and outstanding, and (b) issuable
directly or indirectly upon, or subject to, the conversion, exercise or settlement of any Scage Preferred Shares and Scage convertible
securities.

 " Per
Share Price " means the redemption price, which shall be no less than the par value of our Ordinary Shares.

 " Redemption
Price " means an amount equal to the price at which each Ordinary Share is redeemed or converted pursuant to the redemption
of Ordinary Shares (as equitably adjusted for share sub-divisions, share dividends, consolidations, capitalizations, re-designations
and the like after the Closing).

 Scage
Reorganization

 Prior
to the execution and delivery of the Scage Business Combination Agreement, Nanjing Scage, a company incorporated in the
People's Republic of China as a company with limited liability, Mr. Chao Gao, the Chairman, Chief Executive Officer, and
founder of Scage, and other relevant parties had entered into certain agreements (together with all agreements, instruments or other
documents as may be necessary or appropriate, the "Reorganization Documents") to implement and effect the
reorganization, including the issuance of shares by and of Scage to Nanjing Scage's shareholders (or their designees), the
acquisition of all shares and assets of Nanjing Scage by Scage (or its wholly-owned subsidiaries) pursuant to the terms and
conditions of the Reorganization Documents (the "Reorganization"). As of the date of this Report, Scage has issued
certain numbers of shares to Nanjing Scage's shareholders (or their designees, collectively, the "Reorganization
Shareholders"), and Scage's indirect wholly-owned subsidiaries, Scage (Hong Kong) Limited and Nanjing Xinneng Hydrogen
Automotive Technology Co., Ltd., have been registered as the shareholders of Nanjing Scage. It is expected that the Reorganization
will be completed as soon as Scage receives all the share purchase consideration from the Reorganization Shareholders.

 Representations
and Warranties

 The Scage
Business Combination Agreement contains a number of representations and warranties made by the parties as of the date of such agreement
or other specific dates solely for the benefit of certain of the parties to the Scage Business Combination Agreement, which in certain
cases are subject to specified exceptions and materiality, Material Adverse Effect (as defined below), knowledge and other qualifications
contained in the Scage Business Combination Agreement or in information provided pursuant to certain disclosure schedules to the Scage
Business Combination Agreement. "Material Adverse Effect" as used in the Scage Business Combination Agreement means with respect
to any specified person or entity, any fact, event, occurrence, change or effect that has had or would reasonably be expected to have,
individually or in the aggregate, a material adverse effect on the business, assets, liabilities, results of operations or condition (financial
or otherwise) of such person and its subsidiaries, taken as a whole, or the ability of such person or any of its subsidiaries on a timely
basis to consummate the transactions contemplated by the Scage Business Combination Agreement or the ancillary documents to which it is
a party or bound or to perform its obligations hereunder or thereunder, in each case subject to certain customary exceptions. The representations
and warranties made by the parties are customary for transactions similar to the Scage Business Combination.

 In the
Scage Business Combination Agreement, Scage made certain customary representations and warranties to us, including among others, related
to the following: (1) corporate matters, including due organization, existence and good standing; (2) authority and binding effect relative
to execution and delivery of the Scage Business Combination Agreement and other ancillary documents; (3) capitalization; (4) subsidiaries;
(5) governmental approvals; (6) non-contravention; (7) financial statements; (8) absence of certain changes; (9) compliance with laws;
(10) Scage permits; (11) litigation; (12) material contracts; (13) intellectual property; (14) taxes and returns; (15) real property;
(16) personal property; (17) title to and sufficiency of assets; (18) employee matters; (19) benefit plans; (20) environmental matters;
(21) transactions with related persons; (22) insurance; (23) books and records; (24) top customer and suppliers; (25) certain business
practices; (26) the Investment Company Act; (27) finders and brokers; (28) disclosure; (29) information supplied; (30) independent investigation;
and (31) exclusivity of representations and warranties. Scage also made certain representations and warranties to us with respect to the
Reorganization.

 In the
Scage Business Combination Agreement, we made certain customary representations and warranties to Scage and Pubco, including among others,
related to the following: (1) corporate matters, including due organization, existence and good standing; (2) authority and binding effect
relative to execution and delivery of the Scage Business Combination Agreement and other ancillary documents; (3) governmental approvals;
(4) non-contravention; (5) capitalization; (6) SEC filings, Company financials, and internal controls; (7) absence of certain changes;
(8) compliance with laws; (9) actions, orders and permits; (10) taxes and returns; (11) employees and employee benefit plans; (12) properties;
(13) material contracts; (14) transactions with affiliates; (15) Investment Company Act and the JOBS Act; (16) finders and brokers; (17)
certain business practices; (18) insurance; (19) information supplied; (20) independent investigation; (21) the Trust Account; (22) registration
and listing; and (23) termination of prior agreements.

 In the
Scage Business Combination Agreement, Pubco, the First Merger Sub and the Second Merger Sub made customary representations and warranties
to us, including among others, related to the following: (1) organization and good standing; (2) authority and binding effect relative
to execution and delivery of the Scage Business Combination Agreement and other ancillary documents; (3) governmental approvals; (4) non-contravention;
(5) capitalization; (6) activities of Pubco, the First Merger Sub and the Second Merger Sub; (7) finders and brokers; (8) the Investment
Company Act; (9) information supplied; (10) independent investigation; and (11) exclusivity of representations and warranties.

 None
of the representations and warranties of the parties shall survive the Closing.

 Covenants
of the Parties

 Each
party agreed in the Scage Business Combination Agreement to use its commercially reasonable efforts to effect the Closing. The Scage Business
Combination Agreement contains certain customary covenants by each of the parties during the period between the signing of the Scage Business
Combination Agreement and the earlier of the Closing or the termination of the Scage Business Combination Agreement in accordance with
its terms, including covenants regarding: (1) the provision of access to their properties, books and personnel; (2) the operation of their
respective businesses in the ordinary course of business; (3) provision of financial statements of Target Companies; (4) our public filings;
(5) "no shop" obligations; (6) no insider trading; (7) notifications of certain breaches, consent requirements or other matters;
(8) efforts to consummate the Closing and obtain third party and regulatory approvals and efforts to cause Pubco to maintain its status
as a "foreign private issuer" under Rule 3b-4 of the Exchange Act; (9) further assurances; (10) public announcements; (11)
confidentiality; (12) indemnification of directors and officers and tail insurance; (13) use of trust proceeds after the Closing; (14)
efforts to support a private placement or backstop arrangements, if sought; (15) intended tax treatment of the Business Combination
and (16) use of Trust Account proceeds. Scage agreed to use commercially reasonable efforts to consummate the Reorganization by September
30, 2023. Scage agreed to deliver the audited financial statements of Scage for the fiscal years ended June 30, 2022 and June 30, 2023
to us by September 30, 2023. Scage agreed to cause its subsidiaries to use commercially reasonable efforts to ensure the sustainability
of the collaboration with its cooperative manufacturers for its new energy road vehicles and off-road vehicles manufacturing and enter
into definitive contracts with its cooperative manufacturers as soon as practicable. Pubco shall be responsible for paying the SPAC transaction
expenses in an amount up to $9,000,000, subject to certain exclusions, if the Closing Date occurs prior to February 29, 2024. Scage also
agreed to cause all of the Scage shareholders to each enter into a lock-up agreement.

 In addition,
the parties agreed to take all necessary actions to cause Pubco's board of directors immediately after the Closing to consist of
seven directors, including: (i) two persons who are designated by us prior to the Closing as independent directors; and (ii) five persons
who are designated by Scage prior to the Closing.

 The Scage
Business Combination Agreement and the consummation of the Business Combination require the approval of both our shareholders and Scage's
shareholders. We and Pubco also agreed to jointly prepare, and Pubco shall file with the SEC, a registration statement on Form F-4 in
connection with the registration under the Securities Act of the issuance of securities of Pubco to the holders of the ordinary shares
and warrants of our Company and Scage and containing a proxy statement/prospectus for the purpose of soliciting proxies from our shareholders
for the matters relating to the Business Combination to be acted on at the special meeting of our shareholders and providing such shareholders
an opportunity to participate in the redemption of their Public Shares upon the Closing. Scage agreed to call a meeting of its shareholders
or cause a written resolution to be passed, as promptly as practicable after the Scage Registration Statement has become effective, in
order to obtain the approval of Scage shareholders for the approval of the Scage Business Combination Agreement and the Business Combination,
and we agreed to use our commercially reasonable efforts to solicit from Scage shareholders proxies prior to such special meeting or written
resolution, and to take all other actions necessary or advisable to secure the approval of the Scage shareholders.

 Conditions to Closing

 The
obligations of the parties to consummate the Business Combination are subject to various conditions, including the following mutual
conditions of the parties unless waived: (1) the approval of the Scage Business Combination Agreement and the Scage Business
Combination and related matters by the requisite vote of our Company's and Scage's shareholders; (2) obtaining material
regulatory approvals; (3) receipt of specified third party consents from any bank that has granted a valid credit facility to Scage
or any notifications to be made to any such bank; (4) no law or order preventing or prohibiting the Business Combination; (5) our
Company or Pubco shall have consolidated net tangible assets of at least $5,000,001 (as calculated and determined in accordance with
Rule 3a51-1(g)(1) of the Exchange Act) either immediately prior to the Closing (after giving effect to the redemption) or upon the
Closing after giving effect to the Mergers (including the redemption), or Pubco otherwise is exempt from the provisions of Rule 419
promulgated under the Exchange Act (i.e. one of several exclusions from the "penny stock" rules of the SEC applies and
we rely on another exclusion); (6) amendment by the shareholders of Pubco of Pubco's memorandum and articles of association;
(7) the effectiveness of the Scage Registration Statement; (8) appointment of the post-closing directors of Pubco; and (9) Nasdaq
listing requirements having been fulfilled.

 In addition,
unless waived by Scage, the obligations of the Scage, Pubco, the First Merger Sub and the Second Merger Sub to consummate the Business
Combination are subject to the satisfaction of the following Closing conditions, in addition to customary certificates and other closing
deliveries: (1) our representations and warranties being true and correct on and as of the Closing (subject to Material Adverse Effect);
(2) our Company having performed in all material respects its obligations and complied in all material respects with its covenants and
agreements under the Scage Business Combination Agreement required to be performed or complied with by it on or prior the date of the
Closing; (3) absence of any Material Adverse Effect with respect to our Company since the date of the Scage Business Combination Agreement
which is continuing and uncured; (4) the cash proceeds from the PIPE investment shall be not less than an aggregate of $15,000,000; (5)
receipt by Scage and Pubco of the Amended and Restated Registration Rights Agreement; (6) each of the sellers shall have received from
Pubco a registration rights agreement covering the merger consideration shares received by the sellers duly executed by Pubco; and (7)
receipt by Scage and Pubco of employment agreements between certain management persons from Scage and Scage or our Company, in each case
effective as of Closing.

 Unless
waived by us, our obligations to consummate the Business Combination are subject to the satisfaction of the following Closing conditions,
in addition to customary certificates and other closing deliveries: (1) the representations and warranties of Scage, Pubco, the First
Merger Sub, and the Second Merger Sub being true and correct on and as of the Closing (subject to Material Adverse Effect on the Target
Companies, taken as a whole); (2) Scage, Pubco, the First Merger Sub, and the Second Merger Sub having performed in all material respects
the respective obligations and complied in all material respects with their respective covenants and agreements under the Scage Business
Combination Agreement required to be performed or complied with on or prior the date of the Closing; (3) absence of any Material Adverse
Effect with respect to the Target Companies (taken as a whole) since the date of the Scage Business Combination Agreement which is continuing
and uncured; (4) the Non-Competition Agreements, the Employment Agreements, the Amended and Restated Registration Rights Agreement, each
Key Seller Lock-Up Agreement and each Seller Lock-Up Agreement shall be in full force and effect from the Closing; (5) resignation of
the directors and officers of Scage as requested by us prior to the Closing; (6) the Reorganization having been consummated by September
30, 2023; and (7) our Company and Nanjing Scage shall have reached a waiver, compromise, conciliation, settlement or similar resolution
of disputes with Shenzhen Deju Brothers Special II Corporate Management Partnership (Limited Partnership) regarding Scage's or Nanjing
Scage's equity, and the property preservation measures against Nanjing Scage (the equity interest held by Nanjing Scage in Scage
(Shanghai) Hydrogen Energy Technology Co., Ltd. has been judicially frozen) have been released.

 Termination

 The Scage
Business Combination Agreement may be terminated at any time prior to the Closing by either us or Scage if the Closing does not occur
by February 29, 2024, or such other date as may be extended pursuant to the Scage Business Combination Agreement.

 The Scage
Business Combination Agreement may also be terminated under certain other customary and limited circumstances at any time prior the Closing,
including, among other reasons: (1) by mutual written consent of our Company and Scage; (2) by either our Company or Scage if a governmental
authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise
prohibiting the Business Combination, and such order or other action has become final and non-appealable; (3) by Scage for our uncured
breach of the Scage Business Combination Agreement, such that the related Closing condition would not be met; (4) by us for the uncured
breach of the Scage Business Combination Agreement by Scage, Pubco, the First Merger Sub, or the Second Merger Sub, such that the related
Closing condition would not be met; (5) by us if Scage fails to deliver to us audited Scage financials by September 30, 2023, or if Scage's
total assets as of June 30, 2023 calculated in accordance with the Scage financial statements is more than five (5%) lower than the total
assets as of the same date calculated in accordance with the Scage financials; (6) by either us or Scage if the we hold our shareholder
meeting to approve the Scage Business Combination Agreement and the Scage Business Combination, and such approval is not obtained; (7)
by either Scage or us if Scage holds its shareholder meeting to approve the Scage Business Combination Agreement and the Scage Business
Combination, and such approval is not obtained; and (8) by us if the Reorganization has not been completed by September 30, 2023.

 If the
Scage Business Combination Agreement is terminated, all further obligations of the parties under the Scage Business Combination Agreement
(except for certain obligations related to confidentiality, effect of termination, fees and expenses, trust fund waiver, miscellaneous
and definitions to the foregoing) will terminate, no party to the Scage Business Combination Agreement will have any further liability
to any other party thereto except for liability for fraud or for willful breach of the Scage Business Combination Agreement prior to termination.

 Trust Account Waiver

 Scage,
Pubco, the First Merger Sub and the Second Merger Sub have agreed that they and their affiliates will not have any right, title, interest
or claim of any kind in or to any monies in our Trust Account held for its Public Shareholders, and have agreed not to, and waived any
right to, make any claim against the Trust Account (including any distributions therefrom).

 Related Agreements
and Documents

 Lock-Up Agreements

with the execution of the Scage Business Combination Agreement, Pubco, Scage, our Company and certain key Scage stockholders, as shareholders
holding Scage shares sufficient to constitute the required company shareholder approval (either as the holder of record or the beneficial
owner within the meaning of Rule 135-3 under the Exchange Act, each entered into Lock-Up Agreements (each, a "Key Seller Lock-Up
Agreement"). It is a condition to the Closing that all other Scage stockholders between signing and Closing enter into a lock-up
agreement (each, a "Seller Lock-Up Agreement").

to each Key Seller Lock-Up Agreement, each key Scage shareholder agreed not to, during the period commencing from the Closing Date and
ending on (A) the 6-month anniversary of the Closing Date with respect to 40% of the restricted securities and (B) the 36-month anniversary
of the Closing Date with respect to the remaining 60% of the restricted securities, (i) lend, offer, pledge, hypothecate, encumber, donate,
assign, sell, offer to sell, contract or agree to sell, sell any option or contract to purchase, purchase any option or contract to sell,
grant any option, right or warrant to purchase, or otherwise transfer or dispose of or agree to transfer or dispose of, directly or indirectly,
or establish or increase of a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section
16 of the Exchange Act and the rules and regulations of the SEC promulgated thereunder, or otherwise transfer or dispose of, directly
or indirectly, any restricted securities, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of the Lock-up Securities, whether any such transaction is to be settled by delivery of
such restricted securities, in cash or otherwise, or (iii) publicly disclose the intention to do any of the foregoing, whether any such
transaction described in clauses (i), (ii) or (iii) above is to be settled by delivery of restricted securities or other securities,
in cash or otherwise (any of the foregoing described in clauses (i), (ii) or (iii), a "Prohibited Transfer") (subject to
early release if Pubco consummates a change of control).

to each Seller Lock-Up Agreement, the remaining Scage shareholders agreed not to make a Prohibited Transfer during the period commencing
from the Closing Date and ending on the 6-month anniversary of the Closing Date (subject to early release if Pubco consummates a change
of control).

 Copies
of the forms of Key Seller Lock-Up Agreement and Seller Lock-Up Agreement are filed as Exhibits 10.13 and 10.14, respectively, and are
incorporated herein by reference, and the foregoing descriptions of the forms of Key Seller Lock-Up Agreement and Seller Lock-Up Agreement
are qualified in their entirety by reference thereto.

 Shareholder
Support Agreement

with the execution of the Scage Business Combination Agreement, our Company, Scage, and key Scage shareholders entered into a Shareholder
Support Agreement (the "Shareholder Support Agreement"), pursuant to which, among other things, key Scage shareholders have
agreed (a) to support the adoption of the Scage Business Combination Agreement and the approval of the Business Combination, subject to
certain customary conditions, and (b) not to transfer any of their subject shares (or enter into any arrangement with respect thereto),
subject to certain customary conditions.

 A copy
of the form of Shareholder Support Agreement is filed as Exhibit 10.15 and is incorporated herein by reference, and the foregoing description
of the form Shareholder Support Agreement is qualified in its entirety by reference thereto.

 Sponsor
Support Agreement

with the execution of the Scage Business Combination Agreement, our Company, Scage, Pubco and the Sponsor entered into a Sponsor Support
Agreement (the "Sponsor Support Agreement"), pursuant to which the Sponsor agreed to vote all of its shares of our Company
in favor of the Scage Business Combination Agreement and the Scage Business Combination. The Sponsor Support Agreement also prevents transfers
of our securities held by the Sponsor between the date of the Sponsor Support Agreement and the termination of the Sponsor Support Agreement.

 A copy
of the Sponsor Support Agreement is filed as Exhibit 10.16 and is incorporated herein by reference, and the foregoing description of the
form of Sponsor Support Agreement is qualified in its entirety by reference thereto.

 Insider
Letter Amendment

with the execution of the Scage Business Combination Agreement, our Company, Scage, the Sponsor, Pubco, Calvin Kung, Wang Chiu Wong, Chunyi
Hao, Tiemei Li, and Sanjay Prasad entered into an amendment (the "Insider Letter Amendment") to the Letter Agreement (the
"Insider Letter"), by and among our Company, the Sponsor and the Initial Shareholders named therein, pursuant to which Pubco
and Scage are added as parties to the Insider Letter.

 A copy
of the Insider Letter Amendment is filed as Exhibit 10.17 and is incorporated herein by reference, and the foregoing description of the
form of Insider Letter Amendment is qualified in its entirety by reference thereto.

 Non-Competition
and Non-Solicitation Agreement

with the execution of the Scage Business Combination Agreement, certain shareholders and officers (each, a " Subject
Party ") of Scage each entered into a non-competition and non-solicitation agreement with our Company, Pubco, Scage,
and the Sponsor (collectively, the " Non-Competition and Non-Solicitation Agreement "). Under the
Non-Competition and Non-Solicitation Agreement, the Subject Party agrees not to compete with Pubco, the Sponsor, our Company, Scage
and their respective affiliates during the three-year period following the Closing and, during such three-year restricted period,
not to solicit employees or customers of such entities. The Non-Competition and Non-Solicitation Agreement also contains customary
confidentiality and non-disparagement provisions.

 A copy
of the Non-Competition and Non-Solicitation Agreement is filed as Exhibit 10.18 and is incorporated herein by reference, and the foregoing
description of the form of Non-Competition and Non-Solicitation Agreement is qualified in its entirety by reference thereto.

 Assignment,
Assumption and Amendment to Warrant Agreement

 Prior
to the Closing, our Company, Pubco and Continental, as warrant agent, will enter the Assignment, Assumption and Amendment to Warrant
Agreement (the " Warrant Amendment ") which will amend that certain Warrant Agreement, dated as of November 8,
2021, relating to the Warrants (the " Warrant Agreement "), filed with the SEC on November 8, 2021. Pursuant
to the Warrant Amendment: (i) Pubco will assume the obligations of our Company under the Warrant Agreement, such that, among other things,
Pubco will be added as a party thereto and (ii) references to our Class A Ordinary Shares in the Warrant Agreement shall
mean Pubco ordinary shares.

 A
copy of the form of the Warrant Assignment, Assumption and Amendment Agreement is filed as Exhibit 10.19 and is incorporated herein
by reference, and the foregoing description of the form of Warrant Assignment, Assumption and Amendment Agreement is qualified in its
entirety by reference thereto.

 Other
than as specifically discussed, this Report does not assume the Closing of the Scage Business Combination.

 Acquisition
Strategy

 Our acquisition strategy is to
identify and complete a Business Combination by exploiting what we believe is an untapped opportunity and offer a public-ready business
a vehicle through which to enter the public marketplace, access capital markets and advance its business. Our non-exclusive focus has
been on Israel-related companies, including companies focused on payments, insuretech, wealthtech, regtech, digital banking, fintech as
a service, banking as a service, cyber area for financial institutions, blockchain and crypto, algo-trading and exchanges, and lending
and credit line platforms, that have a proven model of commercial success and a track record in generating and growing revenues, and,
in some cases, profits. We have also sought to identify companies that are developing disruptive technology with strong market potential
in other verticals and geographies. We believe that we are uniquely positioned to leverage our Sponsor's and its affiliates'
successful track record of helping technology companies grow into large, successful publicly-traded entities, and their deep network of
contacts and corporate relationships around the world. Our Management Team members have significant experience in executing transactions
under varying economic and financial market conditions, allowing their network of contacts and corporate relationships to grow through
sourcing, acquiring and financing businesses, and thereafter maintaining relationships with sellers, financing sources and target management
teams. We have relied on the expertise of our Management Team, our Sponsor and their affiliates and their proven deal-sourcing capabilities
to provide us with a pipeline of potential targets.

 We
believe that our Management Team's experiences in evaluating assets through investing and company building has enabled us to source
high quality targets. Our selection process, which has resulted in us pursuing the Scage Business Combination, has leveraged the relationships
of our Management Team with industry captains, leading venture capitalists, private equity and hedge fund managers, respected peers and
a network of investment banking executives, attorneys and accountants. Target business candidates have also been brought to our attention
from various unaffiliated sources, including, among others, large business enterprises seeking to divest noncore assets or divisions.
Together with our network of trusted partners, we intend to capitalize the target business and create purposeful strategic initiatives
in order to achieve attractive growth and performance targets.

Criteria

 Consistent
with our acquisition strategy, we have identified the following general, non-exclusive criteria and guidelines that we believe are important
in evaluating prospective targets for our initial Business Combination, including Scage. While we have used and will continue to use
these criteria and guidelines in evaluating acquisition opportunities, we may decide to enter into our initial Business Combination with
a target that meets some but not all of these criteria and guidelines. We focus on targets with the following attributes:

 attractive,
 growth business;

 disruptive
 technology;

 business
 with revenue and earnings growth potential;

 strong
 competitive industry position;

 strong
 target management team; and

 appropriate
 valuation.

 These
criteria are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial Business Combination may be
based on these general guidelines as well as other considerations, factors and criteria that our Management may deem relevant.

 In
evaluating a prospective target business, we conduct a thorough due diligence review that encompasses, among other things,
meetings with incumbent management and employees, document reviews, interviews with customers and suppliers, and inspection of facilities,
as well as review of financial and other information which will be made available to us.

 Sourcing
of Potential Business Combination Targets

 We believe that the operational and transactional
experience of our Management Team and members of our Sponsor (and the investors in the Sponsor), and the relationships they have developed
as a result of such experience, has provided us with a substantial number of potential Business Combination targets. Our Management Team
and other members of our Sponsor possess extensive expertise with emerging companies across Asia, particularly in China, Singapore, and
Indonesia. They excel in forging strategic partnerships between the public and private sectors within these regions. The team has successfully
navigated the operational and investment landscapes of these markets, engaging in sourcing, acquiring, and financing businesses. Through
these activities, they have cultivated a robust network of relationships with key stakeholders, including sellers, financing sources,
and management teams of target companies. Our Management Team members bring to the table their substantial experience in executing transactions,
adeptly adapting to the diverse economic and financial conditions present in Asian markets.. We believe that this network of contacts
and relationships and this experience has helped us to identify attractive businesses that can benefit from access to the public markets
and will help us to execute complex Business Combination transactions, thereby enhancing shareholder value. In addition, target business
candidates have been brought to our attention from various unaffiliated sources, including investment market participants, private equity
funds and large business enterprises seeking to divest noncore assets or divisions.

 Our
Management Team's and directors' experiences in evaluating assets through investing and company building has enabled us to
source high-quality targets. Our selection process leverages the relationships of our Management Team with industry captains, leading
venture capitalists, private equity and hedge fund managers, respected peers and a network of investment banking executives, attorneys
and accountants. Together with this network of trusted partners, we intend to capitalize the target business and create purposeful strategic
initiatives in order to achieve attractive growth and performance targets.

 Our current Management Team and
members of our Sponsor consists of professionals and senior operating executives of various companies with decades of experience and industry
exposure in an array of industries, with a particular focus on industrial and commercial real estate as well as the communications and
new energy sectors. Based on our Management Team's extensive experience and industry exposure, we believe we will be able to identify,
evaluate the risk and reward of and execute on attractive acquisition opportunities, including the Scage Business Combination.

 Competitive
Strengths

 Status
as a Public Company

 We believe that our structure
makes us an attractive Business Combination partner to target businesses, including Scage. As an existing public company, we offer a target
business an alternative to a traditional Initial Public Offering through a merger or other Business Combination. In this situation, the
owners of the target business would exchange their shares of stock or other equity interests in the target business for our Ordinary Shares
or for a combination of our Ordinary Shares and cash, allowing us to tailor the consideration used in the transaction to the specific
needs of the sellers. See "Scage Business Combination" above for more information regarding such an exchange in the Scage
Business Combination. Although there are various costs and obligations associated with being a public company, we believe that target
businesses, such as Scage, might find this avenue a more certain and cost-effective method to becoming a public company than a typical
Initial Public Offering. In a typical Initial Public Offering, there are additional expenses incurred in marketing, roadshow and public
reporting efforts that will likely not be present to the same extent in connection with a Business Combination with us.

 Furthermore,
once the Business Combination is consummated, such as the Scage Business Combination, the target business will have effectively become
a public company, whereas an Initial Public Offering is always subject to the underwriters' ability to complete the offering, as
well as general market conditions that could prevent the offering from occurring. Once public, we believe the target business would then
have greater access to capital and an additional means of providing management incentives consistent with shareholders' interests
than it would have as a privately held company. Public company status can offer further benefits by enhancing a company's profile
among potential new customers and vendors and attracting talented employees.

 While we believe that our status
as a public company makes us an attractive business partner, some potential target businesses may view the inherent limitations in our
status as a blank check company as a deterrent and may prefer to effect a Business Combination with a more established entity or with
a private company. These limitations include constraints on our available financial resources, which may be inferior to those of other
entities pursuing the acquisition of similar target businesses; the requirement that we seek shareholder approval of a Business Combination
or conduct a tender offer in relation thereto, which may delay the consummation of a transaction; and the existence of our outstanding
warrants, which may represent a source of future dilution.

 In
addition, the SEC has recently enacted rules relating to certain activities of SPACs, which may complicate efforts to complete our initial
Business Combination. See the Risk Factor titled "Changes in laws or regulations, or a failure to comply with any laws and regulations,
may adversely affect our business, including our ability to negotiate and complete our initial Business Combination, and results of operations"
for more information.

 Financial
Position

 With funds available in our Trust
Account in an amount of approximately $51,200,344 (or $11.07 per share) (as of December 31, 2023) assuming no redemptions (following the
payment of $3,450,000 million to the underwriters as underwriting fees in our Initial Public Offering), payment of $6,037,500 of advisory
fees to be paid to EarlyBirdCapital in connection with the Business Combination before additional fees and expenses associated with our
initial Business Combination, payments in the aggregate of approximately $132.6 million to shareholders as a result of the 2023 Redemptions,
we offer a target business, such as Scage, a variety of options such as creating a liquidity event for its owners, providing capital
for the potential growth and expansion of its operations or strengthening its balance sheet by reducing its debt ratio. Because we are
able to complete our initial Business Combination using our cash, debt or equity securities, or a combination of the foregoing, we have
the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business
to fit its needs and desires. However, we have not taken any steps to secure third-party financing and there can be no assurance that
it will be available to us.

 Effecting
a Business Combination

 General

 We
are not presently engaged in, and we will not engage in, any substantive commercial business for an indefinite period of time following
our Initial Public Offering. We intend to utilize cash derived from the proceeds of our Initial Public Offering and the Private Placement
of Private Placement Warrants, our shares, debt or a combination of these in effecting a Business Combination. Accordingly, investors
in our Initial Public Offering have invested without first having an opportunity to evaluate the specific merits or risks of any one
or more Business Combinations. A Business Combination may involve the acquisition of, or merger with, a company which does not need substantial
additional capital but which desires to establish a public trading market for its shares, while avoiding what it may deem to be adverse
consequences of undertaking a public offering itself. These include time delays, significant expense, loss of voting control and compliance
with various federal and state securities laws. In the alternative, we may seek to consummate a Business Combination with a company that
may be financially unstable or in its early stages of development or growth.

 Sources
of Target Businesses

 The
principal means of identifying potential target businesses has been through the extensive contacts and relationships of our Initial Shareholders,
officers and directors. While our officers and directors are not required to commit any specific amount of time in identifying or performing
due diligence on potential target businesses, our officers and directors believe that the relationships they have developed over their
careers and their access to our Sponsor's members' and affiliates' contacts and resources have generated a number of
potential Business Combination opportunities that have warranted further investigation. Target business candidates also have been brought
to our attention from various unaffiliated sources, including investment bankers, venture capital funds, private equity funds, leveraged
buyout funds, management buyout funds and other members of the financial community.

 Our
officers and directors must present to us all target business opportunities that have a fair market value of at least 80% of the
assets held in the Trust Account (excluding taxes payable on the income accrued in the Trust Account) at the time of the agreement
to enter into the initial Business Combination, subject to any pre-existing fiduciary or contractual obligations. While we do not
presently anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions on
any formal basis (other than EarlyBirdCapital, as described elsewhere in this Report), we may engage these firms or other
individuals in the future, in which event we may pay a finder's fee, consulting fee or other compensation to be determined in
an arm's length negotiation based on the terms of the transaction. In no event, however, will our Sponsor, Initial
Shareholders, officers, directors or their respective affiliates be paid any finder's fee, consulting fee or other
compensation prior to, or for any services they render in order to effectuate, the consummation of an initial Business Combination
(regardless of the type of transaction that it is) other than the fee of $3,000 that we pay each month to our Sponsor pursuant to an
Administrative Services Agreement described in "Item 13. Certain Relationships and Related Transactions, and Director
Independence " in this Report, the repayment of any loans provided by the sponsor or its affiliates and reimbursement of
any out-of-pocket expenses.

 Additionally,
we may in the future pay a customary financial consulting fee to our Sponsor or an affiliate of our Sponsor. We may pay such financial
consulting fee in the event such party or parties provide us with specific target company, industry, financial or market expertise, as
well as insights, relationships, services or resources that we believe are necessary in order to assess, negotiate and consummate an
initial Business Combination. The amount of any such financial consulting fee we pay will be based upon the prevailing market for similar
services for comparable transactions at such time and will be subject to the review of our Audit Committee pursuant to the Audit Committee's
policies and procedures relating to transactions that may present conflicts of interest.

 Our
Audit Committee reviews and approve all reimbursements and payments made to our Sponsor, officers, directors or our or their
respective affiliates, with any interested director abstaining from such review and approval. We have no present intention to enter
into a Business Combination with a target business that is affiliated with any of our officers, directors or Sponsor. However, we
are not restricted from entering into any such transactions and may do so if (i) such transaction is approved by a majority of our
disinterested independent directors and (ii) we obtain an opinion from an independent investment banking firm, or another
independent entity that commonly renders valuation opinions, that the Business Combination is fair to our unaffiliated shareholders
from a financial point of view.

 Selection
of a Target Business and Structuring of a Business Combination

 Subject
to our Management Team's pre-existing fiduciary obligations and the limitations that a target business have a fair market value
of at least 80% of the balance in the Trust Account (excluding taxes payable on the income earned on the Trust Account) at the time of
the execution of a definitive agreement for our initial Business Combination, as described below in more detail, and that we must acquire
a controlling interest in the target business, our Management will have virtually unrestricted flexibility in identifying and selecting
a prospective target business. We have not established any specific attributes or criteria (financial or otherwise) for prospective target
businesses, except as described above under " Investment Criteria."

 Any
evaluation relating to the merits of a particular Business Combination is based, to the extent relevant, on such factors as well
as other considerations deemed relevant by our Management in effecting a Business Combination consistent with our business objective.
In evaluating a prospective target business, we will conduct an extensive due diligence review which will encompass, among other things,
meetings with incumbent management and inspection of facilities, as well as review of financial and other information which is made available
to us. This due diligence review is conducted either by our Management or by unaffiliated third parties we may engage.

 Any costs incurred with respect
to the identification and evaluation of a prospective target business with which a Business Combination is not ultimately completed results
in a loss to us and reduce the amount of capital available to otherwise complete a Business Combination.

 Fair
Market Value of Target Business

 Nasdaq
listing rules require that the target business or businesses that we acquire must collectively have a fair market value equal to at least
80% of the balance of the funds in the Trust Account (excluding taxes payable on the income earned on the Trust Account) at the time
of the execution of a definitive agreement for our initial Business Combination. Notwithstanding the foregoing, if we are not then listed
on Nasdaq for whatever reason, we would no longer be required to meet the foregoing 80% fair market value test. Based on the valuation
analysis of our Management and Board of Directors, we have determined that the fair market value of Scage was substantially in excess
of 80% of the funds in the Trust Account and that the 80% test was therefor satisfied.

 We
currently anticipate several possible structures for a Business Combination. We may structure our Business Combination to acquire 100%
of the equity interests or assets of the target business or businesses. We may, however, structure our initial Business Combination where
we merge directly with the target business or where we acquire less than 100% of such interests or assets of the target business in order
to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such Business
Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act. Even if the post-transaction company owns or acquires 50% or more of the voting securities of the target, our shareholders
prior to the Business Combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed
to the target and us in the Business Combination transaction. For example, we could pursue a transaction in which we issue a substantial
number of new shares in exchange for all of the outstanding capital stock, shares or other equity interests of a target. In this case,
we could acquire a 100% controlling interest in the target; however, as a result of the issuance of a substantial number of new shares,
our shareholders immediately prior to our initial Business Combination could own less than a majority of our outstanding shares subsequent
to our initial Business Combination. If less than 100% of the equity interests or assets of a target business or businesses are owned
or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued
for purposes of the 80% of Trust Account balance test. If our initial Business Combination involves more than one target business, the
80% fair market value test will be based on the aggregate value of all of the target businesses.

 As
an alternative to serving as the legal acquiring entity in a Business Combination transaction, we may instead serve as the target company
from a legal perspective. In that case, our shareholders will receive shares of the acquiring company in exchange for their Ordinary
Shares of our Company, and the acquiring company would succeed us as a publicly traded company. There may be various tax and other ramifications
to the Business Combination transaction being effected in accordance with that alternative structure.

 The
fair market value of the target will be determined by our Board of Directors based upon one or more standards generally accepted by the
financial community (such as actual and potential sales, earnings, cash flow and/or book value). The proxy solicitation materials or
tender offer documents used by us in connection with any proposed transaction will provide Public Shareholders with our analysis of the
fair market value of the target business, as well as the basis for our determinations. If our Board is not able to independently determine
that the target business has a sufficient fair market value, we will obtain an opinion from an unaffiliated, independent investment banking
firm, or another independent entity that commonly renders valuation opinions, with respect to the satisfaction of such criteria. We will
not be required to obtain an opinion from an investment banking firm as to the fair market value if our Board of Directors independently
determines that the target business complies with the 80% threshold.

 Lack
of Business Diversification

 We
may seek to effect a Business Combination with more than one target business, although we expect to complete our Business Combination
with just one business. Therefore, at least initially, the prospects for our success may be entirely dependent upon the future performance
of a single business operation. Unlike other entities which may have the resources to complete several Business Combinations of entities
operating in multiple industries or multiple areas of a single industry, it is probable that we will not have the resources to diversify
our operations or benefit from the possible spreading of risks or offsetting of losses. By consummating a Business Combination with only
a single entity, our lack of diversification may:

 subject
 us to numerous economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact upon
 the particular industry in which we may operate subsequent to a Business Combination, and

 result
 in our dependency upon the performance of a single operating business or the development or market acceptance of a single or limited
 number of products, processes or services.

 If
we determine to simultaneously acquire several businesses and such businesses are owned by different sellers, we will need for each of
such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other acquisitions, which may
make it more difficult for us, and delay our ability, to complete the Business Combination. With multiple acquisitions, we could also
face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence investigations
(if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or
products of the acquired companies in a single operating business.

 Limited
Ability to Evaluate the Target Business' Management

 Although we scrutinize the management
of a prospective target business, including the management team of Scage, when evaluating the desirability of effecting a Business Combination
with that business, and plan to continue to do so if the Scage Business Combination is not consummated and we seek other Business Combination
opportunities, we cannot assure you that our assessment of the target business' management will prove to be correct. In addition,
we cannot assure you that the future management will have the necessary skills, qualifications or abilities to manage a public company.
Furthermore, the future role of our officers and directors, if any, in the target business following a Business Combination cannot presently
be stated with any certainty. While it is possible that some of our key personnel will remain associated in senior management or advisory
positions with us following a Business Combination, including the Scage Business Combination, it is unlikely that they will devote their
full-time efforts to our affairs subsequent to a Business Combination. Moreover, they would only be able to remain with us after the consummation
of a Business Combination if they are able to negotiate employment or consulting agreements in connection with the Business Combination.
Such negotiations would take place simultaneously with the negotiation of the Business Combination and could provide for them to receive
compensation in the form of cash payments and/or our securities for services they would render to us after the consummation of the Business
Combination. While the personal and financial interests of our key personnel may influence their motivation in identifying and selecting
a target business, we believe that their ability to remain with us after the consummation of a Business Combination will not be the determining
factor in our decision as to whether or not we will proceed with any potential Business Combination. Additionally, we cannot assure you
that our officers and directors will have significant experience or knowledge relating to the operations of the particular target business.

 Following
a Business Combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We
cannot assure you that we will have the ability to recruit additional managers, or that any such additional managers we recruit will
have the requisite skills, knowledge or experience necessary to enhance the incumbent management.

 Stockholders
May Not Have the Ability to Approve an Initial Business Combination

 In
connection with any proposed Business Combination, we will either (1) seek shareholder approval of our initial Business Combination at
a general meeting called for such purpose at which shareholders may seek to convert their shares, regardless of whether they vote for
or against the proposed Business Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit
in the Trust Account (net of taxes payable), or (2) provide our shareholders with the opportunity to sell their shares to us by means
of a tender offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount
then on deposit in the Trust Account (net of taxes payable), in each case subject to the limitations described herein. The decision as
to whether we will seek shareholder approval of a proposed Business Combination or will allow shareholders to sell their shares to us
in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction
and whether the terms of the transaction would otherwise require us to seek shareholder approval. If we determine to engage in a tender
offer, such tender offer will be structured so that each shareholder may tender all of his, her or its shares rather than some pro rata
portion of his, her or its shares. In that case, we will file tender offer documents with the SEC which will contain substantially the
same financial and other information about the initial Business Combination as is required under the SEC's proxy rules. Whether
we seek shareholder approval or engage in a tender offer, we will consummate our initial Business Combination only if we have net tangible
assets of at least $5,000,001 either immediately prior to or upon such consummation and, if we seek shareholder approval, a majority
of the outstanding shares voted are voted in favor of the Business Combination.

 We chose our net tangible asset
threshold of $5,000,001 to ensure that we would avoid being subject to Rule 419 promulgated under the Securities Act. However, if we seek
to consummate an initial Business Combination with a target business that imposes any type of working capital closing condition or requires
us to have a minimum amount of funds available from the Trust Account upon consummation of such initial Business Combination, we may need
to have more than $5,000,001 in net tangible assets either immediately prior to or upon consummation and this may force us to seek third-party
financing, which may not be available on terms acceptable to us or at all. As a result, we may not be able to consummate such initial
Business Combination and we may not be able to locate another suitable target within the applicable time period, if at all. Public Shareholders
may therefore have to wait until the end of our Combination Period in order to be able to receive a pro rata share of the Trust Account (with
such Combination Period ending on May 8, 2024). Our Sponsor, Initial Shareholders, officers and directors have agreed (1) to vote any
Ordinary Shares owned by them in favor of any proposed Business Combination, (2) not to convert any Ordinary Shares in connection with
a shareholder vote to approve a proposed initial Business Combination and (3) not sell any Ordinary Shares in any tender in connection
with a proposed initial Business Combination.

 If
we hold a meeting to approve a proposed Business Combination and a significant number of shareholders vote, or indicate an intention
to vote, against such proposed Business Combination or that they wish to have their shares redeemed, our officers, directors, Sponsor,
Initial Shareholders or their affiliates could make such purchases in the open market or in private transactions in order to influence
the vote and reduce the number of redemptions. Notwithstanding the foregoing, our officers, directors, Sponsor, Initial Shareholders
and their affiliates will not make purchases of Class A Ordinary Shares if the purchases would violate Section 9(a)(2) or Rule 10b-5
of the Exchange Act, which are rules designed to stop potential manipulation of a company's stock.

 Conversion
Rights

 At
any general meeting called to approve an initial Business Combination, Public Shareholders may seek to convert their shares, regardless
of whether they vote for or against the proposed Business Combination or do not vote at all, into their pro rata share of the aggregate
amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, less
any taxes then due but not yet paid. Alternatively, we may provide our Public Shareholders with the opportunity to sell their Class A
Ordinary Shares to us through a tender offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata
share of the aggregate amount then on deposit in the Trust Account, less any taxes then due but not yet paid.

 Our Sponsor, Initial Shareholders
and our officers and directors do not have conversion rights with respect to any Ordinary Shares owned by them, directly or indirectly,
whether acquired prior to our Initial Public Offering or purchased by them in our Initial Public Offering or in the aftermarket. Additionally,
the holders of the EBC Founder Shares do not have conversion rights with respect to the EBC Founder Shares.

 We
may require Public Shareholders, whether they are a record holder or hold their shares in "street name," to either (i) tender
their certificates to our transfer agent or (ii) deliver their shares to the transfer agent electronically using the DWAC System, at the holder's option, in each case prior to a date set forth in the proxy materials
sent in connection with the proposal to approve the Business Combination. There is a nominal cost associated with the above-referenced
delivery process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent will typically
charge the tendering broker approximately $100.00 and it would be up to the broker whether or not to pass this cost on to the holder.
However, this fee would be incurred regardless of whether or not we require holders seeking to exercise conversion rights to tender their
shares. The need to deliver shares is a requirement of exercising conversion rights regardless of the timing of when such delivery must
be effectuated. However, in the event we require shareholders seeking to exercise conversion rights to tender their shares prior to the
consummation of the proposed Business Combination and the proposed Business Combination is not consummated, this may result in an increased
cost to shareholders.

 Any
proxy solicitation materials we furnish to shareholders in connection with a vote for any proposed Business Combination, such as the Scage Registration Statement, will indicate
whether we are requiring shareholders to satisfy such certification and delivery requirements. Accordingly, a shareholder would have
from the time the shareholder received our proxy statement up until two business days prior to the scheduled vote on the proposal to
approve the Business Combination to deliver his, her or its shares if he, she or it wishes to seek to exercise his conversion rights.
This time period varies depending on the specific facts of each transaction. However, as the delivery process can be accomplished by
the shareholder, whether or not he, she or it is a record holder or his, her or its shares are held in "street name," in
a matter of hours by simply contacting the transfer agent or his broker and requesting delivery of his, her or its shares through the
DWAC System, we believe this time period is sufficient for an average investor. However, we cannot assure you of this fact.

 Any
request to convert such shares once made, may be withdrawn at any time up to the vote on the proposed Business Combination or the expiration
of the tender offer. Furthermore, if a holder of Class A Ordinary Shares delivered his certificate in connection with an election of
their conversion and subsequently decides prior to the applicable date not to elect to exercise such rights, he or she may simply request
that the transfer agent return the certificate (physically or electronically).

 If
the Initial Business Combination is not approved or completed for any reason, then our Public Shareholders who elected to exercise their
conversion rights would not be entitled to convert their Public Shares for the applicable pro rata share of the Trust Account. In such case,
we will promptly return any shares delivered by Public Shareholders.

 Redemption
of Public Shares and Liquidation if No Initial Business Combination

 We currently have until the end
of our Combination Period to complete our Initial Business Combination (with such Combination Period ending on May 8, 2024). If we are
unable to complete our initial Business Combination within such 30-month period, we will: (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including accrued interest (less
up to $100,000 of interest to pay dissolution expenses, which interest shall be net of taxes payable) divided by the number of then issued
and outstanding Public Shares, which redemption will completely extinguish Public Shareholders' rights as shareholders (including
the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject
in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to
complete our initial Business Combination within the 30-month time period. Our Initial Shareholders and directors, officers, and Sponsor
have entered into an Insider Letter Agreement with us, pursuant to which they have waived their rights to liquidating distributions from
the Trust Account with respect to their Founders Shares if we fail to complete our initial Business Combination within the Combination
Period. However, if our Initial Shareholders acquire Public Shares, they will be entitled to liquidating distributions from the Trust
Account with respect to such Public Shares if we fail to complete our initial Business Combination within the allotted 30-month time frame.

 Our Sponsor, officers and directors
have agreed, pursuant to the Insider Letter Agreement with us, and EarlyBirdCapital has agreed, pursuant to the underwriting agreement
relating to our Initial Public Offering, that they will not propose or vote in favor of any amendment to our Amended and Restated Memorandum
(A) that would affect our Public Shareholders' ability to convert or sell their shares to us in connection with a Business Combination
as described herein or to modify the substance or timing the redemption rights provided to shareholders as described in this Report or
(B) with respect to any other provision relating to shareholders' rights or pre-initial Business Combination activity, unless we
provide our Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including accrued interest (which interest
shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares. However, we may not redeem our Public
Shares in an amount that would cause our net tangible assets to be less than $5,000,001 either immediately prior to or upon completion
of our initial Business Combination (so that we do not then become subject to the SEC's "penny stock" rules).

 We
expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be
funded from amounts remaining out of the $37 held outside the Trust Account, although we cannot assure you that there
will be sufficient funds for such purpose. However, if those funds are not sufficient to cover the costs and expenses associated with
implementing our plan of dissolution, to the extent that there is any interest accrued in the Trust Account not required to pay taxes,
we may request the trustee to release to us an additional amount of up to $100,000 of such accrued interest to pay those costs and expenses.

 If
we were to expend all of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, other than the proceeds deposited
in the Trust Account, and without taking into account interest, if any, earned on the Trust Account, the per-share redemption amount
received by shareholders upon our dissolution would be approximately $11.07. The proceeds deposited in the Trust Account could, however,
become subject to the claims of our creditors which would have higher priority than the claims of our Public Shareholders. We cannot
assure you that the actual per-share redemption amount received by shareholders will not be substantially less than $11.07 While we intend
to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors' claims.

 Although
we will seek to have all vendors, service providers (other than our independent auditors), prospective target businesses or other entities
with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held
in the Trust Account for the benefit of our Public Shareholders, there is no guarantee that they will execute such agreements or even
if they execute such agreements that they would be prevented from bringing claims against the Trust Account including but not limited
to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability
of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the
Trust Account. If any third party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, our Management
will perform an analysis of the alternatives available to it and will enter into an agreement with a third party that has not executed
a waiver only if Management believes that such third party's engagement would be significantly more beneficial to us than any alternative.
Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party
consultant whose particular expertise or skills are believed by Management to be significantly superior to those of other consultants
that would agree to execute a waiver or in cases where we are unable to find a service provider willing to execute a waiver. In addition,
there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of,
any negotiations, contracts or agreements with us and will not seek recourse against the Trust Account for any reason. Upon redemption
of our Public Shares, if we are unable to complete our initial Business Combination within the prescribed time frame, or upon the exercise
of a redemption right in connection with our initial Business Combination, we will be required to provide for payment of claims of creditors
that were not waived that may be brought against us within the 10 years following redemption. Our Sponsor has agreed that it will be
liable to us if and to the extent any claims by a third party (other than our independent auditors) for services rendered or products
sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of
funds in the Trust Account to below (i) $10.20 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account
as of the date of the liquidation of the Trust Account, due to reductions in value of the trust assets, in each case net of the amount
of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed
a waiver of any and all rights to seek access to the Trust Account and except as to any claims under our indemnity of the underwriters
of Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Because we are a blank check company, rather
than an operating company, and our operations will be limited to searching for prospective target businesses to acquire, the only third
parties we currently expect to engage would be vendors such as lawyers, investment bankers, computer or information and technical services
providers or prospective target businesses. In the event that an executed waiver is deemed to be unenforceable against a third party,
then our Sponsor will not be responsible to the extent of any liability for such third-party claims. We have not independently verified
whether our Sponsor has sufficient funds to satisfy its indemnity obligations and believe that our Sponsor's only assets are securities
of our Company and, therefore, our Sponsor may not be able to satisfy those obligations. We have not asked our Sponsor to reserve for
such obligations. None of our other officers will indemnify us for claims by third parties including, without limitation, claims by vendors
and prospective target businesses.

 In
the event that the proceeds in the Trust Account are reduced below (1) $10.20 per Public Share or (2) such lesser amount per Public Share
held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in the value of the trust assets,
in each case net of the amount of interest which may be withdrawn to pay taxes, and our Sponsor asserts that it is unable to satisfy
its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors
would determine whether to take legal action against our Sponsor to enforce its indemnification obligations. While we currently expect
that our independent directors would take legal action on our behalf against our Sponsor to enforce its indemnification obligations to
us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any particular instance.
Accordingly, we cannot assure you that due to claims of creditors the actual value of the per-share redemption price will not be substantially
less than $10.20 per share.

 We seek to reduce the possibility
that our Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers
(other than our independent auditors), prospective target businesses or other entities with which we do business execute agreements with
us waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Our Sponsor will also not be liable
as to any claims under our indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities
under the Securities Act. We have access to$37 from the funds held outside of the Trust Account with which to pay any such potential claims
(including costs and expenses incurred in connection with our liquidation, currently estimated to be no more than approximately $100,000).
In the event that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders
who received funds from our Trust Account could be liable for claims made by creditors.

 If
we file a winding-up or bankruptcy petition or an involuntary winding-up or bankruptcy petition is filed against us that is not dismissed,
the proceeds held in the Trust Account could be subject to applicable insolvency laws and may be included in our insolvency estate and
subject to the claims of third parties with priority over the claims of our shareholders. To the extent any insolvency claims deplete
the Trust Account, we cannot assure you we will be able to return $10.20 per share to our Public Shareholders. Additionally, if we file
a winding-up or bankruptcy petition or an involuntary winding-up or bankruptcy petition is filed against us that is not dismissed, any
distributions received by shareholders could be viewed under applicable debtor/creditor and/or insolvency laws as a voidable preference.
As a result, a bankruptcy court could seek to recover some or all amounts received by our shareholders. Furthermore, our Board may be
viewed as having breached its fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our
Company to claims of punitive damages, by paying Public Shareholders from the Trust Account prior to addressing the claims of creditors.
We cannot assure you that claims will not be brought against us for these reasons.

 Our Public Shareholders are entitled
to receive funds from the Trust Account only upon the earliest to occur of: (1) the completion of our initial Business Combination, and
then only in connection with those Class A Ordinary Shares that such shareholder properly elected to redeem, subject to the limitations
described herein, (2) the redemption of any Public Shares properly submitted in connection with a shareholder vote to amend our Amended
and Restated Memorandum (A) that would affect our Public Shareholders' ability to convert or sell their shares to us in connection
with a Business Combination as described herein or to modify the substance or timing of the redemption rights provided to shareholders
as described in this Report, or (B) with respect to any other provision relating to shareholders' rights or pre-initial Business
Combination activity and (3) the redemption of our Public Shares if we are unable to complete our initial Business Combination within
the Combination Period, subject to applicable law and as further described herein. In no other circumstances will a shareholder have any
right or interest of any kind to or in the Trust Account. In the event we seek shareholder approval in connection with our initial Business
Combination, a shareholder's voting in connection with our initial Business Combination alone will not result in a shareholder's
redeeming its shares to us for an applicable pro rata share of the Trust Account. Such shareholder must have also exercised its redemption
rights described above.

 Amended
and Restated Memorandum and Articles of Association

 Our Amended and Restated Memorandum
contains certain requirements and restrictions relating to the Initial Public Offering that will apply to us until the completion of our
initial Business Combination. Our Amended and Restated Memorandum will contain a provision which provides that, if we seek to amend our
Amended and Restated Memorandum (A) that would affect our Public Shareholders' ability to convert or sell their shares to us in
connection with a Business Combination as described herein or to modify the substance or timing of our obligation to redeem our Public
Shares if we do not complete our initial Business Combination within the Combination Period or (B) with respect to any other provision
relating to shareholders' rights or pre-initial Business Combination activity, we will provide Public Shareholders with the opportunity
to redeem their Public Shares in connection with any such amendment. Specifically, our Amended and Restated Memorandum provide, among
other things, that: prior to the completion of our initial Business Combination, we shall either (1) seek shareholder approval of our
initial Business Combination at a general meeting called for such purpose at which Public Shareholders may elect to redeem their Public
Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed Business Combination, or (2)
provide our Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of our initial
Business Combination by means of a tender offer (and thereby avoid the need for a shareholder vote), for an amount payable in cash equal
to the aggregate amount then on deposit in the Trust Account as of two business days prior to the completion of our initial Business Combination,
including accrued interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public
Shares, subject to the limitations described herein;

 we
 will consummate our initial Business Combination only if we have net tangible assets of at least $5,000,001 either immediately prior
 to or upon completion of our initial Business Combination and, solely if we seek shareholder approval, a majority of the issued and
 outstanding Ordinary Shares voted are voted in favor of the Business Combination;

 if our initial Business Combination is not consummated within 3the Combination
Period, then our existence will terminate and we will distribute all amounts in the Trust Account; and

 prior to our initial Business Combination, we may not issue additional
shares that would entitle the holders thereof to (1) receive funds from the Trust Account or (2) vote as a class with our Public Shares
(a) on any initial Business Combination or (b) to approve an amendment to our Amended and Restated Memorandum to (x) extend the time we
have to consummate a Business Combination beyond the Combination Period or (y) amend the foregoing provisions.

 These provisions cannot be amended
without the approval of holders of at least two-thirds of our Ordinary Shares present and voting at a general meeting. In the event we
seek shareholder approval in connection with our initial Business Combination, our Amended and Restated Memorandum provide that we may
consummate our initial Business Combination only if approved by an ordinary resolution under Cayman Islands law, being the affirmative
vote of a majority of the shares represented in person or by proxy and entitled to vote thereon and who vote at a general meeting in favor
of the Business Combination.

 Additionally, our Amended and
Restated Memorandum provide that, prior to our initial Business Combination, holders of our Founder Shares are the only shareholders that
will have the right to vote on the appointment of directors and the right to remove a member of the Board of Directors for any reason.
These provisions of our Amended and Restated Memorandum may only be amended by a special resolution passed by at least 90% of our shares
voting in a general meeting. With respect to any other matter submitted to a vote of our shareholders, including any vote in connection
with our initial Business Combination, except as required by law, holders of our Founder Shares and holders of our Public Shares will
vote together as a single class, with each share entitling the holder to one vote.

 Competition

 We
have encountered and expect to continue to encounter intense competition from other entities having a business objective similar to ours,
including private investors (which may be individuals or investment partnerships), other blank check companies and other entities, domestic
and international, competing for the types of businesses we intend to acquire. Many of these individuals and entities are well-established
and have extensive experience in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing
services to various industries. Many of these competitors possess greater technical, human and other resources or more local industry
knowledge than we do and our financial resources will be relatively limited when contrasted with those of many of these competitors.
Our ability to compete with respect to the acquisition of certain target businesses that are sizable will be limited by our available
financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses.
Furthermore, in the event we seek shareholder approval of our initial Business Combination and we are obligated to pay cash for our Class
A Ordinary Shares, it will potentially reduce the resources available to us for our initial Business Combination. Any of these obligations
may place us at a competitive disadvantage in successfully negotiating a Business Combination. We may furthermore face competition from
other newly formed entities that may target a Business Combination transaction with similar focus areas as ours, which may intensify
the competition that we face in achieving our objective.

 Conflicts
of Interest

 Certain of our executive officers
and directors have or may have fiduciary and contractual duties to certain companies in which they have invested. These entities may compete
with us for acquisition opportunities. If these entities decide to pursue any such opportunity, we may be precluded from pursuing it.
However, we do not expect these duties to present a significant conflict of interest with our search for an initial Business Combination.

 Certain of our officers and directors
presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to
which such officer or director is or will be required to present a Business Combination opportunity to such entity. Accordingly, if any
of our officers or directors becomes aware of a Business Combination opportunity that is suitable for an entity to which he or she has
then-current fiduciary or contractual obligations, he or she may need to honor these fiduciary or contractual obligations to present such
Business Combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. We do not believe, however,
that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial
Business Combination. Our Amended and Restated Memorandum provide that, to the fullest extent permitted by applicable law: (i) no individual
serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging
directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy
in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for
any director or officer, on the one hand, and us, on the other.

 Facilities

 We currently maintain our executive
offices at 265 Franklin Street, Suite 1702, Boston, MA 02110. In addition, we have entered into an Administrative Services Agreement pursuant
to which we are paying our sponsor for office space, utilities and administrative support services, in an amount of $3,000 per month.
We consider our current office space adequate for our current operations.

 Employees

 As of the date of this Report,
we have two (2) officers. Members of our Management Team are not obligated to devote any specific number of hours to our matters, but
they devote as much of their time as they deem necessary to our affairs until we have completed our initial Business Combination. The
amount of time that our officers or any other members of our Management Team devote in any time period varies based on the current stage
of the Business Combination process.

 Periodic
Reporting and Financial Information

 We have registered our Units,
Class A Ordinary Shares and Warrants under the Exchange Act and have reporting obligations, including the requirement that we file annual,
quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports, including this
Report, contain financial statements audited and reported on by our independent registered public auditors.

 We will provide shareholders with
audited financial statements of the prospective target business as part of the tender offer materials or proxy solicitation materials
sent to shareholders to assist them in assessing the target business, such as the Scage Registration Statement. These financial statements
may be required to be prepared in accordance with, or be reconciled to, GAAP or International Financial Reporting Standards, depending
on the circumstances and the historical financial statements may be required to be audited in accordance with PCAOB standards. These financial
statement requirements may limit the pool of potential target businesses we may acquire because some targets may be unable to provide
such financial statements in time for us to disclose such financial statements in accordance with federal proxy rules and complete our
initial Business Combination within the prescribed time frame. While this may limit the pool of potential Business Combination candidates,
we do not believe that this limitation will be material.

 We
have evaluated our internal control procedures for the fiscal year ending December 31, 2023, as required by the Sarbanes-Oxley Act. Only
in the event we are deemed to be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company,
will we be required to have our internal control procedures audited. A target business may not be in compliance with the provisions of
the Sarbanes-Oxley Act regarding adequacy of their internal controls. The development of the internal controls of any such entity to
achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete any such acquisition.

 We
are an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such,
we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not "emerging growth companies" including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 In
addition, Section 107 of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other
words, an "emerging growth company" can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We intend to take advantage of the benefits of this extended transition period.

 We will remain an emerging growth
company until the earlier of (1) the last day of the fiscal year (a) following November 8, 2026, (b) in which we have total annual gross
revenue of at least $1.235 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our
Ordinary Shares that is held by non-affiliates exceeds $700 million as of the end of the prior fiscal year's second fiscal quarter,
and (2) the date on which we have issued more than $1.00 billion in non-convertible debt securities during the prior three-year period.
References herein to "emerging growth company" shall have the meaning associated with it in the JOBS Act.

 Additionally,
we are a "smaller reporting company" as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our Ordinary Shares
held by non-affiliates exceeds $250 million as of the end of that year's second fiscal quarter, or (2) our annual revenues exceeded
$100 million during such completed fiscal year and the market value of our Ordinary Shares held by non-affiliates exceeds $700 million
as of the end of that year's second fiscal quarter.

 We are a Cayman Islands exempted
company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted
from complying with certain provisions of the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to
time. As an exempted company, we have applied for and received a tax exemption undertaking from the Cayman Islands government that, in
accordance with Section 6 of the Tax Concessions Act (Revised) of the Cayman Islands, for a period of 20 years from the date
of the undertaking, no law that is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations
will apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in
the nature of estate duty or inheritance tax will be payable (i) on or in respect of our shares, debentures or other obligations
or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to
our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.

 Item
1A. Risk Factors

 As
a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. However,
the following is a partial list of material risks, uncertainties and other factors that could have a material effect on us and our operations:

 we
 are a blank check company and an early-stage company with no revenue or basis to evaluate our ability to select a suitable business
 target;

 we
 may not be able to select an appropriate target business or businesses and complete our initial Business Combination, including the
 Scage Business Combination, in the prescribed time frame;

 our
 expectations around the performance of a prospective target business or businesses, such as Scage, may not be realized;

 we
 may not be successful in retaining or recruiting required officers, key employees or directors following our initial Business Combination,
 including the Scage Business Combination;

 our
 officers and directors may have difficulties allocating their time between our Company and other businesses and may potentially have
 conflicts of interest with our business or in approving our initial Business Combination;

 we
 may not be able to obtain additional financing to complete our initial Business Combination or reduce the number of shareholders
 requesting redemption;

 we
 may issue our shares to investors in connection with our initial Business Combination at a price that is less than the prevailing
 market price of our shares at that time;

 our
 shareholders may not be given the opportunity to choose the initial business target or to vote on the initial Business Combination;

 Trust
 Account funds may not be protected against third-party claims or bankruptcy;

 an
 active market for our public securities may not develop and our shareholders will have limited liquidity and trading;

 our
 financial performance following a Business Combination with an entity may be negatively affected by their lack of an established
 record of revenue, cash flows and experienced management;

 there
 may be more competition to find an attractive target for an initial Business Combination, which could increase the costs associated
 with completing our initial Business Combination and may result in our inability to find a suitable target;

 changes
 in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate
 and complete an initial Business Combination;

 if
 we do not consummate the Scage Business Combination, we may attempt to simultaneously complete Business Combinations with multiple
 prospective targets, which may hinder our ability to complete our initial Business Combination and give rise to increased costs and
 risks that could negatively impact our operations and profitability;

 we
 may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after the Initial
 Public Offering, which may include acting as a financial advisor in connection with an initial Business Combination or as placement
 agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred underwriting commissions
 that will be released from the Trust Account only upon completion of an initial Business Combination. These financial incentives
 may cause them to have potential conflicts of interest in rendering any such additional services to us after the Initial Public Offering,
 including, for example, in connection with the sourcing and consummation of an initial Business Combination;

 we
 may attempt to complete our initial Business Combination with a private company about which little information is available, such
 as Scage, which may result in a Business Combination with a company that is not as profitable as we suspected, if at all

 some
 of our Warrants are accounted for as derivative liabilities and are recorded at fair value upon issuance with changes in fair value
 each period reported in earnings, which may have an adverse effect on the market price of our Ordinary Shares or may make it more
 difficult for us to consummate an initial Business Combination;

 since
 our Initial Shareholders will lose their entire investment in us if our initial Business Combination is not completed (other than
 with respect to any Public Shares they may acquire during or after the Initial Public Offering), and because our Sponsor, officers
 and directors may profit substantially even under circumstances in which our Public Shareholders would experience losses in connection
 with their investment, a conflict of interest may arise in determining whether a particular Business Combination target is appropriate
 for our initial Business Combination;

 the
 value of the Founder Shares following completion of our initial Business Combination is likely to be substantially higher than the
 nominal price paid for them, even if the trading price of our Ordinary Shares at such time is substantially less than $11.07 per
 share (as of December 31, 2023);

 resources
 could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to
 locate and acquire or merge with another business. If we have not completed our initial Business Combination within the Combination
 Period, our Public Shareholders may receive only approximately $11.07 per share (as of December 31, 2023), or less than such amount in certain circumstances,
 on the liquidation of our Trust Account and our Warrants will expire worthless;

 We
 may not be able to complete an initial Business Combination with certain potential target companies if a proposed transaction with
 the target company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or
 regulations, including the Committee on Foreign Investment in the United States ("CFIUS"). Of the approximately 98% of
 interests in the Sponsor owned by non-U.S. persons, approximately 58% are owned by persons in Hong Kong S.A.R., 16% are owned by
 persons in Israel, 12% are owned by persons in Malaysia and 12% are owned by persons in China. Accordingly, CFIUS may consider us to
 be a "foreign person";

 recent
 increases in inflation and interest rates in the United States and elsewhere could make it more difficult for us to consummate an
 initial Business Combination;

 market
 conditions, economic uncertainty or downturns could adversely affect our business, financial condition, operating results and our
 ability to consummate a Business Combination;

 adverse
 developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance
 by financial institutions, could adversely affect our business, financial condition or results of operations, or our prospects;

 military
 or other conflicts in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded
 securities, or affect the operations or financial condition of potential target companies, which could make it more difficult for
 us to consummate an initial Business Combination;

 if
 our initial Business Combination involves a company organized under the laws of a state of the United States, it is possible the
 Excise Tax will be imposed on us in connection with redemptions of our Ordinary Shares after or in connection with such initial Business
 Combination;

 we
 have received notices from the Listing Qualifications Department of Nasdaq notifying us that we were not
 in compliance with certain Nasdaq Listing Rules, namely the requirements to hold an annual meeting of shareholders and to maintain
 a certain number of Public Shareholders. If we cannot regain compliance, our securities will be subject to delisting, and the liquidity
 and the trading price of our securities could be adversely affected;

 there
 is substantial doubt about our ability to continue as a "going concern"; and

 we
 have identified a material weakness in our internal control over financial reporting as of December 31, 2023. If we are unable to
 develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our
 financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our
 business and operating results.

 We
may seek to further extend the Combination Period, which could have a material adverse effect on the amount held in our Trust Account
and other adverse effects on our Company.

 We
may seek to further extend the Combination Period. Such an extension would require the approval of our Public Shareholders, who will
be provided the opportunity to redeem all or a portion their Public Shares. Such redemptions will likely have a material adverse effect
on the amount held in our Trust Account, our capitalization, principal shareholders and other impacts on our Company or Management Team,
such as our ability to maintain our listing on Nasdaq.

 Cyber
incidents or attacks directed at us or third parties could result in information theft, data corruption, operational disruption and/or
financial loss.

 We
depend on digital technologies, including information systems, infrastructure and cloud applications and services, including those of
third parties with whom we may deal. Sophisticated and deliberate attacks on, or security breaches in, our systems or infrastructure,
or the systems or infrastructure of third parties or the cloud, could lead to corruption or misappropriation of our assets, proprietary
information and sensitive or confidential data. As an early-stage company without significant investments in data security protection,
we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to
investigate and remediate any vulnerability to, cyber incidents. Any of these occurrences, or a combination of them, could have material
adverse consequences on our business and lead to financial loss.

 Changes
in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability
to negotiate and complete our initial Business Combination, and results of operations.

 We
are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with
certain SEC and other legal requirements and numerous complex tax laws. Compliance with, and monitoring of, applicable laws and regulations
may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from
time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition,
a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business,
including our ability to negotiate and complete our initial Business Combination, and results of operations.

 On
January 24, 2024, the SEC adopted the 2024 SPAC Rules requiring, among other matters, (i) additional disclosures relating to SPAC Business
Combination transactions (ii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their
affiliates in both SPAC initial public offerings and Business Combination transactions; (iii) additional disclosures regarding projections
included in SEC filings in connection with proposed Business Combination transactions and (iv) the requirement that both the SPAC
and its target company be co-registrants for Business Combination registration statements

 In
addition, the SEC's adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation
under the Investment Company Act, including its duration, asset composition, business purpose, and the activities of the SPAC and its
management team in furtherance of such goals.

 Compliance
with the 2024 SPAC Rules and related guidance may (i) increase the costs of and the time needed to negotiate and complete an initial
Business Combination and (ii) constrain the circumstances under which we could affect our ability to complete an initial Business Combination.

 If
we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements
and our activities may be restricted, which may make it difficult for us to complete our initial Business Combination.

 The
SEC's adopting release with respect to the 2024 SPAC Rules provided guidance relating to the potential status of SPACs as investment
companies subject to regulation under the Investment Company Act and the regulations thereunder. Whether a SPAC is an investment company
is dependent on specific facts and circumstances and we can give no assurance that a claim will not be made that we have been operating
as an unregistered investment company.

 If
we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including (i) restrictions
on the nature of our investments; and (ii) restrictions on the issuance of securities, each of which may make it difficult for us to
complete our initial Business Combination.

 In
addition, we may have imposed upon us burdensome requirements, including: (i) registration as an investment company; (ii) adoption of
a specific form of corporate structure; and (iii) reporting, record keeping, voting, proxy and disclosure requirements and other rules
and regulations.

 In
order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must
ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities
do not include investing, reinvesting, owning, holding or trading "investment securities" constituting more than 40% of our
total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. We are mindful of the SEC's investment
company definition and guidance and intend to complete an initial Business Combination with an operating business, and not with an investment
company, or to acquire minority interests in other businesses exceeding the permitted threshold.

 We
do not believe that our business activities will subject us to the Investment Company Act. To this end, the proceeds held in the Trust
Account were initially invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds
meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations;
the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination.
To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases
the longer that we hold investments in the Trust Account, on November 1, 2023, we instructed Continental, as trustee of the Trust Account,
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing
demand deposit account at a bank.

to the Trust Agreement, Continental is not permitted to invest in securities or assets other than as described above. By restricting
the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the
long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intended to avoid
being deemed an "investment company" within the meaning of the Investment Company Act. Our Initial Public Offering was not
intended for persons who were seeking a return on investments in government securities or investment securities. The Trust Account is
intended solely as a temporary depository for funds pending the earliest to occur of: (i) the completion of our initial Business Combination;
(ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend our Amended and Restated Charter
(x) in a manner that would affect the substance or timing of our obligation to redeem 100% of our Public Shares if we do not complete
our initial Business Combination within the Combination Period; or (y) with respect to any other provision relating to the rights of
holders of our Class A Ordinary Shares or pre-initial Business Combination activity; or (iii) absent an initial Business Combination
within the Combination Period, our return of the funds held in the Trust Account to our Public Shareholders as part of our redemption
of the Public Shares.

 We
are aware of litigation claiming that certain SPACs should be considered investment companies. Although we believe that these claims
are without merit, we cannot guarantee that we will not be deemed to be an investment company and thus subject to the Investment Company
Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require
additional expenses for which we have not allotted funds and may hinder our ability to complete an initial Business Combination or may
result in our liquidation. If we are unable to complete our initial Business Combination, our Public Stockholders may receive only approximately
$11.07 (as of December 31, 2023) per Public Share upon the liquidation of our Trust Account and our Warrants will expire worthless.

 We have identified a material weakness in our
internal control over financial reporting as of December 31, 2023. If we are unable to develop and maintain an effective system of internal
control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely
affect investor confidence in us and materially and adversely affect our business and operating results.

 We have identified a material
weakness in our internal controls over financial reporting as of December 31, 2023 relating to our accounting for complex financial instruments,
recognition of billed and unbilled professional fees, recognition of prepaid expenses, classification of related party payables and accounting
for related party notes payable. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial
reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will
not be prevented or detected and corrected on a timely basis.

 Effective internal controls are
necessary for us to provide reliable financial reports and prevent fraud. Measures to remediate material weaknesses may be time-consuming
and costly and there is no assurance that such initiatives will ultimately have the intended effects. If we are unable to develop and
maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results
in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating
results. If we identify any new material weaknesses in the future, any such newly identified material weakness could limit our
ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual
or interim financial statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely
filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial
reporting and adversely affect our business and operating results. We cannot assure you that the measures we have taken to date, or any
measures we may take in the future, will be sufficient to avoid potential future material weaknesses.

 For
additional risks relating to our operations, other than as set forth above, see the section titled "Risk Factors" contained
in our (i) IPO Registration Statement, (ii) 2022 Annual Report, (iii) Quarterly Reports
on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, and September 30, 2023,
 as filed with the SEC on May 22, 2023, November 6, 2023, and December 14, 2023, respectively,
and (iv) Definitive Proxy Statement on Schedule 14A filed with the SEC on April 28, 2023. Any of these factors could result in
a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also
affect our business or ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose
additional risk factors from time to time in our future filings with the SEC.

 For
risks related to Scage and the Scage Business Combination, please see the Scage Registration Statement once filed.

 Item
1B. Unresolved Staff Comments

 None.

 Item
1C. Cybersecurity.

 As
a blank check company, we do not have any operations and our sole business activity has been to search for and consummate a Business
Combination. However, because we have investments in our Trust Account and bank deposits and we depend on the digital technologies of
third parties, we and third parties may be subject to attacks on or security breaches in our or their systems. Because of our reliance
on the technologies of third parties, we also depend upon the personnel and the processes of third parties to protect against cybersecurity
threats, and we have no personnel or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, the
Management Team will report to the Board of Directors and provide updates on the Management Team's incident response plan for addressing
and mitigating any risks associated with such an incident. As an early-stage company without significant investments in data security
protection, we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against,
or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination
of them, could have material adverse consequences on our business and lead to financial loss. We have not encountered any cybersecurity
incidents since our Initial Public Offering.

 Item
2. Property

 Our
executive offices are located at 265 Franklin Street, Suite 1702, Boston, MA, and our telephone number is (424) 253-0908. The cost for
our use of this space is included in the $3,000 per month fee we pay to our Sponsor or to an affiliate of our Sponsor for office space,
administrative and shared personnel support services, pursuant to the Administrative Services Agreement. We consider our current office
space adequate for our current operations.

 Item
3. Legal Proceedings

 To
the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our officers
or directors in their capacity as such or against any of our property.

 Item
4. Mine Safety Disclosures

 Not
applicable.

 PART
II

 Item
5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 (a)

 Market
 Information

 Our
Units, Public Shares and Public Warrants are each traded on Nasdaq under the symbols "FNVTU,"
"FNVT" and "FNVTW," respectively. Our Units commenced public trading on November
4, 2021, and our Public Shares and Public Warrants commenced separate public trading on December
8, 2021.

 (b)

 Holders

 On April 1, 2024 there was one
holder of record of our Units, seven holders of record of our Class A Ordinary Shares, and three holders of record of our Warrants (on
a stand-alone basis, apart from our Units).

 (c)

 Dividends

 We
have not paid any cash dividends on our Ordinary Shares to date and do not intend to pay cash dividends prior to the completion of our
initial Business Combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital
requirements and general financial condition subsequent to completion of our initial Business Combination. The payment of any cash dividends
subsequent to our initial Business Combination will be within the discretion of our Board of Directors at such time. In addition, our
Board of Directors is not currently contemplating and does not anticipate declaring any stock dividends in the foreseeable future. Further,
if we incur any indebtedness in connection with our initial Business Combination, our ability to declare dividends may be limited by
restrictive covenants we may agree to in connection therewith.

 (d)

 Securities
 Authorized for Issuance Under Equity Compensation Plans

 None.

 (e)

 Recent
 Sales of Unregistered Securities

 On May
8, 2023, we issued an aggregate of 4,237,499 Class A Ordinary Shares to the Sponsor and an aggregate of 75,000 Class A Ordinary Shares
to Mitch Garber, Nadav Zohar and Gustavo Schwed, our former directors, upon the conversion of an equal number of Class B Ordinary Shares
held by the Sponsor, Mitch Garber, Nadav Zohar and Gustavo Schwed in the Founder Share Conversion. The Class A Ordinary Shares issued
in connection with the Founder Share Conversion are subject to the same restrictions as applied to the Class B Ordinary Shares before
the Founder Share Conversion, including, among others, certain transfer restrictions, waiver of redemption rights and the obligation to
vote in favor of an initial Business Combination as described in the IPO Registration Statement; consequently, the Class A Ordinary Shares
issued in connection with the Founder Share Conversion are not registered under the Securities Act and remain unregistered until registration
is demanded by the Sponsor pursuant to the Letter Agreement. Following the Founder Share Conversion and the redemptions in connection
with the Extension, (i) there were (i) 9,085,831 Class A Ordinary Shares issued and outstanding and one Class B Ordinary Share issued
and outstanding, and (ii) the Sponsor and certain designees of Sunorange held 47.4% of the outstanding Class A Ordinary Shares. For more
information on the Founder Share Conversion, see "Item 1. Business—Founder Share Conversion. "

 (f)

 Use
 of Proceeds from the Initial Public Offering

 For
a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of our
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the SEC on November 10, 2022. There
has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in
the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.

 On
November 1, 2023, we instructed Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the
Trust Account in an interest-bearing demand deposit account at Morgan Stanley, with Continental continuing to act as trustee, until the
earlier of the consummation of our initial Business Combination or our liquidation. As a result, following the liquidation of investments
in the Trust Account, the remaining proceeds from the Initial Public Offering and Private Placement are no longer invested in U.S. government
securities or money market funds invested in U.S. government securities.

 (g)

 Purchases
 of Equity Securities by the Issuer and Affiliated Purchasers

 None.

 Item
6. [Reserved]

 Item
7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

 Cautionary
Note Regarding Forward-Looking Statements

 All
statements other than statements of historical fact included in this Report including, without limitation, statements under this Item
regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking
statements. When used in this Report, words such as "anticipate," "believe," "estimate," "expect,"
"intend" and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking
statements are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management.
Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed
in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf
are qualified in their entirety by this paragraph.

 The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial
statements and the notes thereto contained elsewhere in this Report.

 Overview

 We are a blank check company incorporated
in the Cayman Islands on March 15, 2021 and formed for the purpose of entering into a Business Combination with one or more businesses.

 We
consummated our Initial Public Offering on November 8, 2021 and are currently in the process of consummating the Scage Business Combination.

 The
issuance of additional shares in an initial Business Combination:

 may
 significantly dilute the equity interest of investors in the Initial Public Offering, which dilution would increase if the anti-dilution
 provisions in our Class B Ordinary Shares resulted in the issuance of our Class A Ordinary Shares on a greater than one- to-one basis
 upon conversion of our Class B Ordinary Shares;

 may
 subordinate the rights of holders of our Class A Ordinary Shares if shares of preferred shares are issued with rights senior to those
 afforded our Class A Ordinary Shares;

 could
 cause a change in control if a substantial number of shares of our Class A Ordinary Shares are issued, which may affect, among other
 things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present
 officers and directors;

 may
 have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person
 seeking to obtain control of us; and

 may
 adversely affect prevailing market prices for our Class A Ordinary Shares and/or Warrants.

 Similarly,
 if we issue debt securities, or otherwise incur significant debt, it could result in:

 default
 and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt
 obligations;

 acceleration
 of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants
 that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of such covenants;

 our
 immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;

 our
 inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing
 while the debt is outstanding;

 our
 inability to pay dividends on our ordinary or preferred shares;

 using
 a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends
 on our Ordinary Shares if declared and our ability to pay expenses, make capital expenditures and acquisitions and fund other general
 corporate purposes;

 limitations
 on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

 increased
 vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
 and

 limitations
 on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements and execution
 of our strategy and for other purposes, and other disadvantages compared to our competitors who have less debt.

 We
completed the sale of 15,000,000 Units at $10.00 per Unit on November 8, 2021. Simultaneous with the closing of the Initial Public Offering,
we completed the sale of 7,900,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement
to our Sponsor as well as to EarlyBirdCapital, generating gross proceeds of $7,900,000 from the sale of the Private Placement Warrants.

 On
November 12, 2021, we closed on the full exercise of the underwriters' over-allotment option, which resulted in the sale of an
additional 2,250,000 Units for additional gross proceeds to us of $22,500,000 and aggregate IPO and over-allotment gross proceeds of
$172,500,000. Simultaneously with the exercise of the over-allotment, the Sponsor purchased an additional 900,000 Private Placement Warrants,
which resulted in additional gross proceeds of $900,000 and aggregate private placement proceeds from the IPO and over-allotment of $8,800,000.

 Following the closing of the IPO
on November 8, 2021 and the subsequent exercise of the over-allotment option, $175,950,000 ($10.20 per Unit) from the net proceeds of
the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in the Trust Account, located in the United
States at a nationally recognized financial institution, with Continental acting as trustee and until November 2, 2023 invested only in
in United States "government securities" within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity
of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which
invest only in direct U.S. government treasury obligations. Pursuant to the Trust Agreement, the trustee will not be permitted to invest
in other securities or assets. As of November 2, 2023, the funds in the Trust Account were moved to an interest-bearing demand deposit
account.

 Sunorange

 On
April 27, 2023, we entered into the Investment Agreement with the Sponsor and Sunorange, pursuant to which Sunorange and its designees
shall acquire partnership interests in the Sponsor and Class B Ordinary Shares directly held by certain of our directors, which combined
interests will entitle Sunorange to receive, in the aggregate, the Insider Securities, consisting of 3,557,813 Class B Ordinary Shares
and 6,160,000 Private Placement Warrants, and we shall introduce a change in Management and the Board as follows: (i) Calvin Kung shall
replace David Gershon as Chairman of the Board and Chief Executive Officer and Wang Chiu (Tommy) Wong shall replace Ron Golan as Chief
Financial Officer and director on the Board, effective upon closing of the Sunorange Investment; (ii) Jonathan Ophir and Uri Chaitchik
shall tender their resignations as Chief Investment Officer and Senior Consultant, respectively, effective upon closing of the Sunorange
Investment; and (iii) Mitch Garber, Gustavo Schwed and Nadav Zohar shall tender their resignations as directors, to be effective upon
expiration of the Waiting Period and whose vacancies shall be filled by New Management.

 On
May 8, 2023, we completed the closing of the Sunorange Investment after our shareholders approved of certain proposals at the 2023 EGM,
and after certain closing conditions were met, including but not limited to: (i) a minimum of $30 million remaining in the Trust Account
after accounting for all redemptions in connection with the 2023 EGM; (ii) us obtaining or extending a directors and officers insurance
policy on terms satisfactory to the parties; (iii) the conversion of Class B Ordinary Shares into Class A Ordinary Shares as needed to
retain shareholders and meet continued listing requirements of Nasdaq in the event that the Extension is approved; (iv) the amendment
of the Sponsor's existing limited partnership agreement; (v) the transfer of 61,875 Class B Ordinary Shares from certain of our
directors to Sunorange or its designees and (vi) the cancellation of the outstanding Working Capital Loan from the Sponsor and the reduction
of certain advisory fees to be due upon the closing of an initial Business Combination.

 In
connection with the closing of the Sunorange Investment, on May 8, 2023, Sunorange caused $300,000 to be deposited into the Trust Account
to support the first three months of the Extension. Sunorange has agreed to deposit into the Trust Account an additional $100,000 for
each successive month, or portion thereof, that is needed by us to complete an initial Business Combination until May 8, 2024. Through
December 31, 2023, $800,000 has been deposited into the Trust Account in support of the Extension.

 Extension
of our Combination Period

 On
May 8, 2023, we held the 2023 EGM to amend our Amended and Restated Memorandum to: (i) approve the Extension and (ii) to entitle holders
of Class B Ordinary Shares to convert such shares into Class A Ordinary Shares prior to the closing of an initial Business Combination
at the election of the holder.

 There
were 21,712,500 of our Ordinary Shares issued and outstanding on April 14, 2023, the record date for the 2023 EGM. At the 2023 EGM, there
were 14,402,264 ordinary shares present in person or by proxy, representing approximately 66.33% of the total Ordinary Shares outstanding
as of the record date, which constituted a quorum.

 Shareholders
holding 12,626,668 Class A Ordinary Shares exercised their right to redeem such shares for a pro rata portion of the funds in our Trust
Account. These shares were redeemed for approximately $10.50 per share for a total redemption value paid from the Trust Account of approximately
$132,616,922.

 In
connection with the 2023 EGM and pursuant to the Investment Agreement, Sunorange will contribute to us loans of the lesser of (i) $100,000
or (ii) $0.033 for each Public Share that is not redeemed for each calendar month (commencing on May 8, 2023 and ending on the 8th day
of each subsequent month), or portion thereof, that is needed by us to complete an initial Business Combination until May 8, 2024.

 On
June 2, 2023, we issued the June 2023 Promissory Note in the aggregate principal amount of up to $1,200,000 to the Sponsor, which will
be deposited into the Trust Account for the benefit of each Public Share that was not redeemed in connection with our May 8, 2023 shareholder
vote to approve the Extension. The Sponsor agreed to pay $100,000 per month until the completion of an initial Business Combination,
commencing on May 8, 2023 and continuing through May 8, 2024. The June 2023 Promissory Note bears no interest and is due and payable
upon the earlier to occur of (i) the date on which we consummate our Business Combination and (ii) the date that our winding up is effective.
At the election of the Sponsor, up to $1,200,000 of the unpaid principal amount of the June 2023 Promissory Note may be converted into
Conversion Warrants at a conversion price of $1.00 per Warrant. The Conversion Warrants shall be identical to the Private Placement Warrants
issued by us at the IPO. We have determined that the fair value of the June 2023 Promissory Note is its face value as the note was not
issued with a substantial premium. The Sponsor funded the first three months of the June 2023 Promissory Note in its first payment. As
of December 31, 2023, the Sponsor had deposited an aggregate of $800,0000 into the Trust Account to support the Extension on behalf of
the Company. As of December 31, 2023, the outstanding balance of the June 2023 Promissory Note was $800,000, and no interest was accrued.

 Founder
Share Conversion

 On
May 8, 2023, we issued an aggregate of 4,237,499 Founder Shares to the Sponsor upon the Founder Share Conversion.

 Also
on May 8, 2023, we issued an aggregate of 75,000 Class A Ordinary Shares to our former independent directors and the holders of our 75,000
Class B Ordinary Shares upon the conversion of an equal number of shares of Class B Ordinary Shares. On the same day, in connection with
the closing of the Sunorange Investment, the Class A Ordinary Shares held by the directors were transferred to designees of Sunorange.

 The
Class A Ordinary Shares issued in connection with the Founder Share Conversion are subject to the same restrictions as applied to the
Class B Ordinary Shares before the Founder Share Conversion, including, among other things, certain transfer restrictions, waiver of
redemption rights and the obligation to vote in favor of an initial Business Combination as described in the IPO Registration Statement.
Following the Conversion, there were 9,085,831 Class A Ordinary Shares issued and outstanding and one Class B Ordinary Share issued and
outstanding. As a result of the Founder Share Conversion, the Sponsor and certain designees of Sunorange hold, in the aggregate, approximately
47.5% of our Class A Ordinary Shares that are outstanding.

 Scage
Business Combination

 On August 21, 2023, we entered
into the Scage Business Combination Agreement with Pubco, First Merger Sub, Second Merger Sub and Scage. The Scage Business Combination
Agreement was unanimously approved by our Board of Directors. If the Scage Business Combination Agreement is approved by our stockholders,
and the Scage Business Combination is consummated, (i) First Merger Sub will merge with and into Scage, with Scage surviving the First
Merger as a wholly-owned subsidiary of Pubco and the outstanding securities of Scage being converted into the right to receive securities
of Pubco; and (ii) immediately following the First Merger, Second Merger Sub will merge with and into our Company, with our Company surviving
the Second Merger as a wholly-owned subsidiary of Pubco and the outstanding securities of our Company being converted into the right to
receive securities of Pubco.

 For
a full description of the Scage Business Combination Agreement and the proposed Scage Business Combination, please see "Item 1.
Business".

 Nasdaq
Compliance – Minimum Total Holders

 On October 9, 2023, we received
a deficiency notice from the Listing Qualifications Department of Nasdaq (the "Staff:") notifying us that we no longer meets
the minimum 400 total holders requirement for Nasdaq pursuant to Listing Rule 5450(a)(2) (the "Minimum Total Holders Requirement").
The notification received has no immediate effect on our Nasdaq listing. On November 24, 2023, we submitted to Nasdaq a plan to regain
compliance with the Minimum Total Holders Requirement.

 Recent
Developments

 Nasdaq
Compliance—Annual Meeting Requirement

 On
January 22, 2024, we received a deficiency notice from the Staff of Nasdaq notifying us that we are not in compliance with Nasdaq Listing
Rule 5620(a), which requires that Nasdaq-listed companies hold an annual meeting of shareholders within twelve months of their fiscal
year end (the "Annual Meeting Requirement"), because the Company did not hold an annual meeting of shareholders within twelve
months of its fiscal year ended December 31, 2022. The notification received has no immediate effect on the Company's Nasdaq listing.
On March 7, 2024, we submitted to Nasdaq a plan to regain compliance with the Annual Meeting Requirement, pursuant to which we requested an extension through June 28, 2024, by
which date we must regain compliance with the Annual Meeting Requirement.

 Scage
January 2024 Promissory Note

 On
January 26, 2024, we issued the January 2024 Promissory Note in the aggregate principal amount of up to $1,500,000 to Scage, for our working capital needs. The January 2024 Promissory Note does not bear interest and matures upon the earlier of the closing
of our initial Business Combination and our liquidation.

 Extension
Deposits

 In each of the months of January,
February and March, $100,000, for an aggregate of $300,000, was deposited into the Trust Account in connection with the Extension.

 Results
of Operations

 As
of December 31, 2023, we have not commenced any operations. All activity for the period from March 15, 2021 (inception) through December
31, 2023, relates to our formation and Initial Public Offering that occurred on November 8, 2021, and, since the completion of the Initial
Public Offering, searching for a target to consummate an initial Business Combination. We will not generate any operating revenues until
after the completion of an initial Business Combination, at the earliest. We will generate non-operating income in the form of interest
income from the proceeds derived from the Initial Public Offering and placed in the Trust Account. There has been no significant change
in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements,
December 31, 2023.

 For
the year ended December 31, 2023, we had a net income of $2,494,909 consisting of $4,488,038 in interest earned on the bank account and
the investment held in Trust Account offset by $1,993,129 in formation, general and administrative expenses.

 For
the year ended December 31, 2022, we had a net income of $1,110,622, consisting of $2,583,038 in interest earned on the bank account
and the investment held in Trust Account offset by $1,472,416 in formation, general and administrative
expenses.

 Factors
That May Adversely Affect our Results of Operations

 Our
results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could
cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted
by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in
interest rates, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical
instability, such as the military conflicts in Ukraine and the Middle East. We cannot at this time predict the likelihood of one
or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability
to complete an initial Business Combination.

 Liquidity,
Capital Resources and Going Concern

 As
of December 31, 2023, we had cash outside our Trust Account of $37 available for working capital needs. All remaining cash was held in
the Trust Account and is generally unavailable for our use prior to our initial Business Combination.

 For
the year ended December 31, 2023, we used $786,645 in operating activities, which was largely driven by $4,486,207 in interest earned
on our investments held in the Trust Account offset by $2,494,909 in net income as well as changes in prepaid expenses of $277,113,
accounts payable and accrued expenses of $912,404 and due to related party of $15,136.

 For
the year ended December 31, 2023, we were provided $131,816,922 from our investing activities, which was driven by $132,616,922 redemptions
as a result of our extraordinary shareholder meeting offset by $800,000 in Extension contributions.

 For
the year ended December 31, 2023, we utilized $131,274,419 in our financing activities, which was the result of the $132,616,922 payout
of redemptions by our shareholders offset by $1,342,503 in proceeds from our promissory notes.

 As
noted above, pursuant to our Initial Public Offering on November 8, 2021 and the full exercise of the over-allotment option on November
12, 2021, we sold 17,250,000 Units at a price of $10.00 per Unit, generating gross proceeds to us of $172,500,000. These funds as well
as a portion of the $8,800,000 in proceeds from the sale of Private Placement Warrants were placed in the Trust Account such that the
Trust Account held an aggregate of $175,900,000, or $10.20 per Unit, as of November 12, 2021. These funds are to be invested in U.S.
government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or
less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the
Investment Company Act, as determined by the Company. As of December 31, 2023, $51,200,344 of the Initial Public Offering proceeds as
well as interest earned thereon were held in The Trust Account.

 On
November 1, 2023, we instructed Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the
Trust Account in an interest-bearing demand deposit account at Morgan Stanley with Continental continuing to act as trustee, until the
earlier of the consummation of our initial Business Combination or our liquidation. As a result, following the liquidation of investments
in the Trust Account, the remaining proceeds from the Initial Public Offering and Private Placement are no longer invested in U.S. government
securities or money market funds invested in U.S. government securities.

 `
In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination,
our Initial Shareholders or their affiliates or certain of our officers and directors may, but are not obligated to, loan us funds as
may be required. If we complete our initial Business Combination, we would repay such loaned amounts (subject to the conversion rights
described below). In the event that our initial Business Combination does not close, we may use a portion of the working capital held
outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to
$1,500,000 of such loans may at the option of the lender determined at the time of the loan be convertible into Warrants at a price of
$1.00 per Warrant of the post-initial Business Combination entity. The Warrants would be identical to the Private Placement Warrants,
including as to exercise price, exercisability and exercise period of the underlying Warrants. As of December 31, 2023 and 2022, we had
$0 and $449,765 of outstanding borrowings under the Working Capital Loan, respectively.

 On
May 8, 2023, in connection with the Sunorange Investment, the Working Capital Loan and all amounts outstanding thereunder were canceled
in full. This was deemed to be a benefit to us under SAB Topic 5T. In order to recognize this benefit, we de-recognized the outstanding
promissory note and reclassified it to additional paid-in capital, as an in-substance capital contribution.

 On
November 8, 2023, we issued the November 2023 Promissory Note in the principal amount of up to $1,500,000 to Sunorange. The November
2023 Promissory Note was issued in connection with advances made by Sunorange since May 8, 2023 and advances Sunorange may make in the
future to us for working capital expenses. The November 2023 Promissory Note is non-interest bearing and payable upon the earlier
of (i) the date of the consummation of the Business Combination or (ii) the date of our liquidation. As of December 31, 2023 we had $542,503
outstanding under the November 2023 Promissory Note.

 On
January 26, 2024, we issued the January 2024 Promissory Note in the aggregate principal amount of up to $1,500,000 to Scage, for the
Company's working capital needs, including but not limited to any payment obligations to support the Extension. The note does not
bear interest and matures upon the earlier of the closing of an initial Business Combination by the Company and the Company's liquidation.

 We
could use a portion of the funds not being placed in the Trust Account to pay commitment fees for financing, fees to consultants to
assist us with our search for a target business or as a down payment or to fund a "no-shop" provision (a provision
designed to keep target businesses from "shopping" around for transactions with other companies or investors on terms
more favorable to such target businesses) with respect to a particular proposed initial Business Combination, although we do not
have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from
a target business, the amount that would be used as a down payment or to fund a "no-shop" provision would be determined
based on the terms of the specific initial Business Combination and the amount of our available funds at the time. Our forfeiture of
such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching
for, or conducting due diligence with respect to, prospective target businesses.

 As
agreed by the shareholders at the 2023 EGM, we have until May 8, 2024 to complete a Business Combination.

 If
we are not able to consummate a Business Combination before May 8, 2024, we will commence an automatic winding up, dissolution and liquidation.
Our management has determined that the automatic liquidation, should a Business Combination not occur, and potential subsequent dissolution
also raise substantial doubt about our ability to continue as a going concern for a period of time within one year after the date that
the unaudited condensed financial statements are issued. While management intends to complete a Business Combination on or before May
8, 2024, it is uncertain whether we will be able to do so. No adjustments have been made to the carrying amounts of assets or liabilities
should we be required to liquidate after May 8, 2024.

 Off-Balance
Sheet Financing Arrangements

 We
did not have any off-balance sheet arrangements as of December 31, 2023 as defined in Item 303(a)(4)(ii) of Regulation S-K.

 Contractual
Obligations

 As
of December 31, 2023, we did not have any long-term debt, capital or operating lease obligations.

 We
have entered into an Administrative Services Agreement pursuant to which we are paying our sponsor for office space, utilities and administrative
support services, in the amount of $3,000 per month.

 We
have engaged EarlyBirdCapital as an advisor in connection with our initial Business Combination to assist us in holding meetings with
our shareholders to discuss the potential initial Business Combination and the target business' attributes, introduce us to potential
investors that are interested in purchasing our securities in connection with our initial Business Combination, assist us in obtaining
shareholder approval for the initial Business Combination and assist us with our press releases and public filings in connection with
the initial Business Combination. In connection with the Sunorange Investment, we have agreed to pay EarlyBirdCapital a reduced cash
fee for such services upon the consummation of our initial Business Combination in an amount equal to 1.75% of the gross proceeds of
our IPO (exclusive of any applicable finders' fees which might become payable).

 We
previously engaged a third-party consultant to provide us with assistance in various aspects of our potential Business Combination. Pursuant
to the terms of the agreement, we have agreed to pay a contingent fee of at least $3,500,000 if we consummate a Business Combination.
No expense for which has been included in the financial statements related to this agreement. No expense has been recorded in the financial statements related to this agreement, nor is any due.

 On
August 29, 2023, the Company engaged a third-party consultant to provide the Company with introduction to potential targets for its Business
Combination. Pursuant to the terms of the agreement, the Company has agreed to pay a contingent fee of 0.5% of the implied enterprise
value of the target if the Company consummates a Business Combination. As the Business Combination is not considered probable, no expense
for which has been included in the financial statements related to this agreement.

 Critical Accounting Estimates

 The preparation of financial statements and related disclosures in conformity
with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates. As of the end of the reporting period, we have not identified any critical accounting
estimates.

 Critical
Accounting Policies

 Management's
discussion and analysis of our results of operations and liquidity and capital resources are based on our audited financial information.
We describe our significant accounting policies in "Note 2 – Summary of Significant Accounting Policies, of the Notes to
Financial Statements included in this Report" with those considered critical outlined below. Our audited financial statements
have been prepared in accordance with GAAP. Certain of our accounting policies require that Management applies significant judgments
in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, Management reviews the accounting policies,
assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. Judgments
are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate.
However, by their nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from
our estimates.

 Class
A Ordinary Shares Subject to Possible Redemption

 We
account for our Class A Ordinary Shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 "Distinguishing
Liabilities from Equity." Ordinary Shares subject to mandatory redemption are classified as a liability instrument and are measured
at fair value. Conditionally redeemable Ordinary Shares (including Ordinary Shares that feature redemption rights that are either within
the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control)
are classified as temporary equity. At all other times, Ordinary Shares are classified as shareholder's equity. Our Class A Ordinary
Shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future
events. Accordingly, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside
of the shareholder's equity section of the balance sheet.

 Immediately
upon the closing of the Initial Public Offering, we recognized the accretion from initial book value to redemption amount. Increases
or decreases in the carrying amount of redeemable Ordinary Shares are affected by charges against additional paid-in capital and accumulated
deficit.

 Net
Income Per Ordinary Share

 We
comply with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." Net income per share is computed
by dividing net income by the weighted average number of ordinary shares outstanding during the period. We have two classes of shares,
redeemable Ordinary Shares and non-redeemable Ordinary Shares. Our redeemable Ordinary Shares are comprised of Class A Ordinary Shares
sold in the Initial Public Offering. Our non-redeemable shares are comprised of Class A Ordinary Shares held by EarlyBirdCapital and
Class B Ordinary Shares purchased by the sponsor which were converted to Class A Ordinary Shares in May 2023. Earnings and losses are
shared pro rata between the two classes of shares. Our statement of operations applies the two-class method in calculating net income
per share. Basic and diluted net income per share for redeemable Ordinary Shares and non-redeemable Ordinary Shares is calculated by
dividing net income, allocated proportionally to each class of Ordinary Shares, attributable to us by the weighted average number of
shares of redeemable and non-redeemable Ordinary Shares outstanding.

 The
calculation of diluted income per Ordinary Share does not consider the effect of the Warrants issued in connection with the Initial Public
Offering since exercise of the Warrants is contingent upon the occurrence of future events and the inclusion of such rights would be
anti-dilutive. Accretion of the carrying value of Class A Ordinary Shares to redemption value is excluded from net income per redeemable
share because the redemption value approximates fair value. As a result, diluted income per share is the same as basic income (loss)
per share for the period presented.

 Recent
Accounting Standards

 In
August 2020, the FASB issued ASU No. 2020-06, "Accounting for Convertible Instruments and Contracts in an Entity's Own Equity"
("ASU 2020-06"). The update simplifies the accounting for convertible instruments by removing certain separation models in
Subtopic 470-20, "Debt— Debt with Conversion and Other Options" for convertible instruments and introducing other changes.
As a result of ASU 2020-06, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost
and more convertible preference shares will be accounted for as a single equity instrument measured at its historical cost, as long as
no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal
years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier
than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently assessing
what impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

 In
June 2022, the FASB issued ASU 2022-03 ("ASU 2022-03"), ASC Subtopic 820 "Fair Value Measurement of Equity Securities
Subject to Contractual Sale Restrictions" ("ASC 820"). ASU 2022-03 amends ASC 820 to clarify that a contractual sales
restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities
subject to contractual sale restrictions that are measured at fair value. ASU 2022-03 applies to both holders and issuers of equity and
Equity-Linked Securities measured at fair value. The amendments in ASU 2022-03 are effective for the Company in fiscal years beginning
after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial
statements that have not yet been issued or made available for issuance. We are currently assessing what impact, if any, that ASU 2022-03
would have on its financial position, results of operations or cash flows.

 In
December 2023, the FASB issued ASU No 2023-09, "Income Taxes (Topic 740) — Improvements to Income Tax Disclosures"
("ASU 2023-09") in order to enhance the transparency and usefulness of income tax disclosures. The guidance is applicable
to all entities subject to income tax, and it will require disclosure of certain categories within the rate reconciliation to improve
consistency as well as disclosure of reconciling items which meet a certain quantitative threshold which will improve transparency. Additionally,
entities must disclose the amount of taxes paid to federal, state and foreign municipalities. For public business entities ASU 2023-09
is effective for annual periods beginning after December 15, 2024. We are currently evaluating the impact of its pending adoption of
ASU 2023-09 on our financial position, results of operations or financial statement disclosure.

 We
do not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect
on our audited financial statements contained elsewhere in this Report.

 JOBS
Act

 The
JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify
as an "emerging growth company" under the JOBS Act and are allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that
comply with new or revised accounting pronouncements as of public company effective dates.

 Additionally,
we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject
to certain conditions set forth in the JOBS Act, if, as an "emerging growth company," we choose to rely on such exemptions
we may not be required to, among other things, (i) provide an independent registered public accounting firm's attestation report
on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure
that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii)
comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the independent
registered public accounting firm's report providing additional information about the audit and the financial statements (auditor
discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation
and performance and comparisons of the CEO's compensation to median employee compensation. These exemptions will apply for a period
of five years following the completion of our Initial Public Offering or until we are no longer an "emerging growth company,"
whichever is earlier.

 Item
7A. Quantitative and Qualitative Disclosures about Market Risk

 We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this Item.

 Item
8. Financial Statements and Supplementary Data

 Reference
is made to pages F-1 through F-25 comprising a portion of this Report, which are incorporated herein by reference.

 Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 None.

 Item
9A. Controls and Procedures

 Evaluation
of Disclosure Controls and Procedures

 Disclosure
controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports
filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's
rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information
required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including
our Chief Executive Officer and Chief Financial Officer (together, the "Certifying Officers"), or persons performing similar
functions, as appropriate, to allow timely decisions regarding required disclosure.

 Under
the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the
effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under
the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective
as of the end of the fiscal year ended December 31, 2023, due to material weaknesses in our internal control over financial reporting
of complex financial instruments, recognition of billed and unbilled professional fees, recognition of prepaid expenses, classification
of related party payables and accounting for related party notes payable as further described below.

 A material weakness is a deficiency,
or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material
misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, we concluded
that our controls over recognition of billed and unbilled professional fees, recognition of prepaid expenses, the classification of related
party payables, and accounting for related party notes payable was not effectively designed or maintained. Our Management performed additional
analysis as deemed necessary to ensure that our audited financial statements included in this Report were prepared in accordance with
GAAP. Accordingly, Management believes that the audited financial statements included in this Report present fairly, in all material respects,
our financial position, results of operations and cash flows of the periods presented.

 In light of the material weakness
described above, our Management Team has performed additional accounting and financial analyses and other post-closing procedures. We
have enhanced, and will continue to enhance, internal controls and procedures, including access to accounting literature, identification
and consideration of third-party professionals with whom to consult regarding complex accounting applications and implementing additional
layers of reviews in the financial close process. While we have processes to properly identify and evaluate the appropriate accounting
technical pronouncements and other literature for all significant or unusual transactions, we plan to continue to improve these processes
to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

 We
do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and
procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the
disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there
are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure
controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all
our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain
assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated
goals under all potential future conditions.

 Management's
Annual Report on Internal Control over Financial Reporting

 As
required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our Management is responsible for establishing
and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting
purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that:

 (1)

 pertain
 to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the
 assets of our Company,

 (2)

 provide
 reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with
 GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our Management and directors,
 and

 (3)

 provide
 reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that
 could have a material effect on the financial statements.

 Because
of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial
statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed
the effectiveness of our internal control over financial reporting as of December 31, 2023. In making these assessments, Management used
the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated
Framework (2013). Based on our assessments and those criteria, Management determined that we did not maintain effective internal control
over financial reporting as of December 31, 2023.

 In
light of the material weakness described above, our management team has performed additional accounting and financial analyses and other
post-closing procedures. We have enhanced, and will continue to enhance, internal controls and procedures, including access to accounting
literature, identification and consideration of third-party professionals with whom to consult regarding complex accounting applications
and implementing additional layers of reviews in the financial close process. While we have processes to properly identify and evaluate
the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we plan to continue
to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly
complex accounting standards.

 This
Report does not include an attestation report of our internal controls from our independent registered public accounting firm due to
our status as an emerging growth company under the JOBS Act.

 Changes
in Internal Control over Financial Reporting

 Other than as discussed above,
there have been no changes to our internal control over financial reporting during the fiscal year ended December 31, 2023 that materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 Item
9B. Other Information

 Trading Arrangements

 During
the quarterly period ended December 31, 2023, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange
Act) adopted or terminated any "Rule 10b5-1 trading arrangement" or any "non-Rule 10b5-1 trading arrangement,"
as each term is defined in Item 408 of Regulation S-K.

 Additional Information

 None.

 Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 Not
applicable.

 PART
III

 Item
10. Directors, Executive Officers and Corporate Governance

 Directors
and Executive Officers

 As
of the date of this Report, our directors and officers are as follows:

 Name

 Age

 Position

 Calvin
 Kung

 Chairman
 of the Board and Chief Executive Officer

 Wang
 (Tommy) Chiu Wong

 Chief
 Financial Officer and Director

 Chunyi
 (Charlie) Hao

 Tiemei
 (Sarah) Li

 Sanjay
 Prasad

 The
experience of our directors and executive officers is as follows:

 Calvin
Kung, our Chairman and Chief Executive Officer since April 2023. Mr. Kung recently served as a senior director at GDS Holdings
Limited, a developer and operator of high-performance data centers in mainland China and Hong Kong from June 2020 to March 2023. During
his tenure at GDS, Mr. Kung coordinated its secondary listing on the Hong Kong Stock Exchange, and the release of its sustainability
strategy and inaugural ESG report. He assisted with other projects at GDS across operations, finance, legal and investor relations. From
February 2017 to June 2020, Mr. Kung was director at RADII, a marketing and entertainment platform. Prior to joining RADII, Mr. Kung
worked as a corporate attorney in Beijing and New York with a focus on capital markets. He began his career in credit research at Goldman
Sachs & Co. in New York. Mr. Kung received a bachelor's degree from Duke University and Juris Doctor from Northwestern University.

 Wang
(Tommy) Chiu Wong, our Chief Financial Officer and Director since April 2023. Mr. Wong is a seasoned finance and investment
professional with more than 20 years of experience. Since November 2012, Mr. Wong has worked at Yitian Group in various roles, and most
recently as a vice president with responsibility for urban renewal projects. During his tenure, Mr. Wong led negotiations with numerous
stakeholders and overseen various managerial finance and property management functions. From August 2004 to October 2012, he worked at
Safe Chemical, a Hong Kong-based chemicals company, as general manager. Mr. Wong was also a business development manager at iiLcorp Limited,
a communications firm from January 2003 to August 2004. Mr. Wong received his Bachelor of Science degree from the Chinese University
of Hong Kong and was a visiting student at the University California, Los Angeles. He received a Master of Public Affairs from Indiana
University with a concentration in Information Systems and Public Finance.

 Chunyi
(Charlie) Hao, our Director since April 2023. Mr. Hao is a founding partner and has been a managing director of East
Stone Capital Limited, a private equity firm focusing on emerging industries, since October 2017. He served as chief executive officer
and president of Shandong Haizhishe Energy Engineering Co., Ltd., a solar and wind engineering company in China, and was in charge of
the daily operations and business development of the company from December 2015 to March 2019. Prior to that, Mr. Hao was an investment
officer of Shanghai Guxin Investment Limited, a firm engaging in the investment of solar farms across China, from 2014 to June 2015.
He served as chief financial officer at Delphi Automotive Corp (Saginaw Steering System) ("Delphi") of General Motors Inc.,
overseeing joint venture operation across China and Asia Pacific from 1995 to 1998. Mr. Hao is an independent director of Cogobuy Group
PLC (HKSE: 0400.HK), an e-commerce platform and distributor for electronic goods in China. He served as chief executive officer and director
at China Fundamental Acquisition Corporation and a board director and president of China operations at Asia Automotive Acquisition Corporation,
two SPACs in 2008 and 2005, respectively. Most recently, Mr. Hao served as Chairman of the Board and Chief Financial Officer of East
Stone Acquisition Corporation from August 2018 through November 2022, when it completed its business combination with NWTN, Inc. (Nasdaq:
NWTN). Mr. Hao received his Bachelor's degree in French from Beijing Language and Culture University, a Master of Arts degree from
the University of Notre Dame and an MBA degree from Pace University. Mr. Hao is well qualified to serve as a director due to his extensive
experience with SPACs, as well as his expertise in management, finance and capital investments.

 Tiemei
(Sarah) Li, our Director since April 2023. Ms. Li is a full professor at Telfer School of Management, University of Ottawa. From February
1995 to August 2005, Ms. Li was a managing director at Guotai & Junan Securities Co. Ltd., an investment banking and securities
firm in China. Prior to that, she served as an accountant for Mini Refrigerating Co. Ltd. from July 1991 to August 1992. Ms. Li
received her Bachelor's degree in management from HuaZhong University of Science & Technology, Master's degree in
Economics from Central University of Finance and Economics, a CPA from the Chinese Institute of Certified Public Accountants and a
Ph. D in Accounting from Concordia University. Ms. Li is well qualified to serve as a director due to her financial and accounting
expertise as well as her experience in management across various countries.

 Sanjay
Prasad, our Director since April 2023. Mr. Prasad has been the founder, chief executive officer and president of Global Business
Dimensions Inc., a manufacturer, seller and distributor of PC components, semiconductor and consumer electronic products, since June
1994. Mr. Prasad also founded Cinemagic Entertainment, a home cinema and audio video installation company, in June 2006 and
Buyonlineled.com, a seller of LED lighting products, in April 2017. Mr. Prasad is a member of the New Jersey District Export
Council. Mr. Prasad has helped numerous companies export their products overseas providing guidance on financing, export license
controls and help in marketing to Asia, Europe and Middle East. Mr. Prasad served as a director of East Stone Acquisition
Corporation from February 2020 through November 2022, when it completed its business combination with NWTN, Inc. (Nasdaq: NWTN). Mr.
Prasad received his Bachelor's degree in industrial engineering from BIT India, Master's degree in industrial
engineering from Kansas State University and an MBA degree from Adelphi University. Mr. Prasad is well qualified to serve as a
director due to his extensive experience in entrepreneurship and management across various countries.

 Family
Relationships

 No
family relationships exist between any of our directors or executive officers.

 Involvement
in Certain Legal Proceedings

 There
are no material proceedings to which any director or officer, or any associate of any such director or officer is a party adverse to
our Company or has a material interest adverse to our Company.

 Number
and Terms of Office of Officers and Directors

 Our
Board of Directors consists of five members. Prior to consummation of our Initial Public Offering, holders of our Founder Shares appointed
each of our directors for a two-year term. Holders of our Public Shares do not have the right to vote on the appointment of directors
during such term. The provisions of our Amended and Restated Memorandum regarding director term may only be amended by a special resolution
passed by at least 90% of our Ordinary Shares voting in a general meeting. Subject to any other special rights applicable to the shareholders,
any vacancies on our Board of Directors may be filled by the affirmative vote of a majority of the directors present and voting at the
meeting of our Board or by a majority of the holders of our Founder Shares. Our officers are appointed by the Board of Directors and
serve at the discretion of the Board of Directors, rather than for specific terms of office. Our Board of Directors is authorized to
appoint persons to the offices set forth in our Amended and Restated Memorandum as it deems appropriate. Our Amended and Restated Memorandum
provide that our officers may consist of a Chairman, Chief Executive Officer, President, Chief Financial Officer, Vice Presidents, Secretary,
Assistant Secretaries, Treasurer and such other offices as may be determined by the Board of Directors.

 Committees
of the Board of Directors

to Nasdaq Listing Rules, we have established two standing committees—the Audit Committee, in compliance with Section 3(a)(58)(A)
of the Exchange Act, and a compensation committee, each comprised of independent directors. Under Nasdaq Listing Rule 5615(b)(1), a company
listing in connection with its Initial Public Offering is permitted to phase in its compliance with the independent committee requirements.

 Audit
Committee

 We have established the Audit
Committee. Chunyi (Charlie) Hao, Tiemei (Sarah) Li and Sanjay Prasad each serve as members of our Audit Committee and Ms. Li serves as
its chairman. Under the Nasdaq listing standards and applicable SEC rules, we are required to have at least three members of the Audit
Committee, all of whom must be independent, subject to certain phase-in provisions. Each such member of our Audit Committee meets the
independent director standard under Nasdaq listing standards and under Rule 10A-3(b)(1) of the Exchange Act.

 Each member of the Audit Committee
is financially literate, and our Board of Directors has determined that Ms. Li qualifies as an "audit committee financial expert"
as defined in applicable SEC rules and has accounting or related financial management expertise.

 We
have adopted an amended Audit Committee charter, which details the purpose and principal functions of the Audit Committee,
including:

 the
 appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent
 registered public accounting firm engaged by us;

 pre-approving
 all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged
 by us, and establishing pre-approval policies and procedures;

 and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;

 setting
 clear hiring policies for employees or former employees of the independent auditors;

 setting
 clear policies for audit partner rotation in compliance with applicable laws and regulations;

 obtaining
 and reviewing a report, at least annually, from the independent auditors describing (i) the
 independent auditor's internal quality-control procedures and (ii) any material issues
 raised by the most recent internal quality-control review, or peer review, of the audit firm,
 or by any inquiry or investigation by governmental or professional authorities, within, the
 preceding five years respecting one or more independent audits carried out by the firm and
 any steps taken to deal with such issues;

 meeting
 to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent
 auditor, including reviewing our specific disclosures under "Management's Discussion and Analysis of Financial Condition
 and Results of Operations";

 and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC
 prior to us entering into such transaction; and

 reviewing with management, the independent auditors, and our legal advisors,
as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any
employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any
significant changes in accounting standards or rules promulgated by the FASB, the SEC or other regulatory authorities; and

 advising the Board and any other Board committees if the clawback provisions
of Rule 10D-1 under the Exchange Act (the "Rule") are triggered based upon a financial statement restatement or other financial
statement change, with the assistance of Management and to the extent that our securities continue to be listed on an exchange and subject
to the Rule.

 Compensation
Committee

 We
have established a compensation committee of the Board of Directors. Chunyi (Charlie) Hao, Tiemei (Sarah) Li and Sanjay Prasad each serve
as members of our compensation committee and Mr. Hao serves as its chairman. Under the Nasdaq listing standards and applicable SEC rules,
we are required to have at least two members of the compensation committee, all of whom must be independent, subject to certain phase-in
provisions. Each member of our compensation committee meets the independent director standard under Nasdaq listing standards and Rule
10C-1 of the Exchange Act applicable to members of the compensation committee.

 We
have adopted an amended compensation committee charter, which details the purpose and responsibility of the compensation committee, including:

 and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer's compensation
 (if any is paid by us), evaluating our Chief Executive Officer's performance in light of such goals and objectives and determining
 and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;

 and making recommendations to our Board of Directors with respect to the compensation and any incentive-compensation of all of our
 other officers;

 our executive compensation policies and plans;

 implementing
 and administering our incentive compensation equity-based remuneration plans;

 assisting
 management in complying with our proxy statement and annual report disclosure requirements;

 approving
 all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;

 producing
 a report on executive compensation to be included in our annual proxy statement;

 reviewing,
 evaluating and recommending changes, if appropriate, to the remuneration for directors; and

 advising
 the Board and any other Board committees if the clawback provisions of the Rule are triggered based upon a financial statement restatement
 or other financial statement change, with the assistance of Management and to the extent that our securities continue to be listed
 on an exchange and subject to the Rule.

 The
charter also provide that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such
adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the
compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.

 Director Nominations

 We
do not have a standing nominating committee, though we intend to form a corporate governance and nominating committee as and when required
to do so by law or Nasdaq rules. In accordance with Rule 5605 of the Nasdaq rules, a majority of the independent directors may recommend
a director nominee for selection by the Board of Directors. The Board of Directors believes that the independent directors can satisfactorily
carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee.
The independent directors who participate in the consideration and recommendation of director nominees are Chunyi (Charlie) Hao,
Tiemei (Sarah) Li and Sanjay Prasad. In accordance with Rule 5605 of the Nasdaq rules, all such directors are independent. As there is
no standing nominating committee, we do not have a nominating committee charter in place at this time.

 Prior
to our initial Business Combination, in the event of a vacancy in our Board of Directors, the Board will also consider director candidates
recommended for nomination by holders of our Ordinary Shares, for appointment by the remaining members of our Board then still serving.
During the entire period until our initial Business Combination, only holders of our Class B Ordinary Shares, and not holders of our
Class A Ordinary Shares, will have the right to appoint members of our Board.

 We
have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, the Board of Directors will consider educational background, diversity
of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom and the ability to represent
the best interests of our shareholders.

 Code
of Ethics

 We have adopted a code of ethics
applicable to our directors, officers and employees (our "Code of Ethics"), a copy of which is filed to this Report as Exhibit
14. Our Code of Ethics is a "code of ethics," as defined in Item 406(b) of Regulation S-K. We will make any legally required
disclosures regarding amendments to, or waivers of, provisions of our Code of Ethics on our website.

 Compensation
Recovery and Clawback Policy

 Under
the Sarbanes-Oxley Act, in the event of misconduct that results in a financial restatement that would have reduced a previously paid
incentive amount, we can recoup those improper payments from our executive officers. The SEC also recently adopted rules which direct
national stock exchanges to require listed companies to implement policies intended to recoup bonuses paid to executives if the company
is found to have misstated its financial results.

 On
November 30, 2023, our Board of Directors approved the adoption of the Executive Compensation Clawback Policy (the "Clawback Policy"),
with an effective date of October 2, 2023, in order to comply with the final clawback rules adopted by the SEC under the Rule and the
listing standards, as set forth in the Nasdaq Listing Rule 5608 (the "Final Clawback Rules").

 The
Clawback Policy provides for the mandatory recovery of erroneously awarded incentive-based compensation from our current and former executive
officers as defined in the Rule ("Covered Officers") in the event that we are required to prepare an accounting restatement,
in accordance with the Final Clawback Rules. The recovery of such compensation applies regardless of whether a Covered Officer engaged
in misconduct or otherwise caused or contributed to the requirement of an accounting restatement. Under the Clawback Policy, our Board
of Directors may recoup from the Covered Officers erroneously awarded incentive compensation received within a lookback period of the
three completed fiscal years preceding the date on which we are required to prepare an accounting restatement.

 Item
11. Executive Compensation.

 None
of our officers or directors or our senior consultant has received any cash compensation for services rendered to us. Each of our independent
directors invested, prior to the closing of our Initial Public Offering, as a limited partner holding a minority, non-controlling interest
in our Sponsor and therefore holds an indirect interest in the Founder Shares held by our Sponsor. In addition, our Sponsor, officers
and directors, senior consultant, and any of their respective affiliates, are reimbursed for any bona-fide, documented out-of-pocket
expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence
on suitable Business Combinations. In addition, we may pay a customary financial consulting fee to an affiliate of our Sponsor, which
will not be made from the proceeds of our Initial Public Offering held in the Trust Account prior to the completion of our initial Business
Combination. We may pay such financial consulting fee in the event such party or parties provide us with specific target company, industry,
financial or market expertise, as well as insights, relationships, services or resources that we believe are necessary in order to assess,
negotiate and consummate an initial Business Combination. The amount of any such financial consulting fee we pay will be based upon the
prevailing market for similar services for comparable transactions at such time and will be subject to the review of our Audit Committee.
Our Audit Committee also reviews, on a quarterly basis, all payments that were made to our Sponsor, officers, directors or our or their
affiliates.

 After
the completion of our initial Business Combination, directors or members of our Management Team who remain with us may be paid consulting,
management or other fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known,
in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed Business Combination, such as the Scage Registration Statement.
It is unlikely the amount of such compensation will be known at the time such materials are distributed, because the directors of the
post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers
will be determined by a compensation committee constituted solely by independent directors.

 We
do not intend to take any action to ensure that members of our Management Team maintain their positions with us after the consummation
of our initial Business Combination, although it is possible that some or all of our officers and directors may negotiate employment
or consulting arrangements to remain with us after the initial Business Combination. The existence or terms of any such employment or
consulting arrangements to retain their positions with us may influence our Management's motivation in identifying or selecting
a target business but we do not believe that the ability of our Management to remain with us after the consummation of our initial Business
Combination will be a determining factor in our decision to proceed with any potential Business Combination. We are not party to any
agreements with our officers and directors that provide for benefits upon termination of employment.

 Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 The
following table sets forth information regarding the beneficial ownership of Ordinary Shares as of April 1, 2024, based on information
obtained from the persons named below, with respect to the beneficial ownership of the Ordinary Shares, by:

 each
 person known by us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;

 each
 of our executive officers and directors that beneficially owns our Ordinary Shares; and

 all
 our executive officers and directors as a group.

 In the table below, percentage
ownership is based on 9,085,832 shares of our Ordinary Shares, consisting of (i) 9,085,831 Class A Ordinary Shares and (ii) 1 Class B
Ordinary Share, issued and outstanding as of April 1, 2024. On all matters to be voted upon, except for the election of directors of the
Board, holders of the Class A Ordinary Shares and Class B Ordinary Shares vote together as a single class, unless otherwise required by
applicable law. Currently, the Class B Ordinary Share is convertible into Class A Ordinary Shares on a one-for-one basis.

 Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all Ordinary
Shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the Private Placement Warrants
as these Private Placement Warrants are not exercisable within 60 days of the date of this Report.

 Class A Ordinary Shares

 Class B Ordinary Shares (2)

 Name and Address of Beneficial Owner (1)

 Number of Shares Beneficially Owned

 Approximate Percentage of Class

 Number of Shares Beneficially Owned

 Approximate Percentage

 of Class

 Approximate Percentage of Outstanding Ordinary Shares

 Finnovate Sponsor, LP (our Sponsor) (3)(4)

 4,299,374

 46.6
 %

 %

 46.6
 %

 Calvin Kung (3)(4)

 4,299,374

 46.6
 %

 %

 46.6
 %

 Wang (Tommy) Chiu Wong (3)(4)

 4,299,374

 46.6
 %

 %

 46.6
 %

 Mitch Garber (5)

 4,375

 —

 —

 —

 —

 Gustavo Schwed (5)

 4,375

 —

 —

 —

 —

 Nadav Zohar (5)

 4,375

 —

 —

 —

 —

 Chunyi (Charlie) Hao (3)

 —

 —

 —

 —

 —

 Tiemei (Sarah) Li (3)

 Sanjay Prasad (3)

 —

 —

 —

 —

 —

 All directors and executive officers as a group (5 individuals) after appointment of 14F Directors

 4,312,499

 46.6
 %

 %

 46.6
 %

 Other 5% Shareholders

 Mizuho Financial Group, Inc. (6)

 640,627

 7.1
 %

 —

 —

 7.1
 %

 Glazer Capital, LLC (7)

 630,022

 6.9
 %

 —

 —

 6.9
 %

 (1)

 Unless
 otherwise noted, the principal business address of each of the following entities or individuals is c/o Finnovate Acquisition Corp.,
 265 Franklin Street, Suite 1702, Boston, MA 02110.

 (2)

 Class
 B Ordinary Shares are convertible into Class A Ordinary Shares on a one-for-one basis, subject to adjustment pursuant to the anti-dilution
 provisions contained therein. Class B Ordinary Shares otherwise have the same rights as Class A Ordinary Shares, except that prior
 to our initial Business Combination, only Class B Ordinary Shares have the right to vote in the election of directors.

 (3)

 The
 shares reported in this row are held of record by our Sponsor. Sunorange serves as the sole general partner of our Sponsor. Sunorange
 is controlled by Mr. Kung, our Chief Executive Officer and a director, and Mr. Wong, our Chief Financial Officer and a director.
 Consequently, Messrs. Kung and Wong may be deemed the beneficial owners of the shares held by our Sponsor and have voting and dispositive
 control over such securities. The limited partnership interests of our Sponsor are held by various individuals and entities, including
 Messrs. Hao, Kung, Prasad, Wong and Ms. Li. Each of Messrs. Hao, Kung, Prasad, Wong and Ms. Li disclaim beneficial ownership of the
 securities held by our Sponsor other than to the extent of their direct or indirect pecuniary interest in such securities.

 (4)

 The
 shares beneficially owned include: (i) 4,237,499 Class A Ordinary Shares held by our Sponsor; and (ii) one Class B Ordinary Share
 held by our Sponsor. Excludes 61,875 Class A Ordinary Shares received by a designee of Sunorange, which designee is also a limited
 partner of the Sponsor.

 (5)

 Each
 of these individuals holds a direct or indirect interest in our Sponsor. Each such person disclaims any beneficial ownership of the
 reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

 (6)

 Based
 on the Schedule 13G filed with the SEC on February 13, 2024, the ordinary shares are beneficially owned by Mizuho Financial Group,
 Inc. The business address of the Mizuho Financial Group, Inc. is 265 Franklin Street, Suite 1702, Boston, MA, 02110.

 (7)

 Based
 on the Schedule 13G filed with the SEC on February 14, 2024, the ordinary shares are beneficially owned by Glazer Capital, LLC, a
 Delaware limited liability company ("Glazer Capital") held by certain funds and managed accounts to which Glazer Capital
 serves as investment manager. Mr. Paul J. Glazer serves as the managing member of Glazer Capital. The business address of the reporting
 persons is 250 West 55th Street, Suite 30A, New York, New York 10019.

 Securities
Authorized for Issuance under Equity Compensation Plans

 None.

 Changes
in Control

 None.
 For more information on the Scage Business Combination, please see "Item 1. Business."

 Item
13. Certain Relationships and Related Transactions, and Director Independence

 In
March 2021, our Sponsor purchased 4,312,500 Founder Shares for an aggregate purchase price of $25,000, or approximately $0.0058 per share.
A total of 75,000 Founder Shares were transferred to our independent directors following their appointment.

 Our
Sponsor also purchased, in a Private Placement that occurred simultaneously with the closing of our Initial Public Offering, an aggregate
of 8,243,038 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($8,243,038 in the aggregate). Each Private
Placement Warrant is exercisable to purchase one whole Ordinary Share at $11.50 per share, subject to adjustment as provided herein.
Our Sponsor is permitted to transfer the Private Placement Warrants held by it to certain permitted transferees, including our officers
and directors and other persons or entities affiliated with or related to them, but the transferees receiving such securities will be
subject to the same agreements with respect to such securities as our Sponsor. Otherwise, these Private Placement Warrants will generally
not be transferable or salable until after the completion of our initial Business Combination.

 The
Founder Shares constituted 25% of the Public Shares sold in our Initial Public Offering. Our Sponsor did not purchase any Units in our
Initial Public Offering.

 On May 8, 2023, following the
approval of the Conversion Amendment Proposal by our stockholders at the 2023 EGM, we issued an aggregate of 4,312,499 Class A Ordinary
Shares to our Sponsor and our former independent directors Mitch Garber, Nadav Zohar and Gustavo Schwed upon the conversion of an equal
number of Class B Ordinary Shares held by the Sponsor and our former independent directors Mitch Garber, Nadav Zohar and Gustavo Schwed
as Founder Shares. The 4,312,499 Class A Ordinary Shares issued in connection with the Founder Share Conversion are subject to the same
restrictions as applied to the Class B Ordinary Shares before the Founder Share Conversion, including the Sponsor's agreement not
to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination
and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00
per share (as adjusted for share splits, share reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger,
share exchange, reorganization or other similar transaction that results in all of our shareholders having the right to exchange their
shares of Class A Ordinary Shares for cash, securities or other property. As a result of the Founder Share Conversion and the 2023 Redemptions,
the Sponsor and certain designees of Sunorange hold approximately 47.4% of the issued and outstanding Ordinary Shares.

 We
entered into an Administrative Services Agreement on November 8, 2021, pursuant to which we pay our Sponsor $3,000 per month for office
space, utilities and administrative support services. Upon completion of our initial Business Combination or our liquidation, we will
cease paying any of these monthly fees. Accordingly, in the event the consummation of our initial Business Combination takes the maximum
30 months, our Sponsor will be paid $3,000 per month ($90,000 in the aggregate) for office space, utilities and administrative support
services and will be entitled to be reimbursed for any out-of-pocket expenses.

 In
addition, three of our former independent directors invested, prior to the closing of our Initial Public Offering, as a limited partner
holding a minority, non-controlling interest in our Sponsor and therefore holds an indirect interest in the Founder Shares held by our
Sponsor.

 Our
officers and directors currently have and will in the future have certain relevant fiduciary duties or contractual obligations that may,
subject to applicable law, take priority over their duties to us. Our Sponsor, officers and directors, senior consultant or any of their
respective affiliates, will be reimbursed for any bona-fide, documented out-of-pocket expenses incurred in connection with activities
on our behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Our Audit
Committee will review on a quarterly basis all payments that were made to our Sponsor, officers and directors, or any of their respective
affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement
of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 At
the closing of our initial Business Combination, we may pay a customary financial consulting fee to an affiliate of our Sponsor, which
will not be made from the proceeds of our Initial Public Offering held in the Trust Account prior to the completion of our initial Business
Combination. We may pay such financial consulting fee in the event such party or parties provide us with specific target company, industry,
financial or market expertise, as well as insights, relationships, services or resources that we believe are necessary in order to assess,
negotiate and consummate an initial Business Combination. The amount of any such financial consulting fee we pay will be based upon the
prevailing market for similar services for comparable transactions at such time and will be subject to the review of our Audit Committee
pursuant to the Audit Committee's policies and procedures relating to transactions that may present conflicts of interest.

 As of
the date of our IPO Registration Statement, our Sponsor agreed to loan us up to $250,000 under the March 2021 Promissory Note to be used
for a portion of the expenses of the Initial Public Offering. We repaid the March 2021 Promissory Note in full on November 8, 2021. In
addition, in order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination,
the Sponsor or an affiliate of the Sponsor may, but is not obligated to, provide us with Working Capital Loans. Any such loans would be
on an interest-free basis. If we complete an initial Business Combination, we may repay the Working Capital Loans out of the proceeds
of the Trust Account released to us. In the event that an initial Business Combination does not close, we may use a portion of proceeds
held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the
Working Capital Loans. At the lender's discretion, up to $1,500,000 of such Working Capital Loans may be convertible into Warrants
of the post-initial Business Combination entity at a price of $1.00 per Warrant. The Warrants would be identical to the Private Placement
Warrants. On May 8, 2023, in connection with the Sunorange Investment, the Working Capital Loan and all amounts outstanding thereunder
were canceled in full.

 On
April 27, 2023, we entered into the Investment Agreement with the Sponsor and Sunorange, pursuant to which Sunorange and its designees
shall acquire partnership interests in the Sponsor and Class B Ordinary Shares directly held by certain of our directors, which combined
interests entitled Sunorange to receive, in the aggregate, the Insider Securities, consisting of 3,557,813 Class B Ordinary Shares and
6,160,000 Private Placement Warrants, and we introduced a change in Management and the Board as follows: (i) Calvin Kung replaced David
Gershon as Chairman of the Board and Chief Executive Officer and Wang Chiu (Tommy) Wong replaced Ron Golan as Chief Financial Officer
and director on the Board, effective upon closing of the Sunorange Investment; (ii) Jonathan Ophir and Uri Chaitchik tendered their resignations
as Chief Investment Officer and Senior Consultant, respectively, effective upon closing of the Sunorange Investment; and (iii) Mitch
Garber, Gustavo Schwed and Nadav Zohar tendered their resignations as directors, to be effective upon expiration of the Waiting Period
and whose vacancies shall be filled by New Management.

 On May
8, 2023, we completed the closing of the Sunorange Investment after our shareholders approved of certain proposals at the 2023 EGM, and
after certain closing conditions were met, including but not limited to: (i) a minimum of $30 million remaining in the Trust Account after
accounting for all redemptions in connection with the 2023 EGM; (ii) us obtaining or extending a directors and officers insurance policy
on terms satisfactory to the parties; (iii) the conversion of Class B Ordinary Shares into Class A Ordinary Shares as needed to retain
shareholders and meet continued listing requirements of Nasdaq in the event that the Extension is approved; (iv) the amendment of the
Sponsor's existing limited partnership agreement; (v) the transfer of 61,875 Class B Ordinary Shares from certain of our directors
to Sunorange or its designees and (vi) the cancellation of the outstanding Working Capital Loan from the Sponsor and the reduction of
certain advisory fees to be due upon the closing of an initial Business Combination.

 On
June 2, 2023, the Company issued the June 2023 Promissory Note in the aggregate principal amount of up to $1,200,000 to the Sponsor,
which will be deposited into the Trust Account for the benefit of each Public Share that was not redeemed in connection with the Company's
May 8, 2023 shareholder vote to approve the Extension. The Sponsor agreed to pay $100,000 per month until the completion of an initial
Business Combination, commencing on May 8, 2023 and continuing through May 8, 2024. The June 2023 Promissory Note bears no interest and
is due and payable upon the earlier to occur of (i) the date on which the Company consummates its Business Combination and (ii) the date
that the winding up of the Company is effective. At the election of the Sponsor, up to $1,200,000 of the unpaid principal amount of the
June 2023 Promissory Note may be converted into Warrants at a conversion price of $1.00 per warrant. The Conversion Warrants shall be
identical to the Private Placement Warrants issued by the Company at the IPO. As of March 27, 2024 the Sponsor had deposited an aggregate
of $1,000,000 in payments to support the Extension on behalf of the Company, and the Company paid for one such extension payment of $100,000
itself. As of March 27, 2024, the outstanding balance of the June 2023 Promissory Note was $1,000,000 and no interest was accrued.

 On
November 8, 2023, the Company issued the November 2023 Promissory Note in the amount of $1,500,000 to Sunorange Investment. The November
2023 Promissory Note is non-interest bearing and is due at the earlier of consummation of the Business Combination or liquidation.
Prior to the November 2023 Promissory Note being in place, related parties were making advances to the Company and on behalf of
the Company for the purposes of paying its vendors. All advances made by the related parties between May 8, 2023 and the date of execution
are retroactively covered by the November 2023 Promissory Note. As of March 27, 2024, the outstanding balance of the November 2023 Promissory
Note was $703,123, and no interest was accrued.

 On
January 26, 2024, the Company issued the January 2024 Promissory Note in the aggregate principal amount of up to $1,500,000 to Scage
for the Company's working capital needs, including but not limited to payment obligations to support the Extension. The January
2024 Promissory Note does not bear interest and matures upon the earlier of the closing of an initial Business Combination by the Company
and the Company's liquidation. As of March 27,
2024, the outstanding balance of the January 2024 Promissory Note was $200,000, and no interest was accrued.

 In
addition, in order to finance transaction costs in connection with an intended initial Business Combination, our Sponsor or an affiliate
of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds on a non-interest-bearing basis
as may be required. If we complete an initial Business Combination, we would repay such loaned amounts. In the event that the initial
Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned
amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of those loans may be converted into
Warrants at a price of $1.00 per Warrant at the option of the lender. The Warrants would be identical to the Private Placement Warrants
issued and sold to our Sponsor in a Private Placement which occurred simultaneously with the closing of our Initial Public Offering.
Except as set forth above, the terms of such loans by our officers and directors, if any, have not been determined and no written agreements
exist with respect to such loans. We do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as
we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to
funds in our Trust Account.

 After
our initial Business Combination, members of our Management Team who remain with us may be paid consulting, management or other fees
from the combined company with any and all amounts being fully disclosed to our shareholders, to the extent then known, in the tender
offer or proxy solicitation materials, as applicable, furnished to our shareholders. It is unlikely the amount of such compensation will
be known at the time of distribution of such tender offer materials or at the time of a general meeting held to consider our initial
Business Combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director
compensation.

 We have entered into the Registration
Rights Agreement with respect to the Founder Shares, Private Placement Warrants, EBC Founder Shares and warrants issued upon conversion
of Working Capital Loans (if any).

 We
entered into indemnity agreements with each of our officers and directors and our senior consultant, a form of which is filed as an exhibit
to this Report. Those agreements require us to indemnify those individuals to the fullest extent permitted under applicable Cayman Islands
law and to hold harmless, exonerate and advance expenses incurred as a result of any proceeding against them as to which they could be
indemnified.

Independence

 Nasdaq
listing standards require that a majority of our Board of Directors be independent within one year of our Initial Public Offering. An
"independent director" is defined generally as a person other than an officer or employee of the company or its subsidiaries
or any other individual having a relationship which in the opinion of the company's board of directors, would interfere with the
director's exercise of independent judgment in carrying out the responsibilities of a director. Our Board of Directors has determined
that each of our independent directors, Chunyi (Charlie) Hao, Tiemei (Sarah) Li, and Sanjay Prasad, is an "independent director"
as defined in the Nasdaq listing standards and applicable SEC rules. Our Audit Committee and compensation committee are each entirely
composed of independent directors meeting Nasdaq's and the SEC's additional requirements applicable to members of those committees.
In addition, our independent directors have regularly scheduled meetings at which only independent directors are present.

 Item
14. Principal Accounting Fees and Services

 The
following is a summary of fees paid or to be paid to Marcum for services rendered.

 Audit
Fees

 Audit
fees consist of fees for professional services rendered for the audit of our year-end financial statements and services that are normally
provided by Marcum in connection with regulatory filings. The aggregate fees of Marcum for professional services rendered for the audit
of our annual financial statements, review of the financial information included in our Forms 10-Q for the respective periods and other
required filings with the SEC for the years ended December 31, 2023 and 2022 totaled $281,711 and $161,135, respectively. The above amounts
include interim procedures and audit fees, as well as attendance at Audit Committee meetings.

 Audit-Related
Fees

 Audit-related
fees consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our
financial statements and are not reported under "Audit Fees." These services include attest services that are not required
by statute or regulation and consultations concerning financial accounting and reporting standards. We did not pay Marcum for any audit-related
fees for the years ended December 31, 2023 and 2022.

 Tax
Fees

 Tax
fees consist of fees billed for professional services relating to tax compliance, tax planning and tax advice. We
did not pay Marcum for tax services, planning or advice for the years ended December 31, 2023 and 2022.

 All
Other Fees

 All
other fees consist of fees billed for all other services. We
did not pay Marcum for any other services for the years ended December 31, 2023 and 2022.

 Pre-Approval
Policy

 Our
Audit Committee was formed upon the consummation of our Initial Public Offering. As a result, the Audit Committee did not pre-approve
all of the foregoing services, although any services rendered prior to the formation of our Audit Committee were approved by our Board
of Directors. Since the formation of our Audit Committee, and on a going-forward basis, the Audit Committee has and will pre-approve
all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject
to the de minimis exceptions for non-audit services described in the Exchange Act which are approved by the Audit Committee prior to
the completion of the audit).

 PART
IV

 Item 15. Exhibit and Financial Statement
Schedules.

 (a)

 The
 following documents are filed as part of this Report:

 (1)

 Financial
Statements

 Page

 Report
 of Independent Registered Public Accounting Firm (PCAOB ID # 688, Marcum LLP, Houston, Texas)

 Balance Sheets as of December 31, 2023 and 2022

 Statements of Operations for the fiscal years ended December 31, 2023 and 2022

 Statements of Changes in Shareholders' Deficit for the fiscal years ended December 31, 2023 and 2022

 Statements of Cash Flows for the fiscal years ended December 31, 2023 and 2022

 Notes to Financial Statements

 (2)

 Financial
 Statement Schedules

 All
financial statement schedules are omitted because they are not applicable or the amounts are immaterial and not required, or the required
information is presented in the financial statements and notes thereto beginning on page F-3 of this Report.

 (3)

 Exhibits

 We
hereby file as part of this Report the exhibits listed in the attached Exhibit Index. Exhibits that are incorporated herein by reference
can be inspected on the SEC website at www.sec.gov.

 Item
16. Form 10-K Summary.

 Omitted
at our Company's option.

 PART
IV

TO FINANCIAL STATEMENTS

 Page

 Report
 of Independent Registered Public Accounting Firm (PCAOB ID # 688, Marcum LLP, Houston, Texas)

 Balance Sheets as of December 31, 2023 and 2022

 Statements of Operations for the Years Ended December 31, 2023 and 2022

 Statements of Changes in Shareholders' Deficit for the Years Ended December 31, 2023 and 2022

 Statements of Cash Flows for the Years Ended December 31, 2023 and 2022

 Notes to Financial Statements

 F- 1

 REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To
the Shareholders and Board of Directors of

 Finnovate
Acquisition Corp

 Opinion
on the Financial Statements

 We
have audited the accompanying balance sheets of Finnovate Acquisition Corp. (the "Company") as of December 31, 2023 and
2022, the related statements of operations, stockholders' deficit and cash flows for each of the two years in the period ended
December 31, 2023 and 2022, and the related notes. In our opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash
flows for the years ended December 31, 2023 and 2022, in conformity with accounting principles generally accepted in the United
States of America.

 Explanatory
Paragraph – Going Concern

 The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note
1 to the financial statements, the Company is a Special Purpose Acquisition Corporation that was formed for the purpose of completing
a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more
businesses or entities on or before May 8, 2024. The Company entered into a definitive business combination agreement with a business
combination target on August 21, 2023; however, the completion of this transaction is subject to the approval of the Company's
stockholders among other conditions. There is no assurance that the Company will obtain the necessary approvals, satisfy the required
closing conditions, raise the additional capital it needs to fund its operations, and complete the transaction prior to by May 8,
2024, or such other date as may be extended pursuant to the Business Combination Agreement, if at all. The Company also has no approved
plan in place to extend the business combination deadline and fund operations for any period of time after by May 8, 2024, or such
other date as may be extended pursuant to the Business Combination Agreement, in the event that it is unable to complete a business
combination by that date. These matters raise substantial doubt about the Company's ability to continue as a going concern. Management's
plans with regard to these matters are also described in Note 1. The financial statements do not include any adjustments that may be
necessary should the Company be unable to continue as a going concern.

 Basis
for Opinion

 These
financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit s,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an
opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audit s included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit s also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe
that our audit s provid e a reasonable basis for our opinion.

 /s/
Marcum llp

 Marcum
 llp

 We
have served as the Company's auditor since 2021.

 Houston,
TX

 April

 F- 2

 BALANCE
SHEETS

 As of

 As of

 December 31, 2023

 December 31, 2022

 Assets

 Current Assets

 Cash

 $

 $
 244,179

 Prepaid expenses

 37,389

 314,502

 Total Current Assets

 37,426

 558,681

 Investments held in Trust Account

 Total Assets

 $
 51,237,770

 $
 179,089,740

 Liabilities, Redeemable Ordinary Shares and Shareholders' Deficit

 Current liabilities

 Accounts payable and accrued expenses

 $
 1,435,205

 $
 522,801

 Working capital loan – related party

 542,503

 449,765

 Promissory note payable – related party

 800,000

 -

 Due to related party

 56,600

 41,464

 Total Liabilities

 2,834,308

 1,014,030

 Commitments and Contingencies

 Class A ordinary shares subject to possible redemption, 4,623,332 and 17,250,000 shares at redemption value of $ 11.07 and $ 10.35 at December 31, 2023 and 2022, respectively

 Shareholders' Deficit

 Preference shares, $ 0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding

 -

 -

 Class A ordinary shares, $ 0.0001 par value, 500,000,000 shares authorized, 4,462,499 and 150,000 issued and outstanding (excluding 4,623,332 and 17,250,000 shares subject to possible redemption) at December 31, 2023 and 2022, respectively

 Class B Ordinary Shares, $ 0.0001 par value, 50,000,000 shares authorized, 1 and 4,312,500 issued and outstanding at December 31, 2023 and 2022, respectively

 -

 Common stock, value

 -

 Accumulated deficit

 ( 2,797,328
)

 ( 455,795
)

 Total Shareholders' Deficit

 ( 2,796,882
)

 ( 455,349
)

 Total Liabilities, Redeemable Ordinary Shares and Shareholders' Deficit

 $
 51,237,770

 $
 179,089,740

 The

 F- 3

 STATEMENTS
OF OPERATIONS

 For the Year ended December 31, 2023

 For the Year ended December 31, 2022

 Formation, general and administrative expenses

 $
 1,993,129

 $
 1,472,416

 Loss from operations

 ( 1,993,129
)

 ( 1,472,416
)

 Other income

 Interest earned on Investments held in Trust Account

 4,486,207

 2,578,957

 Interest earned on Bank Account

 1,831

 4,081

 Total other income

 4,488,038

 2,583,038

 Net Income

 $
 2,494,909

 $

 Basic and diluted weighted average shares outstanding, redeemable Class A ordinary shares

 8,982,127

 17,400,000

 Basic and diluted net income per redeemable Class A ordinary share

 $
 0.19

 $
 0.05

 Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares

 4,462,500

 Basic and diluted net income per non-redeemable ordinary share

 $
 0.19

 $
 0.05

 The

 F- 4

 STATEMENT
OF CHANGES IN SHAREHOLDERS' DEFICIT

 FOR
THE YEAR ENDED DECEMBER 31, 2023

 capital

 deficit

 Deficit

 Additional

 Total

 Class A

 Class B

 paid-in

 Accumulated

 Shareholder's

 capital

 deficit

 Deficit

 Balance - December 31, 2022

 $

 $

 $
 -

 $
 ( 455,795
)

 $
 ( 455,349
)

 Conversion of Sponsor Shares

 4,312,499

 ( 4,312,499
)

 ( 431
)

 -

 -

 -

 Promissory Note Forgiveness

 -

 -

 -

 -

 449,765

 -

 449,765

 Remeasurement of Class A redeemable shares to redemption value

 -

 -

 -

 -

 ( 449,765
)

 ( 4,036,442
)

 ( 4,486,207
)

 Extension Contribution

 -

 -

 -

 -

 -

 ( 800,000
)

 ( 800,000
)

 Net income

 -

 -

 -

 -

 -

 2,494,909

 2,494,909

 Balance - December 31, 2023

 4,462,499

 $

 $
 -

 -

 $
 ( 2,797,328
)

 $
 ( 2,796,882
)

 The

 F- 5

 STATEMENT
OF CHANGES IN SHAREHOLDERS' DEFICIT

 FOR
THE YEAR ENDED DECEMBER 31, 2022

 Additional

 Total

 Class A

 Class B

 paid-in

 Accumulated

 Shareholders'

 capital

 deficit

 Deficit

 Balance – December 31, 2021

 $

 $

 $
 1,654,188

 $
 ( 639,546
)

 $
 1,015,088

 Balance

 $

 $

 $
 1,654,188

 $
 ( 639,546
)

 $
 1,015,088

 Remeasurement of Class A redeemable shares to redemption value

 -

 -

 -

 -

 ( 1,654,188
)

 ( 926,871
)

 ( 2,581,059
)

 Net income

 -

 -

 -

 -

 -

 Net income (loss)

 -

 -

 -

 -

 -

 Balance - December 31, 2022

 $

 $

 $
 -

 $
 ( 455,795
)

 $
 ( 455,349
)

 Balance

 $

 $

 $
 -

 $
 ( 455,795
)

 $
 ( 455,349
)

 The

 F- 6

 STATEMENTS
OF CASH FLOWS

 For the Year ended December 31,
 2023

 For the Year ended
 December 31, 2022

 Cash flows from operating activities:

 Net income

 $
 2,494,909

 $

 Interest earned on Investments held in Trust Account

 ( 4,486,207
)

 ( 2,578,957
)

 Changes in operating assets and liabilities:

 Prepaid expenses

 277,113

 355,109

 Accounts payable and accrued expenses

 912,404

 357,064

 Accrued offering expenses

 -

 ( 46,894
)

 Due to Related Party

 15,136

 35,464

 Net cash used in operating activities

 ( 786,645
)

 ( 767,592
)

 Cash flows from investing activities:

 Cash withdrawn from Trust Account in connection with redemptions

 132,616,922

 -

 Extension Contribution

 ( 800,000
)

 -

 Net cash provided by investing activities

 131,816,922

 -

 Cash flows from financing activities:

 Redemption of Class A Ordinary Shares to underwriters

 ( 132,616,922
)

 -

 Proceeds from affiliate promissory note

 542,503

 -

 Proceeds from promissory note – related party

 800,000

 -

 Net cash used in financing activities

 ( 131,274,419
)

 -

 Net change in cash

 ( 244,142
)

 ( 767,592
)

 Cash at beginning of period

 244,179

 1,011,771

 Cash at end of period

 $

 $
 244,179

 Supplemental disclosure of cash flow information:

 Remeasurement of Class A redeemable shares to redemption value

 $
 4,486,207

 $
 2,581,059

 Promissory Note forgiveness

 $
 449,765

 $
 -

 The

 F- 7

 NOTES
TO FINANCIAL STATEMENTS

 NOTE
1 – ORGANIZATION AND BUSINESS BACKGROUND

 Organization
and General

 Finnovate
Acquisition Corp. (the "Company") was incorporated in the Cayman Islands on March 15, 2021. The Company was formed for the
purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar
business combination with one or more businesses or entities (the "Business Combination"). The Company is not limited to
a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth
company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 As
of December 31, 2023, the Company had not commenced any operations. All activity for the period from March 15, 2021 (inception) through
December 31, 2023 relates to the Company's formation and its initial public offering (the "IPO") described below, and,
since the IPO, the search for a target for its Business Combination. The Company will not generate any operating revenues until after
the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income
from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

 IPO

 On
November 8, 2021, the Company completed the sale of 15,000,000 units (the "Units" and, with respect to the shares of Class A Ordinary Shares, par value $ 0.0001 per share (the "Class
A Ordinary Shares") included in the Units being offered, the "Public Shares") at $ 10.00 per Unit. On November 12, 2021, the Company closed
on the full over-allotment resulting in the sale of an additional 2,250,000 Units. The IPO and subsequent exercise of the over- allotment
generated gross proceeds of $ 172,500,000, which is described in Note 3. Each Unit consists of one share of Class A Ordinary Shares and
three-quarters of one redeemable warrant ("Public Warrant").

with the closing of the IPO, the Company completed the sale of 7,900,000 private placement warrants (the "Private Placement Warrants")
at a price of $ 1.00 per Private Placement Warrant in a private placement to Finnovate Sponsor, LP (the "Sponsor") as well
as to EarlyBirdCapital, Inc. ("EarlyBirdCapital"). On November 12, 2021, pursuant to the full exercise of the over- allotment
option, the Sponsor purchased an additional 900,000 Private Placement Warrants. The IPO and subsequent exercise of the over-allotment
generated gross proceeds of $ 8,800,000 from the sale of the Private Placement Warrants.

 Following
the closing of the IPO on November 8, 2021 and the subsequent exercise of the over-allotment option, $ 175,950,000 ($ 10.20 per Unit) from
the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account ("Trust
Account"), located in the United States at a nationally recognized financial institution, with Continental Stock Transfer &
Trust Company acting as trustee, and invested only in in United States "government securities" within the meaning of Section
2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to
the trust agreement, the trustee will not be permitted to invest in other securities or assets. The Trust Account is intended as a holding
place for funds pending the earliest to occur of either: (i) the completion of the Business Combination; (ii) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Amended and Restated Memorandum and Articles of Association (the "Amended
and Restated Memorandum")
to (A) modify the substance or timing of the Company's obligation to allow redemption in connection with the Business Combination
or to redeem the Public Shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating to shareholders' rights or pre-Business Combination activity;
and (iii) the redemption of all of the Public Shares if the Company is unable to complete the Business Combination by May 8, 2024, subject
to applicable law. If the Company does not invest the proceeds as discussed above, the Company may be deemed to be subject to the Investment
Company Act.

 F- 8

 Initial
Business Combination

 The
Company's management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale
of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company
must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value
equal to at least 80 % of the net assets held in the Trust Account as defined below (excluding the underwriting commissions and taxes
payable on the income earned on the Trust Account) at the time of the Company's signing a definitive agreement in connection with
its Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50 %
or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient
for it not to be required to register as an investment company under the Investment Company.

 The
Company will provide its Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion
of the Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account
calculated as of two business days prior to the consummation of the Business Combination, including interest earned on the funds held
in the Trust Account and not previously released to the Company to pay taxes (which interest shall be net of taxes payable), divided
by the number of then issued and outstanding Public Shares, subject to the limitations described herein.

 The
amount in the Trust Account is $ 11.07 per Public Share as of December 31, 2023. The per-share amount the Company will distribute to investors
who properly redeem their shares will not be reduced by the underwriting commissions the Company will pay to the underwriter. The redemption
rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares. There will be
no redemption rights upon the completion of the Business Combination with respect to the warrants. The Company's initial shareholders,
directors and officers have entered into a letter agreement with the Company, pursuant to which they have agreed to waive their redemption
rights with respect to the 4,312,500 shares of Class B ordinary shares, par value $ 0.0001 per share ("Class B Ordinary Shares") purchased in March 2021 (the "Founder Shares", described
in more detail in Note 5) and Public Shares held by them in connection with the completion of the Business Combination.

 The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 either prior to or
upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the shares voted are voted
in favor of the Business Combination. If a shareholder vote is not required by applicable law or stock exchange rules and the Company
does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum conduct the redemptions pursuant to the tender offer
rules of the U.S. Securities and Exchange Commission ("SEC") and file tender offer documents with the SEC prior to completing
a Business Combination. If, however, shareholder approval of the transaction is required by applicable law or stock exchange rules, or
the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval
in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares, and any Public Shares purchased during
or after the IPO in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public
Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.

 Notwithstanding
the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender
offer rules, the Amended and Restated Memorandum provides that a Public Shareholder, together with any affiliate of
such shareholder or any other person with whom such shareholder is acting in concert or as a "group" (as defined under Section
13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares
with respect to more than an aggregate of 15 % or more of the Public Shares, without the prior consent of the Company.

 The Sponsor has agreed (a) to
waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business
Combination and (b) not to propose an amendment to the Amended and Restated Memorandum (i) to modify the substance or timing of the Company's
obligation to allow redemption in connection with the Company's Business Combination or to redeem 100% of its Public Shares if the
Company does not complete a Business Combination or (ii) with respect to any other provision relating to shareholders rights or pre- Business
Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction
with any such amendment.

 F- 9

 The
Company will have until May 8, 2024 to complete a Business Combination (the "Combination Period"). If the Company is
unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the
purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest
earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to
$ 100,000 of
interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely
extinguish Public Shareholders rights as shareholders (including the right to receive further liquidating distributions, if any),
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining
shareholders and the Company's board of directors ("Board" or "Board of Directors"), dissolve and liquidate, subject in each case to the Company's
obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be
no redemption rights or liquidating distributions with respect to the Company's warrants, which will expire worthless if the
Company fails to complete a Business Combination within the Combination Period.

 The
Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination
within the Combination Period. However, if the Sponsor acquires Public Shares in or after the IPO, such Public Shares will be entitled
to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period.
The underwriter has agreed to waive its right to its underwriting commission (see Note 7) held in the Trust Account in the event the
Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with
the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution,
it is possible that the per share value of the assets remaining available for distribution will be less than the IPO price per Unit ($ 10.00).

 In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $ 10.20 per Public Share or (2) such
lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in
the value of the trust assets, in each case net of the interest which may be withdrawn to pay franchise and income taxes. This liability
will not apply with respect to claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account
and except as to any claims under the Company's indemnity of the underwriter of the IPO against certain liabilities, including
liabilities under the Securities Act of 1933, as amended (the "Securities Act"). Moreover, in the event that an executed
waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such
third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to
claims of creditors by endeavoring to have all vendors, service providers (except the Company's independent registered public accounting
firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving
any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 Liquidity,
Capital Resources and Going Concern

 As
of December 31, 2023, the Company had $ 37 in
its operating bank account and a working capital deficit of $ 2,796,882.
The Company's liquidity needs up to December 31, 2023 had been satisfied by payment from the Sponsor for the Founder Shares, a
loan under an unsecured promissory note from the Sponsor of up to $ 250,000
(the "March 2021 Promissory Note"), drawdowns against the available working capital loan (the "Working Capital
Loan"), as well as advances and payments made on behalf of the Company by related parties. The March 2021 Promissory Note was
fully repaid as of November 8, 2021.

 In
order to finance transaction costs in connection with a Business Combination, the Company's Sponsor or an affiliate of the Sponsor
or certain of the Company's officers and directors may, but are not obligated to, loan the Company with funds as may be required
(Working Capital Loans, described in more detail in Note 5). As of December 31, 2023 and December 31, 2022, the Company had $ 0 and $ 449,765
outstanding under the Working Capital Loan, respectively.

 F- 10

 On
June 2, 2023, the Company issued a promissory note (the "June 2023 Promissory Note") in the aggregate principal amount of
up to $ 1,200,000 to the Sponsor, the proceeds from which will be deposited into the Trust Account for the benefit of each Public Share
that was not redeemed in connection with the Company's May 8, 2023 shareholder vote to approve an extension of the Company's
termination date from May 8, 2023 to May 8, 2024 (the "Extension"). The Sponsor agreed to pay $ 100,000 per month until the
completion of an initial Business Combination, commencing on May 8, 2023 and continuing through May 8, 2024. The June 2023 Promissory
Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company consummates its Business
Combination and (ii) the date that the winding up of the Company is effective. At the election of the Sponsor, up to $ 1,200,000 of the
unpaid principal amount of the June 2023 Promissory Note may be converted into warrants of the Company (the "Conversion Warrants")
at a conversion price of $ 1.00 per warrant. The Conversion Warrants shall be identical to the Private Placement Warrants issued by the
Company at the IPO. The Company has determined that the fair value of the June 2023 Promissory Note is its face value as the note was
not issued with a substantial premium. The Sponsor funded the first three months of the June 2023 Promissory Note in its first payment.
As of December 31, 2023, the outstanding balance of the June 2023 Promissory Note was $ 800,000, and no interest was accrued. If the Company
is not able to consummate a Business Combination before May 8, 2024, the Company will commence an automatic winding up, dissolution and
liquidation. Management has determined that automatic liquidation, should a Business Combination not occur, and potential subsequent
dissolution also raises substantial doubt about the Company's ability to continue as a going concern. While management intends
to complete a Business Combination on or before May 8, 2024, it is uncertain whether the Company will be able to do so. No adjustments
have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after May 8, 2024.

 On
November 8, 2023, the Company issued a promissory note in the principal amount of up to $ 1,500,000 to Sunorange (the "November
2023 Promissory Note"). The note is non-interest bearing and is due on the earlier of consummation of the Business Combination
or liquidation. The November 2023 Promissory Note was issued in connection with advances made by Sunorange since May 8, 2023 and
advances Sunorange may make in the future to the Company for working capital expenses. The November 2023 Promissory Note is non-interest
bearing and payable upon the earlier of (i) the date of the consummation of the Business Combination or (ii) the date of the Company's
liquidation. As of December 31, 2023, the Company had $ 542,503 outstanding under the November 2023 Promissory Note included in the
Working capital loan – related party line of the balance sheet.

 These
conditions, involving liquidity concerns and mandatory liquidation, raise substantial doubt about the Company's ability to continue
as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued.
There is no assurance that the Company's plan to consummate a Business Combination will be successful or successful within the
Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 Sunorange

 On
April 27, 2023, the Company entered into an agreement (the "Investment Agreement") with the Sponsor and Sunorange Limited
(the "Sunorange"), pursuant to which Sunorange and its designees acquired partnership interests in the Sponsor and Class
B Ordinary Shares directly held by certain Company directors, which combined interests entitled Sunorange to receive, in the aggregate,
 3,557,813 Class B Ordinary Shares and 6,160,000 Private Placement Warrants (collectively, the "Insider Securities"), and
the Company introduced a change in management and the Board as follows: (i) Calvin Kung shall replace David Gershon as Chairman of the
Board and Chief Executive Officer, and Wang Chiu (Tommy) Wong shall replace Ron Golan as Chief Financial Officer and director on the
Board, effective upon closing of the Sunorange Investment (as defined herein); (ii) Jonathan Ophir and Uri Chaitchik tendered their resignations
as Chief Investment Officer and Senior Consultant, respectively, effective upon closing of the Sunorange Investment; and (iii) Mitch
Garber, Gustavo Schwed and Nadav Zohar tendered their resignations as directors, effective upon expiration of all applicable waiting
periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder (such period of time being referred to herein as the "Waiting
Period"), and whose vacancies were filled by individuals to be designated by Sunorange and effective upon expiration of the Waiting
Period (such new officers and directors collectively referred to herein as the "New Management"). Sunorange's acquisition
of interests in the Insider Securities, the change to New Management and other transactions contemplated by the Investment Agreement
are hereinafter referred to as the "Sunorange Investment."

 F- 11

 On
May 8, 2023, the Company completed the closing of the Sunorange Investment after our shareholders approved certain proposals
discussed below, and after certain closing conditions were met, including but not limited to: (i) a minimum of $30 million remaining
in the Company's Trust Account after accounting for all redemptions in connection with the Company's extraordinary general
meeting of shareholders on May 8, 2023 (the "2023 EGM"); (ii) the Company obtaining or extending a D&O insurance policy
on terms satisfactory to the parties; (iii) the conversion of Class B Ordinary Shares into Class A Ordinary Shares as needed to retain
shareholders and meet continued listing requirements of The Nasdaq Stock Market LLC ("Nasdaq") in the event that the Extension
is approved; (iv) the amendment of the Sponsor's existing limited partnership agreement; (v) the transfer of 61,875 Class B Ordinary Shares from certain Company directors to Sunorange or its designees and (vi) the cancellation of the outstanding Working Capital Loan
from the Sponsor and the reduction of certain advisory fees to be due upon the closing of an initial Business Combination.

 In
connection with the closing of the Sunorange Investment, on May 8, 2023, Sunorange caused $ 300,000 to be deposited into the Trust Account
to support the first three months of the Extension from May 9, 2023 through August 8, 2023 (see Note 5). Sunorange also agreed to cause
to be deposited into the Trust Account an additional $ 100,000 for each successive month, or portion thereof, that is needed by the Company
to complete an initial Business Combination until May 8, 2024. As of December 31, 2023, $ 800,000 has been deposited into the Trust Account
in support of the Extension.

 Business
Combination Agreement

 On
August 21, 2023, the Company and Scage International Limited ("Scage") entered into a definitive Business Combination Agreement
(the "Business Combination Agreement"). Scage is a zero-emission solution provider in China, focusing on the development
and commercialization of heavy-duty NEV trucks and e-fuel solutions. Upon consummation of the two mergers and the other transaction contemplated
by the Business Combination Agreement (the "Scage Business Combination"), Scage Future, a newly formed holding company ("Pubco")
will seek to be listed on Nasdaq. The outstanding securities of Scage and the Company will be converted into the right to receive securities
of Pubco. The transaction represents a post-Business Combination valuation of $1.0 billion ($ 1,000,000,000) for Scage upon closing of
the Scage Business Combination, subject to adjustment.

 On
August 29, 2023, the Company engaged a third-party consultant to provide the Company with an introduction to potential targets for its
Business Combination. Pursuant to the terms of the agreement, the Company has agreed to pay a contingent fee of 0.5 % of the implied enterprise
value of the target if the Company consummates a Business Combination.

 Lock-Up
Agreements

with the execution of the Business Combination Agreement, Pubco, Scage, the Company and certain shareholders of Scage ("Key Scage
Shareholders"), as shareholders holding shares of Scage sufficient to constitute the Required Company Shareholder Approval (as
that term is defined in the Business Combination Agreement) as the holder of record or the beneficial owner within the meaning of Rule
135-3 of the Exchange Act, each entered into Lock-Up Agreements (each, a "Key Seller Lock-Up Agreement"). It is a condition
to the Closing that all stockholders of Scage between signing and Closing enter into a Lock-Up Agreement (each, a "Seller Lock-Up
Agreement").

to each Key Seller Lock-Up Agreement, each Key Scage Shareholder agreed not to, during the period commencing from the date and time at
which the Closing is actually held (the "Closing Date") and ending on (A) the 6-month anniversary of the Closing Date with
respect to 40% of the restricted securities and (B) the 36-month anniversary of the Closing Date with respect to the remaining 60% of
the restricted securities, (i) lend, offer, pledge, hypothecate, encumber, donate, assign, sell, offer to sell, contract or agree to
sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
or otherwise transfer or dispose of or agree to transfer or dispose of, directly or indirectly, or establish or increase of a put equivalent
position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act and the rules and regulations
of the SEC promulgated thereunder, or otherwise transfer or dispose of, directly or indirectly, any restricted securities, (ii) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the
Lock-up Securities (as that term is defined in the Business Combination Agreement), whether any such transaction is to be settled by
delivery of such restricted securities, in cash or otherwise, or (iii) publicly disclose the intention to do any of the foregoing, whether
any such transaction described in clauses (i), (ii) or (iii) above is to be settled by delivery of restricted securities or other securities,
in cash or otherwise (any of the foregoing described in clauses (i), (ii) or (iii), a "Prohibited Transfer") (subject to
early release if Pubco consummates a Change of Control (as that term is defined in the Business Combination Agreement)).

 F- 12

to each Seller Lock-Up Agreement, the remaining Scage shareholders agreed not to make a Prohibited Transfer during the period commencing
from the Closing Date and ending on the 6-month anniversary of the Closing Date (subject to early release if Pubco consummates a Change
of Control).

 Shareholder
Support Agreement

with the execution of the Business Combination Agreement, the Company, Scage, and Key Scage Shareholders entered into a Shareholder Support
Agreement (the "Shareholder Support Agreement"), pursuant to which, among other things, Key Scage Shareholders have agreed
(a) to support the adoption of the Business Combination Agreement and the approval of the transactions contemplated therein, subject
to certain customary conditions, and (b) not to transfer any of their subject shares (or enter into any arrangement with respect thereto),
subject to certain customary conditions.

 Sponsor
Support Agreement

with the execution of the Business Combination Agreement, the Company, Scage, Pubco and the Sponsor entered into a Sponsor Support Agreement
(the "Sponsor Support Agreement"), pursuant to which the Sponsor agreed to vote all of its shares of the Company in favor
of the Business Combination Agreement and the transactions contemplated therein. The Sponsor Support Agreement also prevents transfers
of securities of the Company held by the Sponsor between the date of the Sponsor Support Agreement and the termination of the Sponsor
Support Agreement.

 Insider
Letter Amendment

with the execution of the Business Combination Agreement, the Company, Scage, the Sponsor, Pubco, Calvin Kung, Wang Chiu Wong, Chunyi
Hao, Tiemei Li, and Sanjay Prasad entered into an amendment (the "Insider Letter Amendment") to that certain letter agreement,
dated November 8, 2021 (the "Insider Letter"), by and among the Company, the Sponsor and the directors, officers or other
initial shareholders of the Company named therein, pursuant to which Pubco and Scage are added as parties to the Insider Letter.

 Non-Competition
and Non-Solicitation Agreement

with the execution of the Business Combination Agreement, certain shareholders and officers (each, a "Subject Party") of
the Company each entered into a noncompetition and non-solicitation agreement with the Company, Pubco, Scage, and the Sponsor (collectively,
the "Non-Competition and Non-Solicitation Agreement"). Under the Non-Competition and Non-Solicitation Agreement, the Subject
Party agrees not to compete with Pubco, the Sponsor, the Company, Scage, and their respective affiliates during the three-year period
following the Closing and, during such three-year restricted period, not to solicit employees or customers of such entities. The Non-Competition
and Non-Solicitation Agreement also contains customary confidentiality and non-disparagement provisions.

 Assignment,
Assumption, and Amendment to Warrant Agreement

 Prior
to the Closing, the Company, Pubco and Continental, as warrant agent (the "Warrant Agent"), will enter the Assignment, Assumption,
and Amendment to Warrant Agreement (the "Warrant Amendment"), which will amend that certain Warrant Agreement, dated as of
November 8, 2021, relating to the Company warrants (the "Warrant Agreement"), filed with the SEC on November 8, 2021. Pursuant
to the Warrant Amendment: (i) Pubco will assume the obligations of the Company under the Warrant Agreement, such that, among other things,
Pubco will be added as a party thereto and (ii) references to the Company's Class A Ordinary Shares in the Warrant Agreement shall
mean Pubco ordinary shares.

 F- 13

 Risks
and Uncertainties

 Our
results of operations and our ability to complete an initial Business Combination may be adversely affected by various factors that could
cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted
by, among other things, downturns in the financial markets or in economic conditions, increases in oil prices, inflation, increases in
interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic,
including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflicts in Ukraine and
the Middle East. We cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude
or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.

 Management
is currently evaluating the impact of such risks and has concluded that while it is reasonably possible that they could have a negative
effect on the Company's financial position, results of its operations, close of the IPO and/or search for a target company, the
specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.

 NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 Basis
of Presentation

 The
accompanying financial statements of the Company is presented in U.S. dollars in conformity with accounting principles generally accepted
in the United States of America ("GAAP") and pursuant to the rules and regulations of the SEC. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are
necessary to present fairly the financial position, and the results of its operations and its cash flows.

 Emerging
Growth Company

 The
Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously
approved.

 Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.

 F- 14

 Use
of Estimates

 The
preparation of financial statements in conformity with GAAP requires the Company's management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period.

 Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.

 Cash
and Cash Equivalents

 The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had cash of $ 37 and $ 244,179 as of December 31, 2023 and 2022, respectively.

Held in Trust Account

 As
of December 31, 2023 and 2022, the assets held in the Trust Account consisted of $ 51,200,344 and $ 178,531,059, respectively. The Company's
portfolio of investments is comprised of investments in money market funds that invest in U.S. government securities and generally have
a readily determinable fair value. The investments in money market funds are presented on the balance sheet at fair value at the end
of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments
held in the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account
are determined using available market information.

 Concentration
of Credit Risk

 Financial
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $ 250,000. As of December 31, 2023, the Company has not experienced
losses on this account and management believes the Company is not exposed to significant risks on such account.

 Offering
Costs Associated with the Initial Public Offering

 The
Company complies with the requirements of Accounting Standards Codification ("ASC") 340-10-S99-1 and SEC Staff Accounting Bulletin ("SAB") Topic 5A —
"Expenses of Offering". Offering costs consist principally of professional and registration fees incurred through the balance
sheet date that are related to the IPO. Offering costs were charged to Shareholder's Equity upon the completion of the IPO and
subsequent exercise of the over-allotment. Accordingly, following the IPO on November 8, 2021 and subsequent exercise of the over-allotment
on November 12, 2021, offering costs totaling $ 4,171,912 (consisting of $ 3,450,000 of underwriting fee, and $ 721,912 of other offering
costs) have been charged to Shareholders' Equity.

 Fair
Value Measurements

 The
fair value of the Company's assets and liabilities which qualify as financial instruments under ASC 820, "Fair Value Measurements
and Disclosures," approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term
nature.

 F- 15

 The
fair value of the Company's financial assets and liabilities reflects management's estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:

 Level

 —

 Valuations
 based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.
 Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and
 regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

 Level

 —

 Valuations
 based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active
 for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived
 principally from or corroborated by market through correlation or other means.

 Level

 —

 Valuations
 based on inputs that are unobservable and significant to the overall fair value measurement.

 Class
A Ordinary Shares Subject to Possible Redemption

 The Company accounts for its
Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities
from Equity" ("ASC 480"). Ordinary shares subject to mandatory redemption are classified as a liability instrument and
are measured at fair value. Conditionally redeemable Class A Ordinary Shares and Class B Ordinary Shares (collectively, "Ordinary
Shares") (including Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to
redemption upon the occurrence of uncertain events not solely within the Company's control) is classified as temporary equity. At
all other times, Ordinary Shares are classified as shareholder's equity. The Company's Class A Ordinary Shares feature certain
redemption rights that are considered to be outside of the Company's control and subject to occurrence of uncertain future events.
Accordingly, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of
the shareholder's equity section of the Company's balance sheet.

 Immediately
upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount. Increases or decreases
in the carrying amount of redeemable Ordinary Shares are affected by charges against additional paid-in capital and accumulated deficit.

 As
a result of the shareholder vote held on May 8, 2023, 12,626,668 shareholders exercised their right to redemption which left a remainder
of 4,623,332 Class A Ordinary Shares subject to possible redemption. These shareholders were paid an aggregate of $ 132,616,922, or $ 10.50
per share, on May 18, 2023.

 As
of December 31, 2023 and 2022, the Class A Ordinary Shares subject to possible redemption reflected in the balance sheet is reconciled
in the following table:

 SCHEDULE
OF POSSIBLE REDEMPTION

 December 31, 2023

 December 31, 2022

 As of beginning of the period

 $

 $
 175,950,000

 Plus:

 -

 -

 Remeasurement of carrying value to redemption value

 4,486,207

 2,581,059

 Extension Contributions

 800,000

 -

 Less:

 Redemptions of Class A ordinary shares subject to possible redemption

 ( 132,616,922
)

 -

 $

 $

 F- 16

 Warrants

 The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant's
specific terms and applicable authoritative guidance in ASC 480
and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition
of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including
whether the warrants are indexed to the Company's own Ordinary Shares and whether the warrant holders could potentially require
"net cash settlement" in a circumstance outside of the Company's control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.

 For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of the criteria for equity
classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet
date thereafter. The Company accounts for its outstanding warrants as equity-classified instruments.

 Income
Taxes

 The
Company follows the asset and liability method of accounting for income taxes under ASC 740, "Income Taxes" ("ASC
740"). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to
differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases.
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when
necessary, to reduce deferred tax assets to the amount expected to be realized.

 ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2023
and 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material
deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 There
is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations,
income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company's unaudited condensed financial
statements. The Company's management does not expect that the total amount of unrecognized tax benefits will materially change
over the next twelve months.

 Net
Income Per Ordinary Share

 The Company complies with accounting
and disclosure requirements of the Financial Accounting Standards Board's ("FASB") ASC Topic 260, Earnings Per Share.
Net income per share is computed by dividing net income by the weighted average number of Ordinary Shares outstanding during the period.
The Company has two classes of shares, redeemable Ordinary Shares and non-redeemable Ordinary Shares. The Company's redeemable Ordinary
Shares are comprised of Class A shares sold in the IPO. The Company's non-redeemable shares are comprised of Class A shares held
by EarlyBirdCapital and Class B shares purchased by the Sponsor which were converted into Class A shares with their original legend in
May 2023. Earnings and losses are shared pro rata between the two classes of shares. The Company's statement of operations applies
the two-class method in calculating net income per share. Basic and diluted net income per share for redeemable Ordinary Shares and non-redeemable
Ordinary Shares is calculated by dividing net income, allocated proportionally to each class of Ordinary Shares, attributable to the Company
by the weighted average number of shares of redeemable and non-redeemable Ordinary Shares outstanding.

 F- 17

 The
calculation of diluted income per ordinary share does not consider the effect of the rights issued in connection with the IPO since exercise
of the rights is contingent upon the occurrence of future events and the inclusion of such rights would be anti-dilutive. Accretion of
the carrying value of Class A Ordinary Shares to redemption value is excluded from net income per redeemable share because the redemption
value approximates fair value. As a result, diluted income per share is the same as basic loss per share for the period presented.

 Accordingly,
basic and diluted income per ordinary share for the years ended December 31, 2023 and 2022 is calculated as follows:

 SCHEDULE
OF BASIC AND DILUTED LOSS PER ORDINARY SHARE

 Non-Redeemable

 Non-Redeemable

 For the Year ended

 For the Year ended

 December 31, 2023

 December 31, 2022

 Non-Redeemable

 Non-Redeemable

 Basic and diluted net income per share:

 Numerator:

 Allocation of net income

 $
 1,666,806

 $
 828,103

 $
 890,032

 $
 220,590

 Denominator:

 Weighted-average shares outstanding

 8,982,127

 4,462,500

 17,400,000

 Basic and diluted net income per share

 $
 0.19

 $
 0.19

 $
 0.05

 $
 0.05

 Recent
Accounting Standards

 In
August 2020, the FASB issued ASU No. 2020-06, "Accounting for Convertible Instruments and Contracts in an Entity's Own Equity" ("ASU 2020-06"). The
update simplifies the accounting for convertible instruments by removing certain separation models in Subtopic 470-20, Debt—Debt
with Conversion and Other Options for convertible instruments and introducing other changes. As a result of ASU No. 2020-06, more convertible
debt instruments will be accounted for as a single liability measured at its amortized cost and more convertible preference shares will
be accounted for as a single equity instrument measured at its historical cost, as long as no features require bifurcation and recognition
as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including
interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15,
2020, including interim periods within those fiscal years. The Company is currently assessing what impact, if any, that ASU 2020-06 would
have on its financial position, results of operations or cash flows.

 In
June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820 "Fair Value Measurement of Equity Securities Subject to Contractual Sale
Restrictions". The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity
security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that
are measured at fair value. The ASU applies to both holders and issuers of equity and Equity-Linked Securities measured at fair value.
The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within
those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made
available for issuance. The Company is currently assessing what impact, if any, that ASU 2022-03 would have on its financial position,
results of operations or cash flows.

 In
December 2023, the FASB issued ASU No 2023-09, Income Taxes (Topic 740) — Improvements to Income Tax Disclosures ("ASU 2023-09")
in order to enhance the transparency and usefulness of income tax disclosures. The guidance is applicable to all entities subject to
income tax, and it will require disclosure of certain categories within the rate reconciliation to improve consistency as well as disclosure
of reconciling items which meet a certain quantitative threshold which will improve transparency. Additionally, entities must disclose
the amount of taxes paid to federal, state and foreign municipalities. For public business entities ASU 2023-09 is effective for annual
periods beginning after December 15, 2024. The Company is currently evaluating the impact of its pending adoption of ASU 2023-09 on its financial position, results of operations or financial statement disclosure.

 Management
does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material
effect on the Company's financial statements.

 F- 18

 NOTE
3 – INITIAL PUBLIC OFFERING

 On
November 8, 2021, the Company completed its IPO of 15,000,000 Units at a price of $ 10.00 per Unit. The Company granted the underwriter
a 45-day option from the date of the IPO to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the IPO price
less the underwriting discounts and commissions. On November 12, 2021, the Company closed on the underwriters' full exercise of
their over-allotment option which resulted in the sale of an additional 2,250,000 Units. The IPO and subsequent over-allotment exercise
generated gross proceeds of $ 172,500,000.

 Each
Unit consists of one share of Class A Ordinary Shares and three-quarters of one redeemable Public Warrant. Each whole Public Warrant
entitles the holder thereof to purchase one share of Class A Ordinary Shares at a price of $ 11.50 per share, subject to adjustment (see
Note 8).

 Following
the closing of the IPO on November 8, 2021, and subsequent exercise of the over-allotment an aggregate of $ 175,950,000 ($ 10.20 per Unit)
from the net proceeds of the sale of the Units and the sale of the Private Placement Warrants in the IPO and over-allotment exercise
was deposited into the Trust Account. As of December 31, 2023, the net proceeds deposited into the Trust Account are invested in U.S.
government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or
less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a- 7 of the
Investment Company Act, as determined by the Company.

 NOTE
4 – PRIVATE PLACEMENT WARRANTS

 The
Sponsor and EarlyBirdCapital agreed to purchase an aggregate of 7,900,000 Private Placement Warrants ( 7,400,000 bought by the Sponsor,
and 500,000 bought by EarlyBirdCapital) at a price of $ 1.00 per Private Placement Warrant in a private placement that occurred simultaneously
with the closing of the IPO. Simultaneously with the closing of the sale of the Over-Allotment Units on November 12, 2021, the Company
completed an additional private sale of an aggregate of 900,000 warrants (the "Additional Private Placement Warrants") to
the Sponsor, which purchased 843,038 such warrants, and the underwriter, which purchased 56,962 such warrants. As a result of the IPO
and subsequent over-allotment exercise, an aggregate of 8,800,000 Private Placement Warrants were sold ( 8,243,038 to the Sponsor and
 556,962 to EarlyBirdCapital) for gross proceeds of $ 8,800,000.

 Each
whole Private Placement Warrant is exercisable for one whole share of Class A Ordinary Shares at a price of $ 11.50 per share. A portion
of the proceeds from the sale of the Private Placement Warrants to the Sponsor have been added to the proceeds from the IPO to be held
in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale
of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the
requirements of applicable law), and the Private Placement Warrants will expire worthless.

 NOTE
5 – RELATED PARTY TRANSACTIONS

 Founder

 In
March 2021, the Sponsor paid $ 25,000 (approximately $ 0.006 per share) in consideration for 4,312,500 shares of Class B Ordinary Shares
with par value of $ 0.0001. Up to 562,500 of these Founder Shares were subject to forfeiture by the Sponsor if the underwriter's
over-allotment option was not exercised, so that the number of Founder Shares will collectively represent approximately 20 % of the Company's
issued and outstanding shares after the IPO. On November 12, 2021 the underwriter fully exercised the over- allotment option which resulted
in the 562,500 shares no longer being subject to forfeiture.

 F- 19

 The
Sponsor and the Company's directors and executive officers have agreed, subject to certain limited exceptions, not to transfer,
assign or sell any of the Founder Shares until the earlier of (A) one year after the completion of a Business Combination and (B) subsequent
to a Business Combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $ 12.00 per share (as
adjusted for share splits, share reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period
commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share
exchange, reorganization or other similar transaction that results in all of the Company's shareholders having the right to exchange
their shares of Class A Ordinary Shares for cash, securities or other property.

 On
May 8, 2023, the Company issued an aggregate of 4,237,499 (the "Sponsor Shares") of the Company's Class A Ordinary
Shares to the Sponsor upon the conversion of an equal number of shares of Class B Ordinary Shares (the "Sponsor Conversion").
Combined with the Director Share conversion discussed below, the Sponsor Conversion left 1 Class B ordinary share outstanding. These
Sponsor Shares continue to hold the same legend as they did prior to their conversion. Accordingly, these shares are accounted for as
Class A Ordinary Shares at their par value.

 EarlyBirdCapital
Founder Shares

 In
March 2021, the Company issued to EarlyBirdCapital and its designees an aggregate of 150,000 Class A Ordinary Shares ("EBC Founder
Shares") at a price of $ 0.0001 per share. The Company estimated the fair value of the EBC Founder Shares to be $ 870 based upon
the price of the Founder Shares issued to the Sponsor. The holders of the EBC Founder Shares have agreed not to transfer, assign or sell
any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their conversion rights
(or right to participate in any tender offer) with respect to such shares in connection with the completion of a Business Combination
and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to
complete a Business Combination within the Combination Period.

 The
EBC Founder Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately
following the effective date of the registration statement related to the IPO pursuant to FINRA Rule 5110(e)(1). Pursuant to FINRA Rule
5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result
in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the
registration statements related to the IPO, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180
days immediately following the effective date of the registration statements related to the IPO except to any underwriter and selected
dealer participating in the IPO and their officers or partners, associated persons or affiliates.

 In
October 2021, the Sponsor transferred 75,000 Founder Shares to the independent directors ("Director Shares") at a price of
$ 0.0001 per share. The Company estimated the fair value of the Director Shares to be $ 450,676 based upon the price of the Founder Shares
issued to the Sponsor.

 On
May 8, 2023, the Company issued an aggregate of 75,000 Class A Ordinary Shares (together with the Sponsor Shares, the "Converted
Class A Ordinary Shares") to the Directors and the holders of the Company's 75,000 Class B Ordinary Shares upon the conversion
of an equal number of shares of Class B Ordinary Shares (together with the Sponsor Conversion, the "Conversion"). On the
same day, in connection with the closing of the Sunorange Investment, 61,875 of the Converted
Class A Ordinary Shares held by the Directors were transferred to designees of Sunorange.

 The
conversion of these Director Shares from Class B to Class A was not the result of a Business Combination, and the Company has previously
recognized $ 450,676 in expenses related to these Director Shares. As such, these shares will continue to be held at their book value.

 F- 20

 Related
Party Loans

 In
March 2021, the Sponsor issued an unsecured Promissory Note to the Company, pursuant to which the Company was permitted to borrow an
aggregate principal amount of $ 250,000. The Promissory Note was non-interest bearing, and the Promissory Note was fully repaid as of
November 8, 2021, upon the closing of the IPO.

 In
addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor
or an affiliate of the Sponsor may, but is not obligated to, provide the Company with Working Capital Loans. Any such loans would be
on an interest-free basis. If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the
proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a
portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would
be used to repay the Working Capital Loans. At the lender's discretion, up to $ 1,500,000 of such Working Capital Loans may be convertible
into warrants of the post-Business Combination entity at a price of $ 1.00 per warrant. The warrants would be identical to the Private
Placement Warrants. On May 8, 2023, in connection with the Sunorange Investment, the outstanding balance under the existing Promissory
Note was forgiven. This was deemed to be a benefit to the Company under SAB Topic 5T. In order to recognize this benefit, the Company
de-recognized the outstanding Promissory Note and reclassified it to additional paid-in capital, as an in-substance capital contribution.
As of December 31, 2023 and 2022, the Company had $ 0 and $ 449,765 of outstanding borrowings under the Working Capital Loan, respectively.

 On
June 2, 2023, the Company issued the June 2023 Promissory Note in the aggregate principal amount of up to $ 1,200,000 to the Sponsor,
which will be deposited into the Trust Account for the benefit of each Public Share that was not redeemed in connection with the Company's
May 8, 2023 shareholder vote to approve the Extension. The Sponsor agreed to pay $ 100,000 per month until the completion of an initial
Business Combination, commencing on May 8, 2023 and continuing through May 8, 2024. The June 2023 Promissory Note bears no interest and
is due and payable upon the earlier to occur of (i) the date on which the Company consummates its Business Combination and (ii) the date
that the winding up of the Company is effective. At the election of the Sponsor, up to $ 1,200,000 of the unpaid principal amount of the
June 2023 Promissory Note may be converted into Conversion Warrants at a conversion price of $ 1.00 per warrant. The Conversion Warrants
shall be identical to the Placement Warrants issued by the Company at the IPO. The Company has determined that the fair value of the
June 2023 Promissory Note is its face value as the note was not issued with a substantial premium. The Sponsor funded the first three
months of the June 2023 Promissory Note in its first payment. As of December 31, 2023, the Sponsor had deposited an aggregate of $ 800,000
in payments to support the Extension on behalf of the Company. As of December 31, 2023, the outstanding balance of the June 2023 Promissory
Note was $ 800,000, and no interest was accrued.

 On
November 8, 2023, the Company issued the November 2023 Promissory Note the amount
of $ 1,500,000 to Sunorange Investment. The November 2023 Promissory Note is non-interest bearing and is due at the earlier of consummation
of the Business Combination or liquidation. Prior to the November 2023 Promissory Note being in place, related parties
were making advances to the Company and on behalf of the Company for the purposes of paying its vendors. All advances made by the related
parties between May 8, 2023 and the date of execution are retroactively covered by the November 2023 Promissory Note. As of December
31, 2023, $ 542,503 was outstanding under the November 2023 Promissory Note.

 Administrative
Services Agreement

 Commencing
on the date that the Company's securities are first listed on a U.S. national securities exchange, the Company has committed to
pay a total of $ 3,000 per month to the Sponsor for office space, utilities and administrative support services. This administrative service
arrangement will terminate upon completion of the Business Combination or liquidation of the Company. As of December 31, 2023 the Company
has accrued $ 56,600 under the agreement in Due to related party and expensed $ 36,000 in Formation, general and administrative expenses.

 F- 21

 NOTE
6 — INVESTMENTS HELD IN TRUST ACCOUNT

 As
of December 31, 2023, investments in the Company's Trust Account consisted of $ 51,200,344 in an interest-bearing demand deposit
account. The following tables present information about the Company's assets that are measured at fair value on a recurring basis
at December 31, 2023 and 2022:

 SCHEDULE
OF ASSETS MEASURED AT FAIR VALUE ON RECURRING BASIS

 December 31,
 2023

 Quoted Prices
 in Active
 Markets
 (Level 1)

 Significant
 Other
 Observable
 Inputs
 (Level 2)

 Significant
 Other
 Observable
 Inputs
 (Level 3)

 Cash in demand deposit account

 $

 $

 $
 -

 $
 -

 $

 $

 $
 -

 $
 -

 December 31,
 2022

 Quoted Prices
 in Active
 Markets
 (Level 1)

 Significant
 Other
 Observable
 Inputs
 (Level 2)

 Significant
 Other
 Observable
 Inputs
 (Level 3)

 Money market fund

 $

 $

 $
 -

 $
 -

 $

 $

 $
 -

 $
 -

 NOTE
7 – COMMITMENTS AND CONTINGENCIES

 Registration
Rights

 The
holders of the Founder Shares and Private Placement Warrants (and any shares of Class A Ordinary Shares issuable upon the exercise of
the Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans and upon conversion of the
Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the
IPO, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to shares
of Class A Ordinary Shares). The holders of these securities will be entitled to make up to three demands, excluding short form demands,
that the Company register such securities. In addition, the holders will have certain "piggy-back" registration rights with
respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to
register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides
that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the
applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 Underwriting
Agreement

 The
Company granted the underwriter a 45-day option from the date of the IPO to purchase up to 2,250,000 additional Units to cover over-allotments,
if any, at the IPO price less the underwriting discounts and commissions. The underwriter fully exercised this option which closed subsequent
to the IPO.

 EarlyBirdCapital
earned an underwriting discount of $ 0.20 per Unit, or $ 3,450,000 in the aggregate, upon the closing of the IPO and subsequent exercise
of the full over-allotment option.

 Business
Combination Marketing Agreement

 The
Company has engaged EarlyBirdCapital as an advisor in connection with the Business Combination to assist in holding meetings with shareholders
to discuss the potential Business Combination and the target business' attributes, introduce the Company to potential investors
that are interested in purchasing securities in connection with the Business Combination, assist in obtaining shareholder approval for
the Business Combination and assist with press releases and public filings in connection with the Business Combination. The Company will
pay EarlyBirdCapital a cash fee for such services solely in the event of consummation of the Business Combination in an amount equal
to 1.75 %, or $ 3,018,750) of the gross proceeds of the IPO (exclusive of any applicable finders' fees which might become payable).
This fee will become payable to EarlyBirdCapital upon consummation of the Business Combination. No liability will be recorded for such
fee until it becomes probable that the fee will be paid.

 Consulting
Agreement

 The
Company has engaged a third-party consultant to provide the Company with assistance in various aspects of any potential Business Combination.
Pursuant to the terms of the agreement, the Company has agreed to pay a contingent fee of at least $ 3,500,000 if the Company consummates
a Business Combination. No expense has been recorded in the financial statements related to this agreement. No expense has been recorded in the financial statements related to this agreement, nor is any due.

 F- 22

 On
August 29, 2023, the Company engaged a third-party consultant to provide the Company with an introduction to potential targets for its
Business Combination. Pursuant to the terms of the agreement, the Company has agreed to pay a contingent fee of 0.5 % of the implied enterprise
value of the target if the Company consummates a Business Combination. As the Business Combination is not considered probable, no expense
has been recorded in the financial statements related to this agreement.

 Legal
Agreement

 The
Company has engaged a third-party legal firm to provide the Company with assistance in various aspects of any potential Business Combination.
Pursuant to the terms of the agreement, the Company has agreed to contingent payments upon the achievement of certain milestones. As
of December 31, 2023, the Company has incurred and paid roughly $ 20,000 related to this agreement. An additional $ 90,000 could be earned
by the legal firm as outlined in the contractual milestones. The remaining milestones are not yet considered probable and as such have
not been accrued for.

 NOTE
8 – SHAREHOLDERS' DEFICIT

 Preference
Shares — The Company is authorized to issue 5,000,000 preference shares, with a par value of $ 0.0001 per share, with such designations,
voting and other rights and preferences as may be determined from time to time by the Company's Board of Directors. As of December
31, 2023 and 2022, there were no preference shares issued or outstanding.

 Class
A Ordinary Shares — The Company is authorized to issue 500,000,000 shares of Class A Ordinary Shares with a par value of $ 0.0001
per share. Holders of Class A Ordinary Shares are entitled to one vote for each share. As of December 31, 2023 and 2022, there were 4,462,499
and 150,000 shares of Class A Ordinary Shares issued and outstanding (excluding 4,623,332 and 17,250,000 shares subject to possible redemption),
respectively.

 Class
B Ordinary Shares — The Company is authorized to issue 50,000,000 shares of Class B Ordinary Shares with a par value of $ 0.0001
per share. As of December 31, 2023 and 2022, there were 1 and 4,312,500 shares of Class B Ordinary Shares issued and outstanding, respectively.

 Holders
of Class A Ordinary Shares and Class B Ordinary Shares will vote together as a single class on all matters submitted to a vote of shareholders
except as required by law. Under the terms of the Sunorange Investment, the Class B Ordinary Shares were converted to Class A Ordinary Shares although the Sponsor will retain at least one Class B ordinary share.

 Any
Founder Shares outstanding at the time of the Business Combination will automatically convert into shares of Class A Ordinary Shares
on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A Ordinary Shares, or Equity-Linked Securities,
are issued or deemed issued in excess of the amounts offered in the IPO and related to the closing of a Business Combination, the ratio
at which shares of Class B Ordinary Shares shall convert into shares of Class A Ordinary Shares will be adjusted (unless the holders
of a majority of the outstanding shares of Class B Ordinary Shares agree to waive such adjustment with respect to any such issuance or
deemed issuance) so that the number of shares of Class A Ordinary Shares issuable upon conversion of all shares of Class B Ordinary Shares
will equal, in the aggregate, on an as-converted basis, 20 % of the sum of the total number of all shares of Ordinary Shares outstanding
upon the completion of the IPO plus all shares of Class A Ordinary Shares and Equity-Linked Securities issued or deemed issued in connection
with a Business Combination (excluding any shares or Equity-Linked Securities issued, or to be issued, to any seller in a Business Combination).

 F- 23

 Warrants
— Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation
of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 12 months from the closing
of the IPO and (b) 30 days after the completion of a Business Combination.

 The Company will not be obligated
to deliver any shares of Class A Ordinary Shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant
exercise unless a registration statement under the Securities Act with respect to the shares of Class A Ordinary Shares underlying the
warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect
to registration, or a valid exemption from registration is available. No warrant will be exercisable, and the Company will not be obligated
to issue any shares of Class A Ordinary Shares upon exercise of a warrant unless the share of Class A Ordinary Shares issuable upon such
warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered
holder of the warrants.

 The Company has agreed that as
soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially
reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class
A Ordinary Shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same
to become effective within 60 business days after the closing of a Business Combination, and to maintain the effectiveness of such registration
statement and a current prospectus relating to those shares of Class A Ordinary Shares until the warrants expire or are redeemed, as specified
in the warrant agreement; provided that if the Class A Ordinary Shares is at the time of any exercise of a warrant not listed on a national
securities exchange such that they satisfy the definition of a "covered security" under Section 18(b)(1) of the Securities
Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a "cashless basis"
in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to
file or maintain in effect a registration statement, but it will use its commercially reasonably efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the shares of Class A
Ordinary Shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of a Business Combination, warrant
holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to
maintain an effective registration statement, exercise warrants on a "cashless basis" in accordance with Section 3(a)(9) of
the Securities Act or another exemption, but the Company will use its commercially reasonably efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available.

 Redemption
of warrants. Once the warrants become exercisable, the Company may redeem the Public Warrants:

 in
 whole and not in part;

 at
 a price of $ 0.01 per warrant;

 upon
 not less than 30 days' prior written notice of redemption to each warrant holder; and

 if,
 and only if, the closing price of the Class A Ordinary Shares equals or exceeds $18.00 per share for any 20 trading days within a
 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.

 If
and when the Public Warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to
register or qualify the underlying securities for sale under all applicable state securities laws.

 In
addition, if (x) the Company issues additional Class A Ordinary Shares or Equity-Linked Securities for capital raising purposes in connection
with the closing of the Business Combination at a Newly Issued Price of less than $9.20 per Class A ordinary share, (y) the aggregate
gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding
of our Business Combination on the date of the consummation of the Business Combination (net of redemptions), and (z) the Market Value
is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater
of (i) the Market Value or (ii) the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest
cent) to be equal to 180% of the greater of (i) the Market Value or (ii) the Newly Issued Price.

 The
Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the IPO.

 F- 24

 NOTE
9 – SUBSEQUENT EVENTS

 The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review the Company did not identify any subsequent events, other than those described below, that would
have required adjustment or disclosure in the financial statements.

 In
each of the months of January, February and March, $ 100,000, for an aggregate of $ 300,000, was deposited into the Trust Account in connection
with the agreement to extend the date by which the Company must complete an initial Business Combination to May 8, 2024.

 On January 22, 2024, the Company
received a deficiency notice (the "Notice") from the Listing Qualifications Department (the "Staff") of Nasdaq
notifying the Company that it was not in compliance with Nasdaq Listing Rule 5620(a), which requires that Nasdaq-listed companies hold
an annual meeting of shareholders within twelve months of their fiscal year end (the "Annual Meeting Requirement"), because
the Company did not hold an annual meeting of shareholders within twelve months of its fiscal year ended December 31, 2022. The notification
received had no immediate effect on the Company's Nasdaq listing. In accordance with Nasdaq rules, the Company had 45 calendar days,
or until March 7, 2024, to submit a plan to regain compliance with the Annual Meeting Requirement. On March 7, 2024, the Company submitted
the plan of compliance to Nasdaq, pursuant to which the Company requested an extension through June 28, 2024, by which date the Company
must regain compliance with the Annual Meeting Requirement.

 On
January 26, 2024, the Company issued an unsecured promissory note in the aggregate principal amount of up to $1,500,000 to Scage, a
party to the Business Combination Agreement entered into by the Company, Scage, and other parties on August 21, 2023, for the
Company's working capital needs. The 2024 Promissory Note does not bear interest and matures upon the earlier of the closing
of an initial Business Combination by the Company and the Company's liquidation.

 F- 25

 EXHIBIT

 Exhibit
 No.

 Description

 1.1

 Underwriting Agreement, dated November 3, 2021, by and between the Company and EarlyBirdCapital, Inc., as underwriter. (2)

 1.2

 Business Combination Marketing Agreement, dated November 8, 2021, by and between the Company and EarlyBirdCapital, as advisor. (2)

 2.1

 Business Combination Agreement, dated as of August 21, 2023, by and among the Company, Scage, First Merger Sub, Second Merger Sub and Pubco. (7)+

 3.1

 Amended and Restated Memorandum and Articles of Association. (2)

 3.2

 First Amendment to the Amended and Restated Memorandum and Articles of Association. (5)

 4.1

 Specimen Unit Certificate. (1)

 4.2

 Specimen Class A Ordinary Share Certificate. (1)

 4.3

 Specimen Warrant Certificate. (1)

 4.4

 Warrant Agreement, dated November 8, 2021,by and between the Company and Continental, as warrant agent. (2)

 4.5

 Description of Registered Securities.(3)

 10.1

 Promissory Note, dated March 21, 2021, issued to the Sponsor. (1)

 10.2

 Amendment to Promissory Note, dated September 30, 2021, issued to the Sponsor. (1)

 10.3

 Form of Indemnity Agreement. (1)

 10.4

 Letter Agreement, dated November 8, 2021, by and among the Company, its prior officers and directors and the Sponsor. (2)

 10.5

 Investment Management Trust Agreement, dated November 8, 2021, by and between the Company and Continental, as trustee.(2)

 10.6

 Registration Rights Agreement, dated November 8, 2021, by and between the Company and certain security holders. (2)

 10.7

 Administrative Services Agreement, dated November 8, 2021, between the Company and the Sponsor.(2)

 10.8

 Private Warrants Purchase Agreement, dated November 8, 2021, by and between the Company and the Sponsor.(2)

 10.9

 Private Warrants Purchase Agreement, dated November 8, 2021, by and between the Company and EarlyBirdCapital.(2)

 10.10

 Investment Agreement, dated as of April 27, 2023, by and among the Company, the Sponsor and Sunorange. (4)

 10.11

 Promissory Note, dated June 2, 2023, issued to Sunorange. (6)

 10.12

 Joinder to Insider Letter, dated June 2, 2023, by and among the Company, its current officers and directors and Sunorange. (6)

 10.13

 Form of Key Seller Lock-Up Agreement, dated as of August 21, 2023, by and among Scage, Pubco, the Company and certain key shareholders of Scage. (7)

 10.14

 Form of Seller Lock-Up Agreement, by and among cage, Pubco, the Company and certain shareholders of Scage. (7)

 10.15

 Form of Shareholder Support Agreement, dated as of August 21, 2023, by and among the Company, Scage and certain key shareholders of Scage. (7) +

 10.16

 Sponsor Support Agreement, dated as of August 21, 2023, by and among the Company, the Sponsor, Scage and Pubco. (7).

 10.17

 Insider Letter Amendment, dated as of August 21, 2023, by and among the Company, the Sponsor, Scage, Pubco and the Company's current officers and directors. (7)

 10.18

 Form of Non-Competition and Non-Solicitation Agreement, dated as of August 21, 2023, by and among Scage, Pubco, the Company, the Sponsor and certain shareholders of Scage. (7)

 10.19

 Form of Assignment, Assumption and Amendment to Warrant Agreement to be entered into by and among the Company, Pubco and Continental. (7)

 10.20

 Promissory Note, dated November 8, 2023, issued to Sunorange. (8)

 10.21

 Code of Ethics.*

 31.1

 Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 31.2

 Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 32.1

 Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 32.2

 Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 Policy Related to Recovery of Erroneously Awarded Compensation, adopted November 30, 2023.*

 99.1

 Amended Audit Committee Charter.*

 99.2

 Amended Compensation Committee Charter.*

 101.INS

 101.SCH

 101.CAL

 101.DEF

 101.LAB

 101.PRE

 Cover

 *

 Filed
 herewith.

 **

 Furnished
 herewith.

 +

 The
 exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Company agrees to
 furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 (1)

 by reference to the Company's Registration Statement on Form S-1 (File No. 333-260261), filed with the SEC on October 15, 2021.

 (2)

 by reference to the Company's Current Report on Form 8-K, filed with the SEC on November 8, 2021.

 (3)

 by reference to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on
 April 12, 2022.

 (4)

 by reference to the Company's Current Report on Form 8-K, filed with the SEC on May 3, 2023.

 (5)

 by reference to the Company's Current Report on Form 8-K/A, filed with the SEC on May 24, 2023.

 (6)

 by reference to the Company's Current Report on Form 8-K, filed with the SEC on June 5, 2023.

 (7)

 by reference to the Company's Current Report on Form 8-K, filed with the SEC on August 25, 2023.

 (8)

 by reference to the Company's Current Report on Form 8-K, filed with the SEC on February 1, 2024.

 SIGNATURES

 Pursuant to the requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.

 April

 Finnovate
 Acquisition Corp

 By:

 /s/
 Calvin Kung

 Name:

 Calvin
 Kung

 Title:

 Chairman
 and Chief Executive Officer

 Pursuant to the requirements of
the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the
capacities and on the dates indicated.

 Name

 Position

 Date

 /s/
 Calvin Kung

 Chairman
 and Chief Executive Officer

 April

 Calvin
 Kung

 (Principal
 Executive Officer)

 /s/
 Wang Chiu (Tommy) Wong

 Chief
 Financial Officer and Director

 April

 Wang
 Chiu (Tommy) Wong

 (Principal
 Financial and Accounting Officer)

 /s/
 Chunyi (Charlie) Hao

 April

 Chunyi
 (Charlie) Hao

 /s/
 Tiemei (Sarah) Li

 April

 Tiemei
 (Sarah) Li

 /s/
 Sanjay Prasad

 April

 Sanjay
 Prasad